Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AC005324.3 ENSG00000251537 17 15571491-15651653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 23.3;tongue: 21.1;vagina: 17.9" "Group enriched" "Detected in some" 11 "Club cells: 1.2;Pancreatic endocrine cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.6;HeLa: 3.1;OE19: 2.2" "HPA023623, HPA066431" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (3.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (2.48e-1)" "unprognostic (1.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.87e-3)" "unprognostic (1.93e-1)" "unprognostic (2.98e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (6.35e-3)" "unprognostic (1.80e-11)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (5.30e-2)" "unprognostic (3.09e-1)" 7.5 2.8 0.9 1.5 1.0 1.0 7.7 0.9 1.0 5.3 2.2 1.3 0.0 2.1 0.7 1.5 23.3 0.8 4.0 2.6 0.8 0.9 0.9 1.0 2.1 1.6 3.7 0.0 0.7 1.0 0.8 0.7 12.4 2.7 1.4 0.9 0.2 2.4 1.1 2.9 4.4 1.6 2.1 1.5 1.0 2.8 1.8 1.0 1.6 1.8 21.1 17.5 3.2 17.9 0.6 0.6 0.0 0.1 0.0 0.5 0.0 0.6 3.5 0.1 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 3.1 0.1 0.1 1.0 0.0 6.6 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.4 1.0 0.0 0.0 0.6 0.4 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.3 0.9 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.9 1.0 0.8 0.9 3.7 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.0 0.5 0.0 0.1 0.1 0.0 1.9 0.3 0.0 7.0 1.0 0.1 0.0 0.0 1.0 0.0 15.8 0.9 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.9 0.2 1.9 1.2 0.0 1.8 0.0 0.4 30.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 17.8 14.0 2.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 8.7 0.0 13.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.0 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 3.3 0.2 0.0 0.0 0.0 3.0 9.6 0.1 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 16.0 AKR1B10 "AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI" ENSG00000198074 "Aldo-keto reductase family 1 member B10" O60218 7 134527592-134541408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41.5;intestine: 99.7;stomach 1: 68.6" "Group enriched" "Detected in many" 5 "Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4" "Cancer enhanced" "Detected in many" "liver cancer: 353.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 99 "A549: 217.4;Hep G2: 60.3;OE19: 227.4" "HPA020280, CAB070163, HPA073633" Enhanced Supported "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 68000000 Cytosol "Plasma membrane" "CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (1.29e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.91e-4)" "unprognostic (6.03e-2)" "unprognostic (4.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.16e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (4.80e-9)" "unprognostic (2.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" 0.6 0.8 0.6 2.2 0.6 0.0 0.6 0.6 0.6 13.1 11.5 0.6 0.6 99.7 0.6 0.9 41.5 0.0 28.9 0.6 0.6 0.0 4.0 6.3 2.0 0.6 0.6 0.6 0.6 0.6 0.0 2.5 0.6 0.6 2.0 7.3 1.3 6.1 0.6 0.6 1.0 54.1 7.1 0.6 0.6 68.6 0.8 0.6 0.9 0.7 28.6 3.6 16.3 22.9 0.4 0.1 1.8 0.2 0.4 0.2 0.1 0.0 217.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 60.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 227.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.2 1.8 0.4 0.1 0.1 0.1 0.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.0 0.0 0.5 1.9 2.5 0.0 0.4 275.2 5.3 1.2 0.0 0.0 0.2 0.0 21.5 0.3 0.0 221.4 23.3 23.1 0.1 0.1 0.3 0.0 31.6 0.0 0.0 3.4 3.7 1.6 0.4 3.1 0.0 0.0 1.0 11.7 0.0 89.4 24.6 1.8 1.4 0.0 0.0 0.9 0.0 0.0 9.2 0.2 0.0 41.3 5.2 ALDH3A1 ALDH3 ENSG00000108602 "Aldehyde dehydrogenase 3 family member A1" P30838 17 19737984-19748943 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "pons and medulla: 1.8" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 22 "A549: 261.5;OE19: 326.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB045957, HPA051150, HPA063783" Enhanced Supported "Nucleoplasm,Vesicles,Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "Nucleoplasm, Vesicles" "CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122" "unprognostic (3.11e-5)" "unprognostic (1.20e-2)" "unprognostic (1.08e-1)" "unprognostic (7.04e-3)" "unprognostic (4.36e-3)" "prognostic favorable (7.55e-5)" "unprognostic (3.12e-1)" "unprognostic (3.84e-1)" "unprognostic (2.10e-1)" "unprognostic (1.67e-1)" "unprognostic (2.69e-3)" "unprognostic (5.54e-2)" "unprognostic (1.72e-1)" "unprognostic (3.84e-2)" "unprognostic (1.83e-1)" "unprognostic (2.88e-2)" "unprognostic (7.23e-2)" 0.7 0.1 0.2 0.8 0.4 0.0 0.5 0.2 0.3 1.3 0.9 0.8 0.3 1.3 0.2 0.4 88.2 1.2 3.8 0.2 0.4 0.0 0.4 0.4 26.0 0.2 0.2 0.3 0.6 0.2 0.0 0.3 0.2 1.8 0.5 0.6 0.5 26.7 0.3 0.4 16.2 0.6 0.3 0.3 0.3 49.9 0.3 0.2 0.2 0.2 106.6 70.3 1.6 3.9 1.1 0.3 0.0 0.0 2.4 0.7 0.1 0.0 261.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 13.1 0.0 0.1 0.0 0.1 1.5 0.0 0.6 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 326.9 1.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.3 1.1 0.0 0.7 0.0 2.4 0.0 0.0 0.0 0.1 0.2 0.4 0.2 0.3 0.4 0.0 0.2 0.3 1.8 0.2 3.0 5.6 0.0 23.3 39.2 0.0 0.4 2.5 100.4 55.7 0.0 0.0 0.0 0.0 0.8 1.3 0.4 3.3 0.0 0.4 0.0 0.6 2.6 2.3 0.0 0.2 0.0 1.7 0.6 0.8 1.9 0.9 1.1 0.0 0.0 4.2 1.9 5.8 5.9 1.8 4.4 0.1 0.0 0.3 0.7 7.3 28.0 0.0 0.0 7.5 32.1 ALDH3B2 ALDH8 ENSG00000132746 "Aldehyde dehydrogenase 3 family member B2" P48448 11 67662162-67681200 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "breast: 28.1;esophagus: 48.2;lymphoid tissue: 34.2;skin 1: 38.7" "Cell type enhanced" "Detected in some" 10 "Collecting duct cells: 5.2;Cytotrophoblasts: 8.5;Extravillous trophoblasts: 8.0;Suprabasal keratinocytes: 12.9;Syncytiotrophoblasts: 12.2;Urothelial cells: 6.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "MCF7: 31.6;SK-BR-3: 32.7" "Not detected" "Not detected" HPA045132 Approved NA NA "HPA045132: AB_10795993" "unprognostic (2.25e-1)" "unprognostic (2.41e-1)" "unprognostic (1.65e-1)" "unprognostic (8.65e-2)" "unprognostic (2.13e-1)" "unprognostic (6.09e-2)" "unprognostic (3.12e-2)" "unprognostic (6.32e-2)" "unprognostic (1.48e-1)" "unprognostic (5.56e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-2)" "unprognostic (2.59e-2)" "unprognostic (1.61e-1)" "unprognostic (1.15e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 28.1 0.1 0.1 6.7 0.1 0.1 5.0 0.0 1.5 2.4 48.2 1.5 0.1 0.1 0.1 0.0 0.6 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.6 0.3 11.2 0.1 1.8 0.0 0.1 17.1 4.6 0.1 38.7 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.8 0.1 25.7 34.2 4.6 11.6 1.0 0.1 0.6 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.5 1.8 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.6 2.6 0.0 0.0 4.3 0.0 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 32.7 0.0 0.2 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.9 0.0 1.5 1.4 0.0 0.3 0.0 0.0 0.0 5.2 0.0 8.5 1.7 0.3 0.0 0.0 0.0 0.0 0.2 8.0 0.4 1.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 12.2 0.0 0.0 6.2 ALOX12 12S-LOX ENSG00000108839 "Arachidonate 12-lipoxygenase, 12S type" P18054 17 6996065-7010736 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Hydrolase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 28.6;esophagus: 28.4;tongue: 22.7;vagina: 42.7" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 1.8;Suprabasal keratinocytes: 1.0;Urothelial cells: 1.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.8" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "A-431: 17.5;HEL: 28.0" "Region enriched" "Detected in single" 5 "olfactory region: 5.4" "HPA010691, CAB019287, HPA064819" Enhanced Supported "Nuclear speckles,Vesicles,Cytosol" NA NA 5800000 Cytosol "Nuclear speckles, Vesicles" "CAB019287: , HPA010691: AB_1844756, HPA064819: " "unprognostic (3.61e-3)" "unprognostic (6.93e-2)" "unprognostic (7.17e-5)" "unprognostic (9.43e-2)" "unprognostic (6.06e-2)" "unprognostic (2.25e-3)" "unprognostic (2.45e-1)" "unprognostic (3.16e-1)" "unprognostic (3.02e-2)" "unprognostic (1.59e-2)" "unprognostic (3.96e-5)" "unprognostic (4.01e-3)" "unprognostic (2.25e-2)" "unprognostic (1.56e-1)" "unprognostic (2.87e-1)" "unprognostic (5.90e-2)" "unprognostic (3.47e-2)" 0.3 0.6 0.3 1.5 0.4 2.0 0.3 0.3 1.0 28.6 0.4 0.3 0.3 0.7 3.4 0.5 28.4 0.4 1.6 0.8 0.3 0.1 0.3 0.3 0.5 1.9 0.5 0.3 0.4 0.8 0.0 0.3 0.7 0.4 0.3 0.0 0.4 8.1 0.3 0.5 12.8 0.8 0.3 0.3 1.5 0.3 0.6 0.3 0.3 0.8 22.7 9.5 1.2 42.7 1.1 1.3 4.8 0.9 0.7 0.8 14.3 17.5 2.9 1.3 1.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 2.6 0.6 0.9 0.6 0.0 1.0 2.2 0.0 0.1 0.0 1.9 2.3 28.0 3.9 1.9 0.1 0.2 4.6 0.0 0.0 0.0 0.0 1.7 0.0 1.9 1.8 1.0 0.0 0.2 0.3 0.6 0.9 0.1 0.6 1.0 0.6 0.4 0.0 2.2 0.1 0.6 0.5 0.6 0.2 1.8 1.0 0.7 3.2 1.5 0.9 1.5 0.7 0.5 0.2 0.5 0.9 2.1 0.7 1.8 0.9 1.7 0.7 0.5 0.5 1.1 0.5 0.8 0.7 0.7 0.2 0.4 4.8 0.7 0.4 1.3 0.3 14.3 0.3 0.4 0.3 0.6 0.3 0.1 0.5 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 1.7 ALOX15B 15-LOX-2 ENSG00000179593 "Arachidonate 15-lipoxygenase, type B" O15296 17 8039017-8049134 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9" "Cell type enhanced" "Detected in many" 26 "Alveolar cells type 2: 58.0;Kupffer cells: 33.3;monocytes: 149.7" "Cancer enhanced" "Detected in all" "prostate cancer: 91.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 6.1;myeloid DC: 6.8" "Group enriched" "Detected in many" 9 "dendritic cells: 6.8;monocytes: 6.1" "Cell line enhanced" "Detected in some" "HHSteC: 6.1;HSkMC: 13.0;hTCEpi: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA010562 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA010562: AB_2668305" "unprognostic (1.76e-2)" "unprognostic (6.47e-2)" "unprognostic (2.56e-1)" "unprognostic (2.28e-3)" "unprognostic (1.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.59e-1)" "unprognostic (1.59e-2)" "unprognostic (9.37e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.49e-2)" 8.9 0.6 0.4 0.7 0.6 0.3 57.4 0.1 0.4 7.6 4.6 0.1 0.0 0.2 0.3 0.7 30.6 0.8 0.5 0.2 1.3 0.0 2.9 0.7 44.0 7.1 1.8 0.3 0.8 0.8 0.2 0.9 0.7 1.3 35.9 0.3 0.1 3.6 0.2 0.3 15.4 1.9 0.2 4.1 3.1 1.6 1.0 2.0 0.5 0.8 6.6 4.1 1.1 12.9 0.0 6.8 0.2 6.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 13.0 26.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.7 0.0 0.2 0.0 1.7 0.4 0.6 0.1 0.4 1.3 0.0 1.8 0.3 1.3 2.0 0.0 58.0 0.0 0.5 2.7 0.0 0.3 2.5 2.7 2.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 16.8 1.1 0.0 4.1 0.0 0.0 1.3 33.3 0.0 0.0 1.9 5.0 149.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 1.0 0.7 0.0 0.0 1.8 ANXA1 "ANX1, LPC1" ENSG00000135046 "Annexin A1" P04083 9 73151757-73170393 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Phospholipase A2 inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 432.6;tongue: 235.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA011271, HPA011272, CAB013023, CAB035987, CAB058693" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA Yes 77000000 "Plasma membrane, Cytosol" Nucleoplasm "CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884" "unprognostic (2.53e-2)" "unprognostic (1.31e-1)" "unprognostic (9.08e-2)" "prognostic favorable (5.71e-5)" "unprognostic (1.53e-2)" "unprognostic (4.28e-2)" "unprognostic (1.82e-2)" "unprognostic (1.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.54e-3)" "unprognostic (1.47e-1)" "unprognostic (9.82e-3)" "unprognostic (1.13e-1)" "unprognostic (8.55e-2)" "prognostic favorable (4.57e-5)" "prognostic unfavorable (6.19e-6)" 52.7 3.5 2.7 11.5 3.3 81.4 45.9 0.9 2.5 61.5 8.5 3.6 5.5 2.4 6.9 11.2 432.6 11.9 14.9 8.9 3.2 2.5 9.1 2.1 37.3 7.6 4.3 1.9 11.7 2.4 0.5 6.3 149.5 13.5 12.9 4.4 6.4 93.0 7.2 7.9 11.6 6.4 12.3 6.5 5.9 5.9 5.6 3.1 3.9 21.7 235.4 153.3 18.0 83.1 0.7 98.9 146.2 79.1 27.3 52.5 102.8 66.2 104.7 4.7 4.9 66.8 63.6 0.3 114.8 71.8 47.5 32.2 3.0 59.9 0.1 38.0 100.1 105.0 81.6 10.1 69.5 37.7 37.5 0.7 5.1 31.1 0.1 53.3 11.0 2.5 36.6 57.6 48.0 94.4 44.0 67.3 6.0 21.0 2.8 58.5 0.2 19.5 6.0 5.9 26.5 42.6 0.0 26.7 0.2 106.8 14.0 0.0 0.0 39.5 1.0 26.5 65.5 0.2 1.7 83.1 55.7 35.1 76.5 58.9 0.4 0.1 0.2 128.7 10.3 83.8 146.2 79.1 141.1 52.2 21.5 52.5 0.7 47.0 45.9 98.9 0.2 13.7 25.4 8.6 27.3 19.3 3.5 8.3 102.8 2.7 3.3 0.9 2.5 3.2 2.5 4.3 1.9 13.5 3.1 541.9 512.9 7.3 2232.0 752.1 0.0 11.9 17.8 1060.0 889.5 59.3 0.0 1215.0 0.0 156.6 6.3 398.1 0.8 0.0 20.0 1352.9 735.1 1709.3 2387.0 2.5 570.9 0.0 5.1 113.5 449.6 2.3 206.0 1058.5 291.8 475.3 1.8 0.2 431.7 0.0 8.9 3.1 0.0 64.7 275.6 0.7 2.9 522.6 5914.0 282.4 0.5 4139.3 ANXA8L1 "ANXA8L2, bA145E20.2, bA301J7.3" ENSG00000264230 "Annexin A8 like 1" Q5VT79 10 46375627-46391784 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.9;skin 1: 75.4;tongue: 34.2" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 26.8;Cholangiocytes: 17.8;Ciliated cells: 20.1;Club cells: 36.4;Extravillous trophoblasts: 14.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 3.2;myeloid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 5.0;monocytes: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 72.8;HBEC3-KT: 110.8;hTCEpi: 29.4;SiHa: 26.2" "HPA045246, HPA047451" Approved Nucleoplasm NA NA Nucleoplasm "HPA045246: AB_2679271, HPA047451: AB_2680052" "unprognostic (3.67e-3)" "unprognostic (4.56e-3)" "unprognostic (9.14e-3)" "unprognostic (3.92e-2)" "unprognostic (1.63e-1)" "unprognostic (1.64e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-2)" "unprognostic (8.05e-2)" "unprognostic (6.94e-3)" "unprognostic (8.33e-5)" "unprognostic (3.43e-1)" "unprognostic (8.26e-10)" "unprognostic (1.39e-1)" "unprognostic (1.95e-1)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 4.8 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.7 1.2 35.9 1.2 0.0 0.9 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.4 0.0 0.9 0.0 0.0 1.1 0.7 0.0 75.4 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 34.2 13.3 6.9 0.6 0.0 5.0 0.8 3.2 0.5 0.0 0.5 14.5 3.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.0 0.0 0.3 2.6 0.0 0.1 0.0 0.1 72.8 0.0 110.8 0.0 6.2 0.0 0.0 7.1 0.0 2.6 0.0 0.1 0.0 29.4 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 16.9 0.0 0.0 26.2 2.3 0.0 1.4 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 26.8 1.4 0.0 3.1 0.0 0.0 3.0 17.8 20.1 36.4 0.0 0.0 7.2 0.0 0.7 0.1 0.0 2.0 0.0 0.2 14.1 0.8 1.7 0.0 0.0 0.6 0.0 0.0 0.6 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.1 5.6 0.3 0.0 0.0 0.0 12.9 0.0 0.2 1.0 1.0 5.3 0.0 0.1 3.0 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Group enriched" "Detected in many" 6 "Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Cell line enhanced" "Detected in many" "HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014924: AB_2669120" "unprognostic (4.29e-2)" "prognostic favorable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.6 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 0.1 28.1 1.3 0.1 0.0 13.4 1.3 0.9 51.2 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.0 0.1 28.8 14.3 13.0 1.5 6.2 12.8 5.0 1.1 19.2 0.1 0.2 21.3 2.3 0.2 47.6 0.4 1.1 7.1 32.9 0.0 1.9 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.1 44.2 3.2 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 35.7 265.4 2.2 608.6 1708.5 1.4 2.1 104.4 136.5 215.0 1526.7 2.0 0.6 0.0 27.2 1.3 40.5 4.2 93.5 41.7 1.3 46.3 959.6 19.7 111.7 2.2 0.0 7.9 16.0 3.8 0.0 30.8 32.1 150.1 1.0 63.7 0.3 32.0 2.9 1.1 28.8 0.4 0.0 42.2 0.0 1.0 2172.4 42.0 43.3 3.5 2008.6 ARNTL2 "bHLHe6, BMAL2, CLIF, MOP9, PASD9" ENSG00000029153 "Aryl hydrocarbon receptor nuclear translocator like 2" Q8WYA1 12 27332854-27425289 "Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.0" "Cell type enhanced" "Detected in many" 15 "Glandular cells: 33.6;Pancreatic endocrine cells: 57.8;Urothelial cells: 126.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 35.3;U-2197: 48.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059074 Uncertain Supported Nucleoplasm,Nucleoli No No "Nucleoplasm, Nucleoli" "HPA059074: AB_2683897" "unprognostic (6.86e-2)" "unprognostic (6.16e-2)" "unprognostic (5.88e-3)" "unprognostic (1.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.34e-1)" "unprognostic (2.84e-3)" "unprognostic (2.97e-3)" "unprognostic (1.49e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (5.29e-6)" "unprognostic (5.26e-2)" "prognostic unfavorable (1.56e-5)" "unprognostic (7.81e-3)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (2.79e-1)" 3.5 1.3 5.7 9.8 5.9 2.2 3.3 3.6 10.6 6.8 3.1 1.1 0.0 2.9 1.5 0.5 30.0 1.5 3.9 1.9 9.1 2.8 1.6 10.3 2.7 5.0 2.1 6.8 0.9 2.3 2.4 1.5 14.7 2.6 1.9 3.5 0.0 9.2 0.9 1.0 7.7 2.8 4.7 2.0 1.2 10.9 2.8 1.3 3.8 1.2 15.4 21.1 5.9 12.5 0.6 1.4 4.5 0.5 0.5 1.5 0.2 21.9 5.6 1.2 0.4 1.1 3.4 17.7 7.8 10.3 5.1 8.0 5.3 17.1 0.2 4.4 3.7 15.8 9.1 3.6 27.4 13.1 35.3 4.7 4.2 3.7 4.4 1.5 8.5 1.8 1.2 2.4 17.8 14.0 8.8 23.9 5.3 2.1 9.0 5.8 2.6 4.6 4.6 9.7 7.5 19.7 8.6 20.7 1.3 4.3 12.6 4.1 0.7 4.0 0.6 0.1 3.1 0.8 2.8 16.2 16.6 9.6 48.3 32.2 1.3 2.4 0.0 14.3 6.9 3.2 4.5 0.5 0.5 0.2 0.3 0.2 0.5 0.2 0.2 1.4 0.6 0.2 0.3 2.4 0.5 0.2 0.3 1.5 0.2 5.7 5.9 3.6 10.6 9.1 2.8 2.1 6.8 2.6 1.3 3.0 2.2 0.0 32.7 0.7 1.1 0.8 17.8 0.0 7.9 8.7 0.0 1.3 0.0 22.0 3.3 4.2 0.7 0.0 23.8 3.5 2.3 33.6 0.0 4.2 1.3 0.0 1.2 3.1 2.8 3.0 0.0 5.0 1.7 26.2 2.7 0.0 57.8 0.0 0.0 0.6 0.0 0.0 2.1 3.4 4.9 1.9 3.5 0.0 0.6 126.8 B3GNT8 "B3GALT7, beta3Gn-T8, BGALT15" ENSG00000177191 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8" Q7Z7M8 19 41425359-41428730 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.3;esophagus: 21.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 39.9;Collecting duct cells: 22.7;Enterocytes: 42.4;Paneth cells: 46.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 29.9;neutrophil: 43.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 43.3" "Cell line enhanced" "Detected in some" "HMC-1: 10.0;HUVEC TERT2: 5.4;K-562: 4.4;THP-1: 5.0;U-937: 8.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA043669 Enhanced "Intracellular and membrane" NA NA 43000000 "HPA043669: AB_2678608" "unprognostic (6.89e-2)" "unprognostic (2.46e-1)" "unprognostic (2.98e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (6.44e-3)" "unprognostic (6.51e-3)" "unprognostic (1.84e-2)" "unprognostic (9.92e-3)" "unprognostic (7.30e-2)" "unprognostic (2.56e-2)" "prognostic favorable (9.31e-6)" "unprognostic (5.04e-2)" "unprognostic (2.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" 0.7 0.2 0.0 0.9 0.0 2.7 0.7 0.0 0.0 5.0 7.3 13.0 0.9 0.0 21.5 0.4 0.0 1.9 0.0 0.0 1.5 0.0 4.6 0.1 0.0 0.0 0.6 0.0 0.6 0.1 1.3 2.0 2.8 2.2 0.1 2.2 12.5 0.3 0.0 4.3 1.0 0.0 0.3 0.9 1.2 8.4 0.0 1.6 43.3 6.7 0.4 8.1 1.7 0.3 0.0 0.3 0.1 0.5 2.2 0.5 0.6 0.2 0.0 0.1 3.1 0.0 0.1 0.8 1.5 0.0 2.1 0.0 0.5 0.0 0.1 0.4 0.0 0.1 1.6 0.8 0.7 10.0 2.7 1.9 0.1 0.1 0.0 5.4 0.2 4.4 0.3 0.0 0.8 0.0 2.9 0.7 0.0 0.1 0.2 0.6 0.0 0.2 1.1 1.4 0.9 0.0 0.2 0.0 0.3 0.0 5.0 1.9 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.2 8.1 0.0 21.7 4.3 29.9 0.7 3.3 8.1 0.0 0.3 1.5 1.6 0.0 0.0 0.1 43.3 0.4 6.7 0.1 0.1 1.7 6.0 39.9 0.0 4.4 1.5 0.2 0.4 0.0 1.4 1.2 22.7 0.0 0.5 3.3 4.6 0.0 1.0 42.4 0.0 0.6 1.9 2.3 5.7 4.7 0.0 10.9 0.0 14.5 1.8 9.1 0.0 1.4 3.2 0.0 1.8 19.3 0.0 2.2 46.0 0.7 0.0 0.2 0.0 1.4 0.0 0.0 1.5 1.9 1.3 13.6 11.3 BICDL2 CCDC64B ENSG00000162069 "BICD family like cargo adaptor 2" A1A5D9 16 3027682-3036926 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.1;pancreas: 54.1" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 11.9;Alveolar cells type 2: 19.4;Ciliated cells: 22.7;Club cells: 22.7;Collecting duct cells: 15.7;Ductal cells: 27.6;Exocrine glandular cells: 43.8;Pancreatic endocrine cells: 34.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "eosinophil: 2.6;neutrophil: 3.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "A-431: 6.5;BEWO: 11.5;CAPAN-2: 10.6;HaCaT: 16.5;MCF7: 16.0;RT4: 7.6;SK-BR-3: 8.2;T-47d: 10.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA043251 Approved Approved "Intermediate filaments,Actin filaments,Cytosol" No NA "Intermediate filaments, Actin filaments, Cytosol" "HPA043251: AB_10794925" "unprognostic (2.00e-1)" "unprognostic (5.37e-2)" "unprognostic (1.71e-1)" "unprognostic (6.06e-3)" "unprognostic (9.65e-5)" "unprognostic (5.79e-3)" "unprognostic (6.47e-2)" "unprognostic (1.75e-2)" "unprognostic (2.45e-1)" "unprognostic (1.66e-2)" "unprognostic (2.05e-2)" "unprognostic (4.71e-2)" "unprognostic (8.56e-2)" "unprognostic (2.55e-2)" "unprognostic (2.38e-1)" "unprognostic (4.32e-2)" "prognostic favorable (9.04e-4)" 0.4 0.0 0.4 2.5 0.4 0.0 2.9 0.4 0.4 6.2 7.9 0.4 8.3 5.7 1.0 2.0 31.1 2.2 11.0 0.4 0.4 0.0 1.2 0.4 5.3 0.4 0.4 0.4 0.9 54.1 3.6 0.9 0.5 0.4 5.1 3.5 0.4 13.9 8.3 1.1 13.7 6.9 1.0 0.4 0.4 10.2 0.5 0.4 0.4 2.3 8.6 12.4 6.1 12.0 0.1 0.1 3.5 0.0 0.2 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.9 10.6 0.0 0.0 0.0 0.0 16.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.1 0.0 4.6 0.0 0.1 0.0 0.2 0.0 7.6 0.1 0.0 0.0 8.2 0.0 0.2 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.5 0.2 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 11.9 19.4 0.0 0.0 0.0 0.0 0.0 0.0 22.7 22.7 15.7 0.0 4.0 3.3 27.6 0.0 0.0 0.0 0.0 43.8 3.8 0.0 0.0 2.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 34.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 BNC1 "BNC, HsT19447" ENSG00000169594 "Basonuclin 1" Q01954 15 83255903-83284714 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Disease mutation, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 13.4;testis: 27.5;tongue: 20.2" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 78.8;Early spermatids: 37.3;Late spermatids: 74.8;Suprabasal keratinocytes: 51.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 16.3;HBEC3-KT: 37.1;hTCEpi: 41.7;hTERT-HME1: 40.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063183, HPA066947, HPA077428" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345" "unprognostic (1.86e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (5.55e-2)" "unprognostic (4.06e-2)" "unprognostic (2.47e-2)" "unprognostic (2.45e-2)" "unprognostic (7.91e-2)" "unprognostic (8.89e-4)" "unprognostic (6.94e-2)" "unprognostic (4.13e-1)" "unprognostic (3.85e-3)" "unprognostic (8.46e-3)" "unprognostic (2.20e-1)" "unprognostic (2.95e-3)" "unprognostic (1.01e-2)" 12.7 0.1 0.0 1.6 0.1 0.0 0.9 0.0 0.4 2.7 1.5 0.1 0.0 0.0 0.4 10.8 13.4 0.8 0.1 1.4 0.1 0.0 0.1 0.1 0.7 1.3 0.2 0.2 0.6 0.0 0.0 0.0 1.9 0.5 0.4 0.0 0.7 1.7 0.2 0.1 7.9 0.2 0.3 0.3 0.1 0.0 27.5 0.0 6.0 0.2 20.2 3.7 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 1.4 2.1 0.0 0.6 0.1 7.1 10.0 0.0 0.1 0.0 0.3 4.3 0.0 16.3 0.8 37.1 12.9 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 1.8 41.7 6.3 40.7 1.5 6.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 3.7 0.0 0.0 4.8 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.2 0.2 0.5 0.0 0.0 0.0 0.0 9.7 78.8 0.0 0.4 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 37.3 0.5 0.0 0.0 0.0 0.0 2.4 0.6 0.0 0.0 0.1 0.0 0.0 1.3 0.0 74.8 0.6 0.5 8.5 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 16.3 5.9 51.1 0.0 0.0 0.0 4.6 BNIPL "BNIP-S, BNIP-Salpha, BNIP-Sbeta, BNIPl-1, BNIPL-2, PP753" ENSG00000163141 "BCL2 interacting protein like" Q7Z465 1 151036570-151047600 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.5;skin 1: 68.6" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 14.9;Suprabasal keratinocytes: 49.9;Urothelial cells: 20.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "T-47d: 33.1" "Group enriched" "Detected in some" 9 "basal ganglia: 1.4;cerebellum: 2.7" "Low region specificity" "Detected in some" HPA019946 Uncertain Cytosol NA NA Cytosol "HPA019946: AB_2732424" "unprognostic (2.62e-1)" "unprognostic (7.59e-3)" "unprognostic (3.63e-3)" "prognostic unfavorable (6.50e-4)" "unprognostic (6.58e-2)" "unprognostic (2.82e-2)" "unprognostic (3.32e-3)" "unprognostic (3.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.45e-1)" "unprognostic (3.88e-4)" "unprognostic (1.91e-1)" "unprognostic (8.43e-11)" "unprognostic (1.84e-2)" "unprognostic (6.49e-2)" "prognostic favorable (4.32e-4)" "unprognostic (6.81e-2)" 0.1 0.1 0.2 0.1 0.2 0.3 6.4 0.2 0.2 9.7 0.1 0.1 9.4 0.1 0.6 0.6 42.5 1.0 0.1 0.2 0.2 0.0 0.5 0.2 6.5 0.2 0.1 0.1 0.2 0.1 0.0 0.1 3.2 0.1 3.4 0.1 0.3 7.1 21.0 0.7 68.6 0.2 0.8 0.1 0.1 0.6 1.0 0.1 0.2 2.7 25.8 23.2 5.0 18.2 1.8 0.8 3.2 0.6 0.5 1.7 0.4 0.3 0.2 0.5 0.6 0.3 0.3 0.6 0.3 0.0 0.2 0.1 1.1 0.4 0.6 0.5 0.0 0.1 1.3 0.7 0.2 0.4 0.8 0.8 0.9 0.5 0.2 0.1 0.5 0.6 0.0 2.4 0.1 0.2 0.9 0.0 0.9 0.5 0.5 0.2 1.5 0.6 0.9 0.5 0.7 0.4 0.3 0.2 0.3 0.5 0.3 1.1 0.5 0.4 0.7 0.2 1.9 33.1 0.2 0.7 0.7 0.4 0.2 0.1 1.5 1.1 3.1 0.0 0.2 0.6 2.7 0.6 0.7 1.7 0.6 1.4 0.5 1.0 1.2 0.3 1.8 1.0 0.6 3.2 0.5 0.6 0.8 0.6 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.1 14.9 12.1 0.0 5.4 13.6 0.4 0.3 0.0 9.4 10.3 10.4 0.0 1.5 0.0 0.0 5.9 0.3 0.4 0.0 0.0 0.3 1.3 6.2 0.0 0.0 0.3 0.0 0.0 3.7 1.2 0.9 0.9 0.8 3.3 0.0 0.1 0.5 0.0 0.0 0.0 0.3 1.4 0.0 0.2 0.5 0.1 49.9 2.2 0.8 0.2 20.9 BX255925.3 ENSG00000284976 9 137217452-137219361 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 30.6;pancreas: 25.2" "Cell type enhanced" "Detected in some" 15 "Exocrine glandular cells: 21.2;Pancreatic endocrine cells: 23.6;Proximal tubular cells: 6.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA 0.6 3.0 0.4 1.6 0.3 5.0 1.2 0.3 0.8 3.8 7.1 0.3 0.8 5.3 0.6 3.5 30.6 1.1 12.4 2.1 0.3 1.7 1.2 1.5 2.3 0.3 0.3 0.5 25.2 0.7 0.3 1.5 0.3 3.1 0.5 0.3 14.6 1.4 1.1 6.2 8.9 0.9 0.3 1.9 7.0 15.0 0.3 0.3 0.5 15.0 15.1 1.0 0.3 1.8 4.9 3.7 2.3 2.0 2.9 5.6 5.5 9.1 5.4 7.0 2.5 2.5 21.2 6.5 3.5 6.8 4.9 8.4 6.4 8.1 4.6 2.3 5.1 20.2 3.4 4.7 1.5 8.9 9.5 4.7 21.5 7.5 4.2 6.9 15.8 3.3 4.4 7.7 2.1 1.8 3.1 7.9 11.5 6.9 2.3 15.5 6.1 20.0 9.3 12.6 31.6 15.5 7.3 9.4 2.9 5.5 7.0 8.0 5.8 7.1 5.0 2.0 18.3 10.9 3.7 10.5 12.0 16.9 8.0 5.5 9.3 7.0 6.0 8.0 7.8 0.0 1.9 3.7 1.8 2.3 2.9 1.5 1.4 1.1 1.2 1.8 0.8 0.8 3.3 2.0 1.2 4.9 1.4 5.6 6.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.2 3.5 0.0 0.0 5.0 5.3 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 23.6 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C10orf99 "AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833" ENSG00000188373 "Chromosome 10 open reading frame 99" Q6UWK7 10 84173738-84185294 "Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Cytokine" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1" "Group enriched" "Detected in some" 11 "Enterocytes: 485.1;Mucus-secreting cells: 220.7;Paneth cells: 599.4;Undifferentiated cells: 289.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 32.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA050920 Enhanced "Secreted in other tissues" NA NA "HPA050920: AB_2681274" "unprognostic (3.13e-2)" "unprognostic (1.43e-1)" "unprognostic (6.04e-2)" "unprognostic (1.78e-2)" "unprognostic (7.46e-3)" "unprognostic (2.05e-1)" "unprognostic (7.98e-2)" "unprognostic (2.04e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (1.20e-5)" "unprognostic (3.70e-1)" "unprognostic (4.67e-2)" 0.1 0.0 0.0 48.4 0.0 0.0 0.1 0.0 0.1 22.5 63.5 0.0 0.2 0.0 2.6 0.0 93.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.7 66.0 0.0 5.9 0.7 0.0 8.8 5.4 3.5 0.0 0.0 0.0 0.1 0.0 0.3 0.0 95.1 21.6 17.0 26.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 485.1 0.0 0.0 0.0 0.0 0.6 4.6 0.0 0.0 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 220.7 0.0 0.0 599.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 289.2 36.8 C15orf62 LOC643338 ENSG00000188277 "Chromosome 15 open reading frame 62" A8K5M9 15 40770080-40772449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.8;lymphoid tissue: 21.9;tongue: 18.8" "Group enriched" "Detected in some" 5 "Basal glandular cells: 2.8;Glandular cells: 4.5;Horizontal cells: 3.2;Urothelial cells: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 20.0;SK-BR-3: 6.4" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Low region specificity" "Detected in all" HPA044636 Approved NA NA "HPA044636: AB_10794052" "unprognostic (9.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.06e-1)" "unprognostic (2.22e-2)" "unprognostic (2.52e-1)" "unprognostic (2.83e-2)" "unprognostic (5.56e-2)" "unprognostic (2.24e-2)" "unprognostic (5.37e-3)" "unprognostic (7.68e-3)" "unprognostic (1.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "unprognostic (3.40e-1)" 1.5 0.9 0.8 1.5 1.1 1.5 1.1 4.0 1.7 1.7 1.0 0.8 0.8 2.0 1.1 0.8 22.8 0.9 1.4 0.8 0.8 0.6 0.9 1.9 1.6 2.1 1.1 0.8 1.3 0.9 0.0 1.3 0.8 0.9 1.1 0.0 0.8 5.4 1.8 1.9 11.9 1.8 0.8 0.8 1.5 1.2 0.9 0.8 1.8 1.0 18.8 21.9 0.9 3.8 0.4 0.7 0.0 0.1 0.4 1.0 0.1 0.6 0.5 1.8 2.3 0.7 0.2 0.4 0.8 0.2 0.1 0.2 2.0 2.5 1.1 2.0 0.0 1.6 4.5 0.8 0.0 0.0 1.6 1.9 1.1 4.1 0.6 0.0 0.9 1.4 0.2 1.0 0.0 0.1 2.0 0.6 0.8 0.9 1.4 0.0 0.5 1.4 1.8 0.7 3.0 0.8 1.6 0.3 0.6 20.0 1.7 4.0 1.0 0.6 6.4 0.2 0.7 2.2 1.5 0.9 2.2 1.0 2.0 0.7 1.6 1.0 1.0 0.7 3.3 0.8 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.9 0.6 0.0 0.4 1.0 1.0 0.0 0.4 0.0 0.7 0.8 0.1 0.8 1.1 4.0 0.9 0.8 0.6 1.1 0.8 0.9 0.8 0.0 0.0 0.0 2.8 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.5 0.0 0.5 0.2 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.3 8.8 C19orf33 "H2RSP, IMUP, IMUP-1, IMUP-2" ENSG00000167644 "Chromosome 19 open reading frame 33" Q9GZP8 19 38304161-38305009 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 105.8;tongue: 78.5" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1588.2;Exocrine glandular cells: 683.1;Mucus-secreting cells: 800.2;Pancreatic endocrine cells: 1532.5;Paneth cells: 1006.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 11 "myeloid DC: 15.1" "Lineage enriched" "Detected in many" 11 "dendritic cells: 15.1" "Cell line enhanced" "Detected in some" "A-431: 70.1;A549: 108.2;CAPAN-2: 66.8;HBEC3-KT: 64.8;hTCEpi: 67.9;OE19: 57.5;PC-3: 61.8" "HPA054406, HPA059696" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" No No "Nucleoplasm, Cytosol" "Plasma membrane" "HPA054406: AB_2682478, HPA059696: AB_2684105" "unprognostic (9.31e-2)" "unprognostic (2.06e-1)" "unprognostic (4.34e-2)" "unprognostic (1.44e-2)" "unprognostic (3.92e-3)" "unprognostic (2.37e-2)" "unprognostic (9.49e-2)" "prognostic unfavorable (5.42e-4)" "unprognostic (2.09e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (5.05e-4)" "unprognostic (6.92e-2)" "unprognostic (5.50e-2)" "unprognostic (4.82e-2)" "unprognostic (1.61e-1)" "unprognostic (3.63e-2)" "unprognostic (6.01e-2)" 6.9 0.6 0.5 16.4 0.7 0.3 5.0 0.5 0.8 14.5 58.8 0.6 3.5 34.6 3.9 4.3 88.4 18.2 45.2 9.9 0.8 0.3 5.8 1.0 34.8 0.6 0.7 1.4 4.9 0.8 0.0 2.0 10.0 1.7 10.3 18.2 1.2 21.5 6.8 2.8 53.3 105.8 2.9 3.1 1.9 28.7 1.5 0.5 1.5 4.4 78.5 39.2 16.2 35.1 0.1 15.1 1.4 0.6 0.3 0.4 14.6 70.1 108.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 66.8 0.0 40.1 0.0 0.0 26.3 0.0 64.8 0.0 0.0 0.0 0.0 22.7 1.8 0.5 0.0 0.0 0.0 67.9 0.0 43.6 0.1 1.1 0.0 0.0 0.0 0.0 18.1 0.0 0.1 0.1 57.5 61.8 0.0 0.0 0.0 41.0 20.8 0.1 0.0 41.0 29.7 0.0 0.1 9.2 0.2 14.6 0.0 20.4 0.0 0.3 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.6 1.4 0.3 0.0 0.3 0.1 0.2 0.1 15.1 0.1 0.4 0.3 0.9 0.3 0.0 0.9 0.0 14.6 0.5 0.7 0.5 0.8 0.8 0.3 0.7 1.4 1.7 0.5 497.3 155.5 7.0 25.1 200.2 0.0 1.4 298.1 195.4 353.8 52.4 0.0 5.2 1.7 144.5 0.4 9.8 1588.2 0.0 683.1 1.0 5.6 22.7 39.1 0.0 1.3 0.0 73.3 4.9 1.6 2.8 3.7 8.2 1.7 4.6 800.2 0.0 1532.5 1006.5 0.0 21.6 0.0 0.0 5.0 1.4 1.9 304.5 2.6 0.0 506.3 112.5 C1orf116 "FLJ36507, MGC2742, MGC4309, SARG" ENSG00000182795 "Chromosome 1 open reading frame 116" Q9BW04 1 207018521-207032756 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 163.8;Alveolar cells type 2: 71.9;Club cells: 78.5;Urothelial cells: 120.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.2;CAPAN-2: 32.4;HaCaT: 40.0;HBEC3-KT: 38.4;hTCEpi: 20.4;RPTEC TERT1: 18.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011888, HPA011889" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 7900 "Plasma membrane, Cytosol" "HPA011888: AB_1853872, HPA011889: AB_1853873" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.68e-1)" "unprognostic (2.35e-1)" "unprognostic (5.78e-2)" "unprognostic (3.27e-1)" "unprognostic (5.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.18e-2)" "unprognostic (2.87e-3)" "unprognostic (7.09e-3)" "prognostic favorable (1.01e-5)" "unprognostic (5.17e-1)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (1.19e-1)" 0.2 0.3 0.2 1.6 0.2 0.0 4.1 0.2 0.4 7.1 8.3 0.3 0.2 8.4 1.0 1.1 49.4 0.6 14.0 0.2 0.3 0.1 4.3 1.1 42.8 0.2 0.2 0.2 0.5 7.0 0.0 0.9 1.4 0.4 18.8 2.7 0.3 12.5 1.9 0.3 14.4 16.5 0.6 0.2 0.4 20.3 0.4 0.2 0.4 6.8 16.0 37.1 6.1 12.3 0.0 0.0 0.7 0.0 0.1 0.0 1.8 18.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.4 0.0 2.1 0.0 0.0 40.0 0.0 38.4 0.0 0.0 0.0 3.3 0.3 0.5 0.0 0.0 0.2 0.0 20.4 0.0 11.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 11.8 1.0 0.0 0.0 0.0 18.7 4.8 0.0 0.1 0.3 3.6 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.2 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.4 0.2 163.8 71.9 0.0 39.9 18.4 0.0 42.3 28.1 41.5 78.5 10.4 0.0 0.0 13.3 21.7 4.8 0.0 31.1 0.0 21.6 0.0 0.5 57.3 5.8 0.0 0.2 0.0 10.3 0.0 0.0 3.3 0.3 0.6 0.0 0.0 16.3 0.0 41.6 7.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 20.5 0.0 0.0 7.4 120.4 C2orf54 FLJ22671 ENSG00000172478 "Chromosome 2 open reading frame 54" Q08AI8 2 240886048-240896889 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 63.8;lymphoid tissue: 28.6;tongue: 35.5" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 50.6;Intestinal endocrine cells: 48.2;Paneth cells: 56.1;Suprabasal keratinocytes: 22.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "NK-cell: 3.4" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.4" "Group enriched" "Detected in some" 6 "CACO-2: 21.6;HaCaT: 16.2;SK-BR-3: 57.4" "Not detected" "Not detected" HPA052722 Approved "Nucleoplasm,Golgi apparatus" NA NA "Nucleoplasm, Golgi apparatus" "HPA052722: " "unprognostic (5.86e-3)" "unprognostic (4.17e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (2.77e-4)" "unprognostic (1.43e-2)" "unprognostic (1.33e-1)" "unprognostic (8.95e-2)" "unprognostic (1.70e-1)" "unprognostic (1.89e-2)" "unprognostic (2.83e-2)" "unprognostic (2.96e-1)" "unprognostic (2.08e-1)" "unprognostic (6.46e-2)" "unprognostic (1.55e-1)" "unprognostic (8.26e-2)" "unprognostic (2.05e-1)" 0.3 0.0 0.3 1.5 0.3 0.0 0.9 0.3 0.3 8.9 3.9 0.3 0.3 6.3 0.7 0.4 63.8 0.3 0.3 0.3 0.3 0.0 2.8 2.8 5.5 0.3 0.3 0.3 0.3 0.4 0.0 0.3 0.7 0.3 0.5 1.1 0.3 7.6 0.3 0.3 18.6 3.6 0.3 0.3 0.3 1.0 0.3 0.3 1.0 0.3 35.5 28.6 0.8 19.1 0.8 0.1 0.7 0.2 3.4 0.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 21.6 1.4 0.1 0.1 0.0 0.0 16.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 0.1 3.3 0.0 0.0 0.0 5.3 0.1 3.2 1.0 0.0 0.0 57.4 0.0 0.0 0.4 0.2 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.3 0.5 0.0 0.1 0.8 0.1 0.2 0.1 3.4 0.2 0.0 0.2 0.1 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 50.6 1.7 0.0 0.8 2.5 0.0 0.3 0.0 1.4 10.3 1.8 0.0 1.1 5.0 1.4 0.0 0.0 2.1 0.0 3.2 0.1 0.4 1.3 0.0 3.4 0.0 0.0 48.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.5 0.0 10.5 56.1 0.0 12.6 0.0 0.0 0.2 0.0 0.0 22.7 0.2 0.0 1.2 6.3 C3orf67 "FLJ42117, FLJ42930" ENSG00000163689 "Chromosome 3 open reading frame 67" Q6ZVT6 3 58717365-59050084 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 10.4;testis: 28.4" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 80.6;Late spermatids: 61.4;Spermatocytes: 27.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive B-cell: 2.2;T-reg: 2.2" "Group enriched" "Detected in many" 13 "B-cells: 2.2;T-cells: 2.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069696 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA069696: AB_2686174" "unprognostic (4.59e-1)" "unprognostic (4.63e-3)" "unprognostic (1.99e-1)" "unprognostic (4.49e-5)" "unprognostic (1.91e-1)" "unprognostic (9.33e-3)" "unprognostic (1.67e-3)" "unprognostic (3.72e-1)" "unprognostic (2.43e-1)" "unprognostic (6.68e-3)" "unprognostic (8.95e-2)" "unprognostic (6.19e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (3.06e-2)" "unprognostic (7.79e-2)" "unprognostic (2.81e-2)" 0.5 1.8 1.2 1.0 4.3 0.3 0.6 0.5 2.0 1.5 0.7 0.5 0.0 0.1 0.6 1.6 10.4 3.4 0.7 0.4 0.9 0.9 0.7 1.9 0.6 1.8 0.5 0.9 0.7 0.8 1.3 8.4 1.3 1.3 1.0 0.9 1.6 2.6 0.4 0.2 0.4 0.3 0.5 0.6 0.4 0.5 28.4 0.5 0.4 0.4 2.0 3.6 0.3 2.9 2.2 0.0 0.0 0.1 0.1 2.2 0.3 10.5 1.7 3.0 0.0 1.8 5.8 0.0 5.0 1.7 2.2 1.8 0.9 3.5 11.0 1.7 1.2 0.0 1.1 4.7 2.4 4.0 1.7 0.3 0.0 1.8 0.0 1.0 0.0 0.0 1.1 2.4 4.7 3.8 2.8 4.6 7.3 8.4 0.1 3.0 1.4 0.5 0.0 3.7 3.4 7.5 10.6 0.0 4.5 2.4 0.1 7.7 3.6 1.4 1.0 3.2 5.1 3.4 0.0 0.1 0.2 3.4 5.5 2.3 4.5 9.4 2.1 2.6 0.0 7.0 0.0 0.1 0.0 0.2 0.0 0.0 1.7 0.7 0.0 0.0 2.2 0.1 0.7 0.0 0.1 0.0 0.0 2.2 0.3 1.2 4.3 0.5 2.0 0.9 0.9 0.5 0.9 1.3 0.5 0.0 0.0 0.0 1.5 0.8 0.1 0.8 0.0 13.4 2.3 1.8 0.0 0.7 1.7 3.2 80.6 0.9 0.0 0.0 0.3 1.6 1.6 0.9 0.0 1.7 0.8 0.0 2.4 0.6 0.3 61.4 2.0 0.2 1.7 0.0 0.5 0.6 4.1 0.0 1.1 0.8 0.3 0.0 1.2 27.9 15.8 0.1 0.5 0.0 1.2 1.4 C6orf132 bA7K24.2 ENSG00000188112 "Chromosome 6 open reading frame 132" Q5T0Z8 6 42101118-42142619 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 66.1;lymphoid tissue: 54.3;tongue: 49.3" "Cell type enhanced" "Detected in many" 7 "Exocrine glandular cells: 118.2;Glandular cells: 119.1;Pancreatic endocrine cells: 145.1;Urothelial cells: 193.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 20.6;CACO-2: 18.8;CAPAN-2: 15.6;OE19: 61.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044588 Enhanced Approved "Golgi apparatus,Cytosol" NA NA "Golgi apparatus, Cytosol" "HPA044588: AB_10794293" "unprognostic (7.09e-2)" "unprognostic (8.88e-2)" "unprognostic (1.20e-1)" "unprognostic (1.24e-3)" "unprognostic (1.60e-2)" "unprognostic (1.24e-2)" "unprognostic (1.15e-1)" "unprognostic (6.78e-2)" "unprognostic (1.59e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (4.90e-4)" "unprognostic (1.31e-1)" "unprognostic (4.26e-3)" "unprognostic (1.04e-2)" "unprognostic (5.53e-2)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" 1.3 0.5 0.2 3.7 0.2 0.2 4.2 0.3 0.3 13.3 20.9 0.2 1.4 15.7 0.7 1.2 66.1 2.6 15.5 0.5 0.2 0.1 6.2 0.6 5.9 0.2 0.2 0.2 1.4 20.8 1.1 2.2 3.1 0.2 6.8 5.3 0.2 16.6 4.0 1.2 24.8 37.2 0.7 0.2 0.2 16.2 0.4 0.2 0.6 12.5 49.3 54.3 4.8 17.5 2.1 1.9 3.5 1.3 0.9 1.2 0.7 20.6 0.2 0.0 0.0 0.1 2.4 10.2 1.2 1.5 2.9 3.0 18.8 15.6 0.0 2.2 2.0 0.0 13.9 0.0 6.2 1.9 1.7 2.9 1.0 1.8 4.2 0.7 0.0 0.0 1.4 11.7 2.2 3.3 1.1 0.0 0.1 0.5 0.2 0.6 7.2 0.2 0.1 1.4 61.4 0.5 0.0 0.0 0.1 2.2 9.3 1.1 0.0 1.8 12.6 0.0 1.5 9.2 0.1 0.3 0.1 1.3 5.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.9 1.3 1.7 0.8 0.8 0.6 1.0 0.8 0.8 1.4 2.1 0.9 1.2 3.5 0.9 0.5 1.9 0.5 0.7 0.2 0.2 0.3 0.3 0.2 0.1 0.2 0.2 0.2 0.2 41.7 17.6 0.0 50.1 46.6 0.8 3.6 40.8 61.6 53.4 48.8 19.6 10.6 0.0 41.6 12.9 0.5 80.5 0.0 118.2 0.5 8.4 119.1 1.1 0.0 0.7 4.8 7.0 1.8 1.6 91.9 0.6 1.2 11.8 5.4 33.6 0.5 145.1 43.5 1.4 5.6 7.4 0.0 2.1 4.3 8.3 71.6 3.4 2.2 37.9 193.5 CARD14 "BIMP2, CARMA2, PSORS2" ENSG00000141527 "Caspase recruitment domain family member 14" Q9BXL6 17 80169992-80209331 "Disease related genes, Predicted intracellular proteins" Apoptosis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.1;skin 1: 17.3;tongue: 12.3" "Cell type enhanced" "Detected in some" 5 "Ciliated cells: 4.0;Glandular cells: 4.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "MCF7: 7.3;SK-BR-3: 10.0;T-47d: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA023388 Supported Aggresome,Cytosol NA NA Cytosol Aggresome "HPA023388: AB_1846020" "unprognostic (9.79e-3)" "unprognostic (3.86e-2)" "unprognostic (4.26e-1)" "unprognostic (1.05e-5)" "unprognostic (2.65e-2)" "unprognostic (1.37e-2)" "unprognostic (2.92e-4)" "unprognostic (1.92e-1)" "unprognostic (1.47e-1)" "unprognostic (2.63e-1)" "unprognostic (3.01e-1)" "unprognostic (5.48e-2)" "unprognostic (1.62e-8)" "unprognostic (2.52e-1)" "unprognostic (2.06e-1)" "unprognostic (2.38e-1)" "unprognostic (2.34e-1)" 0.4 1.9 0.4 0.9 0.4 0.1 3.2 0.4 0.7 4.0 0.4 0.4 0.4 2.1 0.8 1.0 12.1 0.3 0.6 0.4 0.4 0.3 0.7 1.1 0.7 1.0 0.4 0.4 1.0 0.4 0.0 0.4 3.0 0.6 2.1 0.0 0.4 6.2 3.6 0.6 17.3 1.6 0.4 1.5 1.8 0.5 0.8 0.4 0.4 0.4 12.3 10.7 1.3 5.8 2.0 0.0 0.0 0.5 0.0 0.4 0.1 3.9 0.6 0.6 0.2 0.0 0.0 3.9 0.2 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.3 0.4 0.0 0.0 0.0 0.5 0.8 0.0 2.0 0.2 0.0 0.3 0.3 0.0 0.4 0.0 0.2 0.0 0.0 0.2 0.3 1.3 0.0 7.3 0.0 0.0 0.1 2.6 0.5 0.0 1.6 0.4 0.0 3.1 0.5 0.1 0.0 10.0 1.6 0.6 22.0 0.0 0.2 0.1 0.5 0.4 0.0 2.1 0.2 0.1 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.4 0.3 2.0 0.2 0.3 0.0 0.0 0.3 0.4 0.0 0.0 0.3 0.0 0.4 0.1 0.4 0.4 0.4 0.7 0.4 0.3 0.4 0.4 0.6 0.4 0.0 1.4 0.0 3.4 1.5 0.8 0.8 2.5 4.0 1.2 0.0 0.0 0.2 0.0 0.6 0.6 0.5 0.0 0.0 2.0 0.3 0.5 4.0 0.0 0.0 0.7 0.0 0.0 0.6 3.2 0.0 0.3 0.7 1.7 0.0 0.0 2.2 1.3 0.0 0.4 0.0 0.9 0.0 0.0 0.7 0.4 2.6 1.3 0.0 0.1 3.3 CDRT1 "FBXW10B, FBXW10P1, HREP, SM25H2" ENSG00000241322 "CMT1A duplicated region transcript 1" O95170 17 15565483-15619512 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 9.8;testis: 12.8" "Cell type enhanced" "Detected in some" 24 "Ciliated cells: 4.0;Early spermatids: 18.5;Late spermatids: 8.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "T-reg: 2.1" "Lineage enriched" "Detected in single" 5 "T-cells: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 15.6;HaCaT: 28.6;HeLa: 9.7;OE19: 7.1" "HPA013332, HPA047457" Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA013332: AB_1848471, HPA047457: " "unprognostic (2.25e-1)" "unprognostic (2.78e-1)" "unprognostic (7.03e-2)" "unprognostic (3.95e-2)" "unprognostic (1.15e-2)" "unprognostic (1.90e-2)" "unprognostic (1.45e-2)" "unprognostic (5.93e-2)" "unprognostic (5.04e-1)" "unprognostic (1.44e-1)" "unprognostic (1.17e-1)" "unprognostic (3.38e-1)" "unprognostic (9.31e-8)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (5.49e-2)" "unprognostic (1.86e-1)" 1.1 1.8 0.0 0.9 0.0 0.0 0.7 0.2 0.0 2.4 0.3 2.9 0.0 0.8 9.8 0.3 0.7 0.7 0.0 0.0 0.1 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.1 1.8 0.3 0.6 2.6 0.1 2.1 4.4 1.3 0.0 0.0 0.2 2.6 12.8 1.6 3.0 2.0 4.1 0.4 0.1 0.0 0.3 0.1 2.1 0.0 2.4 6.8 0.2 2.0 0.2 0.7 0.2 0.5 1.5 0.2 0.7 5.1 15.6 0.1 0.4 1.3 1.6 28.6 0.4 0.3 0.4 2.4 0.3 0.1 9.7 0.2 0.2 0.0 0.1 0.3 0.9 0.6 0.4 0.1 0.1 0.4 0.0 1.2 0.8 0.1 0.4 0.2 0.2 7.1 0.8 0.0 0.4 0.0 1.9 3.7 0.1 0.2 2.3 2.0 0.1 0.8 0.1 0.1 1.2 0.5 1.4 0.0 0.4 0.6 2.9 0.0 1.7 0.1 0.8 0.0 0.2 0.0 0.2 0.3 0.1 0.1 0.2 0.0 0.1 0.4 0.1 0.2 0.0 0.1 0.1 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 18.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.5 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 2.6 0.4 0.0 0.0 0.0 0.0 0.3 CEACAM5 "CD66e, CEA" ENSG00000105388 "Carcinoembryonic antigen related cell adhesion molecule 5" P06731 19 41708585-41729798 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6" "Cell type enhanced" "Detected in some" 19 "Enterocytes: 233.4;Mucus-secreting cells: 290.9;Paneth cells: 482.9;Undifferentiated cells: 102.6" "Cancer enhanced" "Detected in many" "colorectal cancer: 1007.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "OE19: 35.9" "CAB000021, CAB000022, HPA011041, HPA019758" Enhanced Supported "Plasma membrane" "Intracellular and membrane" NA NA 19000000 "Plasma membrane" "CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326" "unprognostic (1.54e-2)" "unprognostic (7.59e-2)" "unprognostic (5.49e-3)" "unprognostic (1.80e-1)" "unprognostic (1.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.49e-1)" "unprognostic (2.11e-1)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (8.67e-9)" "unprognostic (2.92e-1)" "unprognostic (2.71e-2)" "unprognostic (6.31e-2)" "unprognostic (1.85e-1)" 0.1 0.1 0.1 78.8 0.1 0.0 0.1 0.1 0.2 12.5 117.1 0.2 0.1 2.5 0.9 0.1 103.5 0.3 1.2 0.1 0.1 0.1 0.1 0.1 3.3 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.5 0.1 0.3 118.2 0.2 6.8 0.1 0.1 0.6 12.8 3.3 0.1 0.1 20.1 0.2 0.1 0.6 0.2 29.4 100.6 2.0 14.1 0.6 0.6 1.8 0.7 0.6 0.5 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 35.9 0.7 0.1 0.0 0.0 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 1.2 0.3 0.8 0.3 0.2 0.1 0.5 0.2 0.3 0.6 0.6 0.4 0.5 1.8 0.6 0.7 0.5 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 29.8 2.6 0.0 0.6 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 0.0 0.0 0.3 0.3 0.0 233.4 0.0 0.8 0.0 0.0 7.8 4.6 0.0 0.0 0.0 63.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 290.9 0.0 12.4 482.9 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 102.6 36.7 CEACAM6 "CD66c, NCA" ENSG00000086548 "Carcinoembryonic antigen related cell adhesion molecule 6" P40199 19 41750977-41772208 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 81.4;gallbladder: 75.7;lung: 129.1" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 875.4;Club cells: 255.9;Paneth cells: 283.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.6" "Group enriched" "Detected in many" 6 "granulocytes: 2.6;monocytes: 1.3" "Cell line enriched" "Detected in some" 11 "OE19: 196.2" "CAB008370, HPA011041" Enhanced NA NA 79000000 "CAB008370: AB_592067, HPA011041: AB_1078481" "unprognostic (1.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.62e-2)" "unprognostic (8.22e-2)" "unprognostic (1.39e-1)" "unprognostic (9.06e-3)" "unprognostic (2.32e-2)" "unprognostic (1.37e-1)" "unprognostic (2.49e-1)" "unprognostic (5.22e-2)" "unprognostic (3.70e-3)" "unprognostic (1.93e-1)" "unprognostic (2.42e-4)" "unprognostic (4.08e-1)" "unprognostic (8.71e-3)" "unprognostic (2.85e-1)" "unprognostic (7.68e-2)" 0.3 0.3 0.3 7.4 0.3 29.7 0.3 0.3 0.3 16.8 35.3 0.2 0.1 5.8 0.9 0.2 81.4 1.1 75.7 2.3 0.3 0.3 0.3 0.8 129.1 0.1 0.3 0.1 0.3 1.7 0.0 0.3 32.1 0.2 0.9 43.1 0.2 50.1 0.1 0.3 2.1 12.8 0.9 0.3 0.8 2.6 0.3 0.1 1.0 0.3 25.3 58.1 2.3 21.0 0.1 0.3 2.6 1.3 0.1 0.3 5.2 0.0 17.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 196.2 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.6 0.1 0.5 0.3 0.0 5.2 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 875.4 62.6 0.0 2.8 0.0 0.0 0.0 81.5 95.0 255.9 0.0 0.0 0.0 0.0 44.8 0.0 0.0 46.4 0.0 13.9 0.0 0.0 19.2 6.9 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.1 0.0 93.7 283.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11.8 105.5 CKMT1A CKMT1 ENSG00000223572 "Creatine kinase, mitochondrial 1A" P12532 15 43692886-43699222 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.2;esophagus: 19.9;intestine: 25.5" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 64.4;Enterocytes: 82.9;Paneth cells: 55.7;Syncytiotrophoblasts: 78.6;Undifferentiated cells: 74.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 39.8;hTCEpi: 18.1;OE19: 43.7;SK-BR-3: 31.3;T-47d: 27.9" HPA043491 Uncertain "Intracellular and membrane" NA NA 2100000 "HPA043491: AB_2678510" "unprognostic (2.04e-2)" "unprognostic (2.53e-2)" "unprognostic (1.17e-1)" "unprognostic (4.02e-3)" "unprognostic (3.80e-1)" "unprognostic (7.44e-2)" "unprognostic (2.21e-1)" "unprognostic (3.10e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.51e-2)" "unprognostic (3.78e-9)" "unprognostic (3.52e-2)" "unprognostic (1.03e-1)" "unprognostic (7.37e-2)" "unprognostic (1.73e-3)" 0.0 0.7 4.8 1.9 6.3 0.0 2.1 17.2 12.6 1.8 25.5 24.7 0.0 0.0 19.9 0.4 3.0 0.0 5.6 7.9 0.9 0.0 0.0 0.0 5.0 0.0 0.1 2.1 1.4 2.5 0.5 24.1 7.2 0.0 0.0 13.0 21.7 0.9 1.1 0.0 7.8 0.0 0.6 4.4 1.4 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.3 0.0 9.9 0.0 0.0 0.0 0.0 2.1 6.9 0.0 0.4 0.0 0.6 39.8 5.7 11.7 0.0 0.0 4.3 0.0 0.6 0.1 0.0 0.0 1.8 0.0 18.1 0.0 3.1 0.0 0.0 1.4 1.7 0.0 0.0 9.2 0.0 0.0 2.8 43.7 2.1 0.0 0.0 1.8 1.9 1.4 14.1 5.5 0.0 31.3 2.0 0.8 27.9 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 15.8 5.9 0.4 12.7 1.4 5.7 1.8 19.6 64.4 23.2 3.4 0.0 0.1 82.9 0.0 18.3 17.8 0.6 2.2 9.2 0.0 4.0 6.4 17.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 34.6 1.5 9.9 55.7 0.0 0.3 8.7 0.0 0.3 0.0 0.0 16.2 78.6 0.0 74.1 11.5 CLCA2 CLCRG2 ENSG00000137975 "Chloride channel accessory 2" Q9UQC9 1 86424086-86456558 "Predicted membrane proteins" "Cell adhesion, Ion transport, Transport" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8" "Group enriched" "Detected in many" 6 "cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "hTCEpi: 68.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA047192 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 66000 "Plasma membrane, Cell Junctions" Nucleoplasm "HPA047192: AB_2679977" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.96e-3)" "unprognostic (6.99e-2)" "unprognostic (6.33e-2)" "unprognostic (1.40e-1)" "unprognostic (6.15e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (9.99e-3)" "unprognostic (1.97e-8)" "unprognostic (3.88e-1)" "unprognostic (1.03e-1)" "unprognostic (1.17e-1)" "unprognostic (2.72e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 2.0 0.1 0.1 27.7 0.2 0.1 0.4 0.1 1.1 0.7 105.2 0.1 0.2 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 1.4 0.3 0.1 5.1 0.1 0.1 36.4 0.3 0.1 0.2 0.1 0.0 0.2 0.1 0.7 0.1 42.1 33.9 6.1 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 12.6 0.5 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 10.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 68.6 0.3 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 6.0 42.1 0.0 0.3 0.0 10.7 22.7 0.0 0.0 0.2 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 47.9 0.1 0.0 0.0 35.8 CLIC3 ENSG00000169583 "Chloride intracellular channel 3" O95833 9 136994635-136996803 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 163.5;esophagus: 74.1;placenta: 103.5" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 778.7;Extravillous trophoblasts: 921.9;Syncytiotrophoblasts: 1705.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 130.8" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 10 "plasmacytoid DC: 163.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 163.5" "Cell line enhanced" "Detected in some" "BEWO: 68.1;MCF7: 31.0;SK-BR-3: 13.0;T-47d: 29.6;TIME: 23.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA005963 Enhanced Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA005963: AB_1078536" "unprognostic (4.30e-2)" "unprognostic (2.53e-1)" "unprognostic (3.54e-1)" "unprognostic (1.55e-2)" "unprognostic (5.42e-3)" "unprognostic (1.85e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-3)" "unprognostic (1.39e-1)" "unprognostic (3.26e-3)" "unprognostic (7.73e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.74e-4)" 1.9 0.2 0.1 1.6 0.2 1.2 1.1 0.0 0.5 17.6 0.5 0.1 0.0 0.2 1.3 6.8 74.1 0.6 0.8 1.8 0.2 0.1 0.4 0.2 27.3 1.4 0.2 0.2 0.4 0.2 0.1 0.5 103.5 0.8 1.0 0.1 1.3 8.2 0.6 0.2 25.0 0.8 0.3 0.6 2.2 2.9 0.6 0.0 15.7 55.5 53.4 43.1 0.8 28.1 0.2 163.5 0.6 0.1 17.1 15.8 10.2 5.5 0.0 0.0 0.0 0.1 0.3 68.1 0.5 0.2 0.1 0.0 0.3 2.7 0.0 4.5 4.8 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.7 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 11.7 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 9.3 13.0 0.0 0.0 29.6 0.0 23.5 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 15.8 0.1 6.9 0.1 2.2 9.6 0.6 0.2 0.5 8.6 0.6 17.1 0.1 163.5 0.7 10.2 0.1 0.2 0.0 0.5 0.2 0.1 0.2 0.2 0.8 0.0 199.5 37.7 10.4 3.5 3.4 0.0 1.6 0.0 1.4 30.7 1.8 0.0 778.7 8.3 2.3 0.7 5.8 6.5 0.0 5.8 921.9 16.8 2.3 1.1 0.8 81.9 0.0 4.7 4.3 1.0 5.3 116.2 0.2 10.1 3.6 3.8 0.0 49.2 9.9 39.3 0.3 0.0 0.0 1.7 0.0 0.2 16.9 1705.4 70.8 2.9 18.2 CNTNAP3 "CASPR3, CNTNAP3A, FLJ14195, KIAA1714" ENSG00000106714 "Contactin associated protein like 3" Q9BZ76 9 39072767-39288315 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.6;esophagus: 9.5" "Cell type enhanced" "Detected in many" 11 "Ito cells: 22.1;Muller glia cells: 11.5" "Low cancer specificity" "Detected in single" "Cell type enriched" "Detected in single" 22 "neutrophil: 10.6" "Lineage enriched" "Detected in single" 107 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "A549: 12.7;AF22: 15.4;TIME: 9.7;WM-115: 25.7" HPA047731 Uncertain "Intracellular and membrane" NA NA "HPA047731: AB_2680137" "unprognostic (9.06e-3)" "unprognostic (3.07e-2)" "unprognostic (5.74e-2)" "unprognostic (7.89e-2)" "unprognostic (7.03e-2)" "unprognostic (2.33e-3)" "unprognostic (4.58e-2)" "unprognostic (1.34e-2)" "unprognostic (1.51e-1)" "unprognostic (2.94e-2)" "unprognostic (1.11e-1)" "unprognostic (3.04e-1)" "unprognostic (1.29e-1)" "unprognostic (1.15e-2)" "unprognostic (1.20e-1)" "unprognostic (1.95e-3)" "unprognostic (1.93e-3)" 2.9 0.1 1.2 0.3 4.8 1.0 2.6 0.4 2.5 0.8 2.4 0.6 0.2 0.2 9.5 1.6 1.1 4.1 1.2 1.3 1.1 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.3 1.7 1.6 1.4 2.8 1.7 0.0 8.3 1.0 2.5 1.1 2.4 0.1 1.9 1.3 0.3 0.5 1.9 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.7 12.7 15.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.9 3.2 1.3 2.9 0.0 0.0 1.1 0.0 3.4 0.3 0.1 0.2 0.0 0.4 2.8 0.0 1.1 6.5 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.1 3.9 0.0 0.4 3.5 0.3 0.5 1.4 0.5 4.5 0.0 2.5 1.7 0.0 2.1 9.7 0.0 1.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 25.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 3.0 1.7 0.0 3.4 5.6 0.8 2.5 7.6 2.7 0.0 1.8 2.0 0.7 0.0 0.3 1.3 5.8 0.0 0.0 0.2 0.6 0.9 0.8 0.0 1.8 0.1 0.0 3.4 22.1 1.3 0.8 0.3 0.0 0.0 0.0 0.0 11.5 0.5 0.0 0.0 1.5 0.4 0.0 0.5 0.9 5.8 6.8 0.6 0.0 0.0 2.5 CPA4 CPA3 ENSG00000128510 "Carboxypeptidase A4" Q9UI42 7 130293134-130324180 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.0;skin 1: 41.0" "Cell type enhanced" "Detected in some" 18 "Basal keratinocytes: 15.8;Exocrine glandular cells: 45.1;Pancreatic endocrine cells: 12.8;Suprabasal keratinocytes: 27.0" "Cancer enhanced" "Detected in many" "cervical cancer: 10.0;head and neck cancer: 9.8" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 29.6;hTERT-RPE1: 55.9;LHCN-M2: 60.1;U-2 OS: 32.8;U-87 MG: 59.0" "Low region specificity" "Detected in single" HPA021030 Approved Nucleoplasm,Centrosome,Cytosol "Secreted in other tissues" NA Yes 480000 Nucleoplasm "Centrosome, Cytosol" "HPA021030: AB_1846010" "unprognostic (7.60e-3)" "unprognostic (4.00e-2)" "unprognostic (1.59e-3)" "unprognostic (3.63e-3)" "unprognostic (2.24e-2)" "unprognostic (2.91e-2)" "unprognostic (2.78e-2)" "unprognostic (4.36e-3)" "unprognostic (3.23e-1)" "unprognostic (5.79e-2)" "unprognostic (2.37e-3)" "unprognostic (6.49e-2)" "unprognostic (6.21e-10)" "unprognostic (2.39e-1)" "unprognostic (1.67e-1)" "unprognostic (7.56e-2)" "prognostic unfavorable (1.31e-4)" 2.7 2.3 0.1 0.4 0.4 0.2 2.8 0.1 0.4 8.1 1.1 0.3 0.1 0.1 1.1 1.2 18.0 0.2 0.2 4.4 0.1 1.2 1.2 0.2 0.8 0.3 0.1 0.1 1.8 6.9 0.1 1.1 8.8 0.9 0.3 0.1 0.6 4.4 0.1 0.3 41.0 0.5 0.7 0.7 1.7 0.2 2.2 0.1 0.8 0.1 12.3 2.3 1.7 6.7 0.4 0.4 1.6 0.4 1.5 0.4 0.1 19.4 1.0 0.0 0.0 0.1 0.3 0.0 15.6 29.6 15.9 3.9 0.1 1.7 0.0 3.0 6.6 16.1 1.1 0.0 8.6 16.5 0.0 0.0 0.0 6.3 0.4 0.4 0.0 0.0 0.2 13.9 1.4 2.0 55.9 0.0 0.0 0.0 0.0 60.1 0.0 0.0 0.0 0.1 0.1 2.3 0.0 16.1 0.0 7.5 0.8 0.0 0.0 10.3 4.9 0.1 6.3 0.1 0.0 11.9 3.9 32.8 1.3 1.5 0.0 0.0 0.0 59.0 0.0 0.1 1.0 0.4 0.4 0.4 0.1 0.2 0.3 0.2 0.3 0.0 0.4 0.3 0.3 1.6 1.5 0.2 0.4 0.3 0.1 0.1 0.4 0.1 0.3 0.1 1.2 0.1 0.1 0.9 0.1 3.0 0.3 0.0 0.5 15.8 0.0 0.3 0.0 2.7 2.3 0.0 0.0 3.7 0.0 0.5 0.3 0.1 0.0 0.0 45.1 1.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 1.0 0.0 0.0 12.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 27.0 7.9 0.0 0.0 0.9 CRABP2 CRABP-II ENSG00000143320 "Cellular retinoic acid binding protein 2" P29373 1 156699606-156705816 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 154.2;tongue: 80.5" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 286.6;Glandular cells: 140.0;Suprabasal keratinocytes: 166.6;Urothelial cells: 412.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.2;naive CD4 T-cell: 1.3;naive CD8 T-cell: 1.2" "Lineage enhanced" "Detected in single" "T-cells: 1.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 163.8;MCF7: 62.5;T-47d: 126.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA004135 Supported Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA004135: AB_1846516" "unprognostic (1.17e-2)" "unprognostic (9.30e-2)" "unprognostic (3.07e-2)" "prognostic unfavorable (2.11e-5)" "unprognostic (1.75e-2)" "unprognostic (1.08e-1)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" "unprognostic (6.45e-2)" "unprognostic (7.79e-2)" "unprognostic (7.23e-3)" "unprognostic (7.16e-2)" "prognostic unfavorable (3.19e-13)" "unprognostic (3.05e-3)" "unprognostic (1.34e-1)" "unprognostic (3.86e-2)" "unprognostic (2.25e-2)" 4.9 1.1 1.0 1.7 3.2 0.7 16.8 1.3 2.1 66.8 1.3 1.2 38.5 0.0 13.9 2.8 154.2 13.1 2.8 1.2 0.9 2.1 1.4 0.2 0.7 0.4 0.8 2.9 5.9 0.8 2.7 5.0 7.0 3.7 6.7 0.7 7.9 10.6 28.0 0.5 25.7 0.9 8.8 1.1 0.8 0.5 1.1 0.9 2.1 2.2 80.5 33.5 10.0 66.6 0.1 0.0 0.4 0.0 0.0 1.3 0.5 10.4 0.5 12.0 0.1 15.6 23.4 0.0 22.2 163.8 1.8 2.2 18.6 38.6 0.1 11.0 23.6 0.2 13.6 2.9 0.0 0.5 0.2 0.8 0.0 1.4 0.1 3.1 0.0 0.2 7.4 1.1 2.6 0.0 1.4 0.0 0.2 0.1 0.2 0.2 62.5 0.1 0.1 14.4 1.2 5.9 0.1 0.0 0.3 0.2 0.4 29.8 2.1 0.3 38.7 0.1 23.5 126.9 0.0 0.0 0.4 6.8 3.7 1.3 1.0 2.2 0.1 3.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.2 0.0 0.1 1.3 1.2 0.4 0.0 0.0 0.0 0.0 0.5 1.0 3.2 1.3 2.1 0.9 2.1 0.8 2.9 3.7 0.9 0.0 1.6 0.0 100.3 57.8 1.7 0.6 0.0 4.0 10.3 15.7 2.0 42.7 0.0 12.0 2.0 4.3 0.4 0.0 4.5 5.4 286.6 140.0 0.0 0.0 8.9 0.0 0.0 10.4 0.0 0.7 18.4 1.0 59.1 0.0 0.5 0.8 11.9 0.0 35.3 0.0 0.5 0.0 22.7 1.4 6.6 166.6 15.1 2.9 0.6 412.9 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" Q9Y4K1 6 106360808-106571978 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.7;placenta: 96.6" "Group enriched" "Detected in many" 11 "Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "pons and medulla: 10.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1" "Region enriched" "Detected in single" 5 "olfactory region: 5.1" "Low region specificity" "Detected in single" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671" "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 4.6 0.8 0.6 6.8 0.7 6.5 11.3 0.6 0.9 7.4 7.4 1.6 2.5 7.6 1.5 10.8 61.7 2.0 2.0 0.9 1.1 0.6 9.8 3.6 4.0 5.6 0.7 0.7 2.0 5.5 5.0 0.9 96.6 10.3 12.6 5.9 16.0 10.2 4.3 0.8 16.6 7.6 4.4 0.8 6.5 2.5 1.8 0.5 2.3 1.8 24.6 35.8 11.5 13.1 6.8 8.7 3.1 4.4 5.7 10.9 3.9 10.6 0.0 0.0 0.0 9.0 32.1 3.3 1.5 11.8 3.4 3.2 0.7 3.8 16.7 0.7 7.3 4.8 17.2 0.1 40.2 1.7 22.7 0.7 0.0 0.5 5.2 4.2 10.1 0.0 16.0 23.5 6.5 31.1 0.0 14.7 13.2 0.5 2.4 9.2 1.2 2.9 4.0 0.1 0.0 7.1 5.0 0.1 0.1 5.4 25.3 0.7 0.0 6.5 11.1 0.1 1.0 5.5 7.7 4.2 3.9 0.5 0.0 10.6 1.8 1.4 18.2 18.4 12.8 8.3 0.3 3.8 0.4 8.1 4.4 10.9 6.8 10.5 8.9 8.7 3.8 6.7 6.3 3.1 5.7 4.4 1.0 9.9 3.9 0.6 0.7 0.6 0.9 1.1 0.6 0.7 0.7 10.3 0.5 11.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 23.9 31.4 0.0 184.0 3.3 8.8 0.0 0.0 0.0 0.0 10.8 7.2 0.0 0.0 1.1 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 16.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 501.8 0.0 0.0 0.0 CRYBG2 "AIM1L, FLJ38020" ENSG00000176092 "Crystallin beta-gamma domain containing 2" Q8N1P7 1 26321698-26360080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.9;placenta: 55.0" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 40.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA029629 Approved Nucleoplasm NA NA Nucleoplasm "HPA029629: AB_10601331" "unprognostic (2.20e-1)" "unprognostic (2.07e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (6.39e-4)" "unprognostic (1.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.94e-2)" "unprognostic (4.83e-9)" "unprognostic (9.12e-3)" "unprognostic (3.40e-1)" "unprognostic (6.44e-2)" "unprognostic (1.63e-2)" 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 8.0 4.4 0.0 0.0 4.9 0.9 0.6 43.9 0.2 2.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 55.0 0.0 0.8 1.4 0.1 5.1 0.0 0.0 13.8 10.4 0.0 0.0 0.0 0.9 1.2 0.0 0.1 0.0 22.0 19.8 4.9 16.1 0.7 0.0 2.4 0.1 0.2 1.7 0.3 7.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 25.1 16.9 0.1 5.1 0.0 0.1 6.3 0.0 4.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.1 0.3 1.6 0.3 0.0 0.0 3.0 0.0 1.2 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.5 0.7 1.7 0.7 0.0 0.6 0.5 0.5 2.4 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.9 1.7 1.8 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 CSTA "STF1, STFA" ENSG00000121552 "Cystatin A" P01040 3 122325244-122341972 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 312.4;tongue: 421.9" "Cell type enhanced" "Detected in many" 16 "Kupffer cells: 712.6;monocytes: 1063.2;Syncytiotrophoblasts: 279.5" "Cancer enhanced" "Detected in all" "head and neck cancer: 405.0" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 20 "classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6" "Group enriched" "Detected in many" 193 "dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6" "Cell line enhanced" "Detected in some" "HBEC3-KT: 33.8;hTCEpi: 149.9;THP-1: 93.6;U-698: 59.6;U-937: 29.8" "CAB000469, HPA001031, CAB047315" Enhanced Approved Nucleoplasm,Cytosol No No 39000000 "Nucleoplasm, Cytosol" "CAB000469: , CAB047315: , HPA001031: AB_1078610" "unprognostic (5.22e-3)" "unprognostic (6.10e-2)" "unprognostic (2.64e-1)" "unprognostic (6.07e-2)" "unprognostic (7.79e-3)" "prognostic favorable (5.86e-4)" "unprognostic (4.46e-1)" "unprognostic (1.63e-1)" "unprognostic (1.78e-1)" "unprognostic (7.99e-2)" "unprognostic (2.56e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (2.60e-6)" "unprognostic (8.89e-2)" "unprognostic (3.43e-2)" "unprognostic (9.24e-3)" "unprognostic (1.99e-1)" 2.0 0.2 0.3 4.4 0.8 19.8 4.5 0.2 0.5 55.4 0.4 0.2 1.1 0.0 4.7 1.7 312.4 0.2 0.7 1.0 0.3 0.0 0.4 3.4 6.8 4.8 1.1 0.2 1.8 0.2 0.0 0.3 1.3 0.5 1.3 0.1 0.3 57.4 0.7 0.7 28.2 0.3 0.4 0.7 2.0 2.2 0.3 0.6 2.2 0.3 421.9 99.0 1.5 93.5 0.1 54.6 36.0 74.6 0.2 0.2 32.0 1.7 0.1 0.0 0.4 3.9 7.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.7 0.0 10.5 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.8 0.8 13.6 0.2 3.8 149.9 0.3 14.7 0.0 0.0 0.1 0.1 3.6 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 16.8 0.0 0.0 1.6 0.9 1.2 0.0 0.1 93.6 0.0 0.2 2.4 0.0 0.1 0.0 0.2 59.6 3.2 29.8 0.0 0.7 74.6 2.2 0.0 37.5 0.2 0.1 0.1 0.1 54.6 0.0 0.0 0.1 36.0 0.2 21.6 1.0 0.1 32.0 0.3 0.8 0.2 0.5 0.3 0.0 1.1 0.2 0.5 0.6 6.0 27.0 9.0 93.6 74.1 0.0 0.0 2.5 30.8 34.2 0.0 0.0 203.1 0.0 2.0 0.2 3.5 1.3 0.0 19.8 10.9 5.6 14.2 12.8 90.0 136.3 0.0 0.0 8.0 712.6 0.6 9.5 248.7 8.5 1063.2 0.5 0.0 27.6 1.1 3.5 0.5 0.0 32.3 4.2 0.1 0.1 179.2 279.5 4.3 0.8 83.6 CXCL17 "Dcip1, DMC, UNQ473, VCC1" ENSG00000189377 "C-X-C motif chemokine ligand 17" Q6UXB2 19 42428288-42443048 "Predicted secreted proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 68.0;lung: 83.0;stomach 1: 79.9" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 380.6;Ciliated cells: 365.4;Club cells: 424.2;Pancreatic endocrine cells: 272.5;Urothelial cells: 1358.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 1.4" "Group enriched" "Detected in some" 7 "OE19: 13.0;RT4: 3.9" "Not detected" "Not detected" "Secreted to blood" NA NA "unprognostic (2.74e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.03e-2)" "unprognostic (4.46e-3)" "unprognostic (3.77e-1)" "prognostic favorable (4.92e-5)" "unprognostic (6.68e-2)" "unprognostic (3.07e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.70e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-1)" "unprognostic (1.88e-1)" "unprognostic (8.13e-3)" "unprognostic (2.29e-1)" 0.1 0.0 0.1 0.2 0.2 0.0 0.7 0.1 0.1 17.4 0.1 0.4 0.1 0.0 1.0 5.1 68.0 6.3 1.3 0.1 0.1 0.0 0.7 0.4 83.0 0.1 0.1 0.1 2.8 11.4 0.0 2.3 0.1 0.3 6.8 0.0 0.3 39.2 0.5 0.1 0.0 0.1 0.3 0.1 0.1 79.9 0.3 0.1 0.5 1.2 8.8 40.1 5.5 10.0 0.0 0.0 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.3 13.0 0.0 0.0 0.0 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 32.8 380.6 0.0 160.7 0.0 0.2 0.0 2.5 365.4 424.2 5.2 0.0 0.0 0.0 1.6 0.4 0.0 0.0 0.0 159.6 0.0 0.0 167.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 4.6 0.0 0.0 272.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1358.9 CYSLTR1 "CysLT(1), CysLT1, CYSLT1R" ENSG00000173198 "Cysteinyl leukotriene receptor 1" Q9Y271 X 78271464-78327691 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.9;esophagus: 24.6" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 62.5;Alveolar cells type 2: 54.8;Ciliated cells: 65.6;Club cells: 67.1;granulocytes: 76.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 33.9" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 11.6;Karpas-707: 7.5;NB-4: 16.2;RPMI-8226: 24.7;THP-1: 15.2;U-937: 16.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA010546 Approved NA NA "HPA010546: AB_1078268" "unprognostic (9.48e-2)" "unprognostic (6.01e-5)" "unprognostic (4.72e-3)" "unprognostic (3.04e-1)" "unprognostic (6.30e-2)" "unprognostic (2.80e-3)" "unprognostic (2.52e-1)" "unprognostic (8.19e-2)" "unprognostic (1.19e-1)" "unprognostic (2.53e-2)" "unprognostic (4.55e-1)" "unprognostic (2.43e-1)" "unprognostic (4.41e-4)" "unprognostic (5.82e-2)" "unprognostic (3.56e-2)" "unprognostic (9.87e-2)" "unprognostic (8.94e-2)" 7.3 2.0 1.7 7.8 1.7 2.8 5.4 0.8 2.2 3.0 3.3 1.7 2.9 2.2 2.3 4.4 24.6 2.3 5.6 3.1 2.3 1.9 4.8 2.7 6.9 19.5 3.8 0.8 1.7 2.0 1.7 1.5 3.3 2.9 3.7 4.8 3.1 5.4 0.8 1.7 3.1 7.1 4.2 5.1 22.8 5.2 2.3 4.0 4.7 4.5 4.8 11.3 9.8 3.5 8.1 7.4 33.9 11.9 4.1 3.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 11.6 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 16.2 0.0 0.0 0.0 3.3 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 16.8 0.0 5.8 6.3 33.9 0.0 10.9 0.0 8.1 2.4 0.1 4.8 5.8 3.7 0.0 18.4 4.1 11.9 7.4 0.5 2.8 1.7 1.7 0.8 2.2 2.3 1.9 3.8 0.8 2.9 4.0 62.5 54.8 40.4 3.9 3.3 2.9 0.6 0.0 65.6 67.1 0.0 5.9 0.3 0.0 0.1 0.0 9.0 0.0 0.0 0.2 0.2 1.4 1.2 76.2 0.0 23.3 0.0 0.0 3.7 30.2 0.0 0.6 32.2 6.8 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.2 3.1 0.7 17.5 0.5 1.4 DAPL1 ENSG00000163331 "Death associated protein like 1" A0PJW8 2 158795317-158862781 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 522.1" "Group enriched" "Detected in all" 7 "cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 3.7;hTCEpi: 22.1;SCLC-21H: 5.7;U-87 MG: 8.1" "Not detected" "Not detected" "HPA046937, HPA058635" Enhanced Approved "Nucleoplasm,Nuclear bodies,Microtubules" NA NA "Nucleoplasm, Nuclear bodies, Microtubules" "HPA046937: AB_2679870, HPA058635: AB_2732625" "unprognostic (3.95e-5)" "prognostic favorable (8.43e-4)" "unprognostic (2.05e-1)" "unprognostic (1.55e-1)" "unprognostic (2.98e-1)" "unprognostic (4.63e-2)" "unprognostic (8.59e-2)" "unprognostic (5.24e-2)" "unprognostic (4.59e-2)" "unprognostic (2.44e-1)" "unprognostic (1.41e-1)" "unprognostic (2.44e-3)" "unprognostic (4.09e-2)" "unprognostic (6.68e-2)" "unprognostic (3.00e-2)" "unprognostic (2.30e-3)" 0.3 14.7 1.4 0.4 1.3 0.0 7.4 0.4 1.0 11.7 1.0 0.8 1.6 0.0 2.1 53.5 75.6 21.1 0.6 0.2 1.5 3.6 1.3 0.2 0.8 0.4 2.8 0.3 3.8 5.7 0.0 5.6 0.2 1.5 2.3 0.0 63.9 6.8 0.4 0.2 61.3 0.5 1.1 0.4 0.2 0.2 2.1 0.8 0.8 21.5 37.3 16.9 2.0 21.1 1.4 4.0 2.9 2.6 2.8 1.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.1 2.3 0.0 0.0 0.0 0.0 0.2 22.1 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.8 0.0 0.0 0.3 5.7 0.0 0.0 0.0 0.6 0.0 0.6 1.1 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 8.1 0.0 0.0 2.9 2.6 1.6 0.5 1.9 1.0 1.2 0.8 0.4 1.0 1.4 0.4 0.5 2.2 2.8 0.6 4.0 1.3 0.5 1.4 1.3 0.4 1.0 1.5 3.6 2.8 0.3 1.5 0.8 0.0 0.0 14.6 31.4 94.9 6.8 0.0 5.1 1.4 17.0 8.7 5.9 5.5 3.3 8.0 10.6 0.5 2.5 0.0 5.1 10.7 4.1 10.8 4.6 12.1 12.9 3.2 2.9 0.6 7.9 43.8 3.7 5.5 11.8 2.8 1.6 522.1 5.7 3.5 2.1 5.8 16.3 0.0 5.1 9.8 4.1 110.7 3.8 1.9 2.5 25.5 DENND2C "dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1" ENSG00000175984 "DENN domain containing 2C" Q68D51 1 114582848-114670422 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.7;skeletal muscle: 31.1" "Cell type enhanced" "Detected in many" 14 "Basal glandular cells: 99.0;Basal keratinocytes: 97.0;Suprabasal keratinocytes: 150.2;Urothelial cells: 270.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "basophil: 6.1;eosinophil: 2.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 6.1" "Cell line enhanced" "Detected in many" "U-2197: 10.3;U-266/70: 22.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA029935, HPA054955" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA029935: AB_10601208, HPA054955: AB_2682648" "unprognostic (2.25e-1)" "unprognostic (1.08e-1)" "unprognostic (9.97e-2)" "unprognostic (4.89e-4)" "unprognostic (1.52e-1)" "unprognostic (2.46e-1)" "unprognostic (2.53e-1)" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (6.61e-2)" "unprognostic (2.20e-2)" "unprognostic (7.43e-2)" "unprognostic (2.77e-2)" "unprognostic (2.24e-2)" "unprognostic (6.11e-2)" "unprognostic (3.64e-2)" "unprognostic (1.57e-2)" 1.9 0.7 1.5 0.7 1.5 0.8 1.7 1.4 1.1 8.6 1.1 0.5 0.8 0.6 4.2 1.7 28.7 1.0 1.1 1.5 1.3 0.5 0.8 2.1 1.7 1.7 0.6 0.3 1.1 4.0 2.4 3.6 0.3 1.9 2.5 0.6 1.6 3.0 1.4 31.1 10.6 0.6 2.4 0.6 0.5 0.8 4.5 0.2 0.0 1.3 16.0 10.4 6.2 6.6 0.6 0.1 6.1 0.2 0.3 0.5 0.3 1.7 0.0 0.1 1.2 1.5 1.7 0.3 0.5 0.9 0.6 0.9 0.2 0.0 0.0 0.8 3.5 1.2 6.5 1.2 4.0 0.6 0.0 1.6 1.0 0.4 0.1 0.5 0.0 1.6 1.7 3.9 2.4 2.0 0.1 0.2 0.4 0.1 0.3 2.1 5.1 0.2 0.1 0.8 0.0 0.9 0.0 5.5 0.1 0.1 4.9 0.0 0.0 3.9 0.1 0.4 1.1 0.8 0.3 0.2 0.9 1.3 10.3 0.1 22.5 4.0 0.0 0.9 0.0 0.7 6.1 0.2 2.1 0.5 0.0 0.5 0.6 0.1 0.4 0.0 0.4 0.3 0.2 0.5 0.3 0.1 0.1 0.2 0.3 1.5 1.5 1.4 1.1 1.3 0.5 0.6 0.3 1.9 0.2 26.8 2.1 0.0 99.0 97.0 21.6 6.9 12.7 20.1 4.5 7.0 19.6 0.1 0.0 5.6 23.7 8.7 0.0 0.0 6.4 0.0 5.3 46.7 2.3 11.0 0.2 0.0 0.0 13.5 3.4 9.1 4.6 1.6 6.8 1.0 0.8 2.0 20.3 0.0 2.1 0.6 8.7 0.0 8.5 23.4 49.0 150.2 0.0 0.7 0.5 270.3 DKK4 ENSG00000104371 "Dickkopf WNT signaling pathway inhibitor 4" Q9UBT3 8 42374068-42377232 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.6;gallbladder: 9.9" "Group enriched" "Detected in some" 10 "Basal glandular cells: 3.4;Early spermatids: 1.1;Glandular cells: 1.4;Pancreatic endocrine cells: 2.5;Spermatocytes: 1.2;Urothelial cells: 4.3" "Cancer enriched" "Detected in many" 20 "endometrial cancer: 174.4" "Region enhanced" "Detected in some" "cerebellum: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "OE19: 21.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA052916 Uncertain "Secreted in other tissues" NA NA "HPA052916: AB_2681987" "unprognostic (1.64e-1)" "unprognostic (5.84e-2)" "unprognostic (1.97e-1)" "unprognostic (5.37e-3)" "unprognostic (3.23e-1)" "unprognostic (2.91e-2)" "unprognostic (2.13e-2)" "unprognostic (1.99e-1)" "unprognostic (6.80e-2)" "unprognostic (2.71e-2)" "unprognostic (1.63e-2)" "unprognostic (6.73e-2)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (8.11e-2)" 0.2 0.0 0.1 0.1 0.1 0.2 1.6 2.8 0.1 2.3 0.1 0.1 0.1 5.1 1.6 2.3 10.6 0.7 9.9 0.1 0.1 1.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 2.0 0.1 0.5 1.4 0.0 0.1 1.7 1.9 0.2 0.2 0.9 0.5 0.1 0.1 2.2 2.9 0.1 1.8 0.1 5.9 1.6 2.5 4.3 0.7 0.7 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.1 0.1 2.8 0.1 0.1 1.0 0.1 0.1 0.5 0.1 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 4.3 DSC2 "CDHF2, DSC3" ENSG00000134755 "Desmocollin 2" Q02487 18 31058840-31102415 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 127.5;lymphoid tissue: 68.2;tongue: 163.9" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 156.0;Extravillous trophoblasts: 157.3;Paneth cells: 155.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 48.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "eosinophil: 20.4;neutrophil: 5.7" "Lineage enriched" "Detected in many" 14 "granulocytes: 20.4" "Cell line enhanced" "Detected in many" "BEWO: 15.3;CAPAN-2: 19.8;HaCaT: 28.6;hTCEpi: 30.9;OE19: 24.0;SK-BR-3: 18.1;SuSa: 18.6" "Not detected" "Not detected" "HPA011911, HPA012615" Enhanced NA NA 14000000 "HPA011911: AB_1847618, HPA012615: AB_1847619" "unprognostic (3.28e-2)" "unprognostic (3.20e-1)" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (1.90e-1)" "unprognostic (3.04e-2)" "unprognostic (1.30e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (7.66e-2)" "unprognostic (4.07e-2)" "unprognostic (1.22e-3)" "unprognostic (2.10e-1)" "unprognostic (1.43e-3)" "unprognostic (1.60e-1)" "unprognostic (1.75e-1)" "unprognostic (2.49e-1)" "prognostic unfavorable (3.01e-4)" 3.3 1.1 1.1 9.8 1.1 0.0 6.3 0.7 0.9 38.1 23.6 0.6 0.2 12.1 3.0 2.4 127.5 1.5 1.1 9.5 1.0 0.9 4.7 4.3 3.3 6.3 1.1 0.6 1.0 3.8 11.8 0.7 20.0 1.1 4.5 13.3 1.3 22.4 0.0 0.7 4.4 33.5 0.8 1.7 6.1 12.6 0.9 0.7 4.8 2.5 163.9 68.2 1.0 39.6 0.0 0.0 20.4 1.5 0.0 0.0 0.3 7.1 0.7 1.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 3.6 19.8 0.0 0.3 0.0 0.3 28.6 4.8 2.0 0.0 0.0 2.8 10.6 3.4 6.3 0.1 0.0 0.2 0.1 30.9 0.0 3.0 2.5 0.0 0.0 5.1 0.0 0.0 5.7 0.0 0.4 4.6 24.0 7.1 5.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 18.1 0.0 18.6 4.9 7.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 20.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.3 1.1 1.1 0.7 0.9 1.0 0.9 1.1 0.6 1.1 0.7 26.8 6.4 0.9 29.2 74.4 0.7 29.9 22.9 0.0 3.4 7.0 0.0 77.6 0.0 76.8 0.1 5.3 156.0 0.0 28.7 157.3 3.7 131.3 0.0 14.0 21.2 0.0 66.7 9.8 50.9 0.0 0.3 31.7 13.5 34.3 68.2 7.3 108.4 155.6 0.7 8.6 0.6 0.0 3.3 0.1 0.6 48.1 70.1 3.2 63.7 69.4 DSP "DPI, DPII, KPPS2, PPKS2" ENSG00000096696 Desmoplakin P15924 6 7541575-7586717 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cardiomyopathy, Disease mutation, Epidermolysis bullosa, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 138.3;skin 1: 136.5;tongue: 189.6" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 801.2;Cardiomyocytes: 699.5;Suprabasal keratinocytes: 1763.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 314.1" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 19 "naive B-cell: 5.8" "Lineage enriched" "Detected in single" 59 "B-cells: 5.8" "Cell line enhanced" "Detected in many" "BEWO: 46.0;HaCaT: 49.6;HBEC3-KT: 35.7;hTCEpi: 112.8;SuSa: 35.9" "Region enriched" "Detected in single" 23 "hippocampal formation: 12.8" "Low region specificity" "Detected in all" "CAB037324, HPA045840, HPA054950" Enhanced Supported "Cell Junctions" NA NA 110000000 "Cell Junctions" "CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645" "unprognostic (1.65e-1)" "unprognostic (3.09e-1)" "unprognostic (6.13e-2)" "unprognostic (1.05e-2)" "unprognostic (1.09e-1)" "unprognostic (2.05e-2)" "unprognostic (3.82e-2)" "unprognostic (7.03e-3)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (5.02e-2)" "unprognostic (2.94e-2)" "prognostic favorable (1.53e-9)" "unprognostic (2.45e-1)" "unprognostic (2.88e-1)" "unprognostic (8.38e-2)" "prognostic unfavorable (1.82e-4)" 1.3 2.7 0.9 9.6 0.7 0.0 12.5 0.6 0.8 27.5 19.4 0.2 9.1 8.1 2.8 11.2 138.3 2.5 8.7 71.8 0.7 0.6 8.7 21.9 8.0 1.4 0.6 0.9 1.4 23.0 8.1 2.7 25.7 2.5 9.0 7.0 3.4 25.6 8.5 0.6 136.5 28.2 1.1 1.4 1.0 7.4 0.8 0.1 15.0 17.1 189.6 48.7 3.1 46.9 5.8 0.0 0.0 0.0 0.0 0.0 0.0 20.8 6.3 0.0 0.0 0.9 1.4 46.0 4.1 3.6 2.0 2.0 18.0 5.5 0.0 5.9 6.6 1.6 49.6 7.6 35.7 0.3 0.0 8.8 0.0 3.6 24.1 0.0 0.1 0.1 0.3 112.8 1.8 20.6 5.0 0.0 0.1 0.0 0.0 3.6 9.8 0.0 0.1 0.9 10.1 3.1 0.0 0.0 5.3 7.6 5.6 2.1 0.0 4.6 9.9 0.0 35.9 11.7 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.6 0.8 0.7 0.6 0.6 0.9 2.5 0.1 47.6 14.2 5.1 114.0 801.2 2.1 699.5 132.5 179.3 220.6 57.6 13.7 231.6 1.7 136.3 1.3 28.8 238.5 0.0 97.9 229.6 43.4 178.6 3.5 162.5 23.9 0.0 167.6 3.1 1.6 0.5 0.9 5.6 96.2 4.6 145.6 14.8 137.3 200.0 0.0 11.0 27.9 0.0 22.7 1.4 2.5 1763.9 322.6 2.9 145.6 184.4 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 19.1;esophagus: 19.2" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 51.5" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 28.3;CAPAN-2: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Nucleoplasm, Nuclear membrane" "HPA042931: AB_2678227" "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 2.9 1.3 0.4 4.8 0.5 1.5 3.2 0.4 0.2 4.8 5.7 4.1 3.0 0.0 19.2 3.2 3.8 1.8 0.5 0.5 1.6 2.8 3.2 3.9 0.7 2.7 4.3 3.8 2.1 1.8 4.6 3.2 10.5 1.3 2.8 11.6 5.5 1.3 1.1 4.9 6.1 8.3 2.7 4.0 4.6 8.8 7.0 14.7 19.1 14.1 3.3 9.0 6.4 12.9 28.3 4.2 6.2 2.4 2.3 9.1 2.8 2.4 3.1 4.3 7.9 46.8 4.0 2.0 2.8 16.4 9.7 2.2 13.4 1.9 9.0 4.8 2.3 5.8 6.9 3.2 3.3 5.8 4.2 8.2 8.0 4.3 2.4 2.3 7.2 7.0 6.1 3.7 6.3 5.1 11.6 6.1 9.8 4.3 5.6 3.9 7.2 1.4 10.1 1.7 3.5 4.5 7.8 3.8 3.9 7.8 8.9 2.4 17.5 8.4 5.9 11.2 4.6 5.4 4.6 3.8 3.6 9.0 12.4 9.2 13.3 7.6 10.9 5.5 6.0 6.4 7.5 8.4 7.0 6.6 6.9 19.1 3.3 14.1 14.7 9.0 6.4 6.0 5.3 7.3 17.3 30.1 2.6 1.7 5.1 29.4 18.2 7.0 7.9 16.0 3.3 16.6 13.7 4.7 27.5 0.0 9.5 11.1 6.0 16.5 3.5 3.2 18.8 3.2 8.7 9.2 11.1 6.7 5.2 11.6 6.8 9.0 26.8 5.0 19.5 35.3 4.6 2.9 8.7 6.5 4.1 9.2 10.1 30.9 31.5 8.3 21.7 51.5 DUOXA1 "FLJ32334, mol, NIP, NUMBIP" ENSG00000140254 "Dual oxidase maturation factor 1" Q1HG43 15 45117367-45129938 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 48.0" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 56.6;Alveolar cells type 2: 90.0;Ciliated cells: 38.8;Club cells: 36.4;Urothelial cells: 33.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "MAIT T-cell: 2.1" "Lineage enriched" "Detected in single" 12 "T-cells: 2.1" "Cell line enriched" "Detected in some" 7 "HaCaT: 48.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041578 Approved NA NA "HPA041578: AB_10795691" "unprognostic (1.28e-1)" "unprognostic (1.32e-3)" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (2.71e-1)" "unprognostic (6.87e-3)" "unprognostic (1.03e-1)" "unprognostic (4.45e-2)" "unprognostic (6.69e-2)" "unprognostic (3.68e-2)" "unprognostic (5.82e-2)" "unprognostic (1.86e-1)" "unprognostic (2.17e-5)" "unprognostic (8.11e-2)" "unprognostic (1.12e-2)" "unprognostic (4.69e-2)" "unprognostic (5.36e-2)" 0.5 1.2 0.4 0.9 0.5 0.0 1.4 0.4 0.6 8.5 0.4 0.7 18.8 0.1 2.0 18.9 48.0 1.9 1.8 0.4 0.4 0.0 0.6 0.4 23.7 0.4 0.4 0.4 0.4 0.4 1.0 0.4 1.0 0.5 5.7 0.0 1.6 7.5 9.5 0.4 32.8 0.5 1.7 0.4 0.4 9.1 0.6 0.4 0.4 30.3 34.1 26.2 10.0 17.9 0.1 0.0 0.0 0.1 0.1 2.1 0.3 4.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 48.5 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 0.5 0.4 0.6 0.4 0.0 0.4 0.4 0.5 0.4 56.6 90.0 0.0 16.5 8.4 0.4 0.4 0.0 38.8 36.4 0.0 2.0 1.6 0.0 1.1 0.1 0.6 0.0 0.0 2.7 0.1 1.5 6.6 1.1 0.0 0.2 0.0 2.9 0.0 0.0 0.0 0.3 1.1 0.0 1.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 19.2 2.5 0.0 0.0 33.5 ECM1 ENSG00000143369 "Extracellular matrix protein 1" Q16610 1 150508062-150513789 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Angiogenesis, Biomineralization, Mineral balance, Osteogenesis" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 80.6;Ito cells: 56.4;Melanocytes: 70.9;Pancreatic endocrine cells: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.2;myeloid DC: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 77.4;BJ hTERT+: 53.9;fHDF/TERT166: 50.8;hTEC/SVTERT24-B: 36.5;LHCN-M2: 39.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA027241, HPA076029" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 12000000000 Cytosol Nucleoplasm "HPA027241: AB_1847976, HPA076029: " "unprognostic (2.89e-2)" "unprognostic (1.17e-1)" "unprognostic (2.11e-1)" "unprognostic (1.13e-2)" "unprognostic (1.09e-1)" "unprognostic (6.79e-3)" "unprognostic (8.42e-2)" "unprognostic (2.15e-2)" "unprognostic (4.90e-2)" "unprognostic (7.50e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.33e-2)" "prognostic unfavorable (1.51e-9)" "unprognostic (1.23e-2)" "unprognostic (1.92e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (1.20e-5)" 16.1 2.5 0.9 1.8 1.3 0.1 11.0 0.9 4.2 37.9 2.8 0.1 7.4 1.5 10.5 133.2 257.1 3.3 30.7 11.6 0.9 1.0 2.5 16.7 3.8 0.2 1.0 1.7 3.0 0.8 0.3 2.0 20.2 4.2 2.6 3.1 1.6 28.7 2.9 3.5 11.5 2.0 5.3 0.8 3.6 2.1 5.9 0.0 0.0 1.8 45.5 107.2 6.0 46.6 0.0 1.8 0.0 1.2 0.0 0.4 1.3 6.2 0.6 2.3 0.0 14.0 77.4 2.1 22.7 53.9 14.2 18.6 0.3 3.5 0.1 0.2 50.8 1.6 13.1 0.0 2.7 14.9 0.1 0.1 0.9 0.8 0.1 3.9 0.0 23.5 6.8 0.1 36.5 1.3 20.9 3.9 0.1 4.8 0.1 39.5 0.0 0.0 0.7 0.2 26.5 0.7 0.3 17.0 0.1 0.5 0.0 0.1 0.0 5.2 0.1 19.4 1.1 0.0 6.0 1.0 30.1 4.5 3.4 4.9 0.1 0.2 0.2 15.8 2.1 4.0 0.0 1.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.9 1.3 0.9 4.2 0.9 1.0 1.0 1.7 4.2 0.0 0.0 0.6 1.4 1.8 13.1 0.7 1.1 12.7 0.0 2.3 3.5 0.0 1.3 0.0 4.8 0.2 4.4 0.2 0.0 3.7 26.0 80.6 1.0 10.3 0.6 16.0 1.6 0.0 56.4 2.1 0.0 9.2 4.8 70.9 0.0 0.3 0.8 42.0 0.0 20.8 0.0 1.1 12.9 16.1 0.5 0.4 16.7 9.2 0.0 0.2 5.8 EDAR "DL, ED1R, ED3, ED5, EDA1R, EDA3, Edar" ENSG00000135960 "Ectodysplasin A receptor" Q9UNE0 2 108894471-108989372 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Developmental protein, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 10.2;esophagus: 9.2;lymphoid tissue: 11.3" "Cell type enhanced" "Detected in some" 15 "Ciliated cells: 1.4;Club cells: 1.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 10.2;naive CD8 T-cell: 4.8" "Lineage enriched" "Detected in single" 102 "T-cells: 10.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 6.6;HaCaT: 14.2;OE19: 3.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA042292 Approved NA NA "HPA042292: AB_10794648" "unprognostic (1.07e-3)" "unprognostic (1.61e-1)" "unprognostic (2.22e-2)" "unprognostic (1.24e-2)" "unprognostic (4.68e-2)" "unprognostic (1.21e-2)" "unprognostic (2.30e-1)" "unprognostic (2.53e-2)" "unprognostic (3.70e-1)" "unprognostic (1.31e-1)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (8.83e-7)" "unprognostic (9.21e-2)" "unprognostic (5.61e-2)" "unprognostic (2.29e-1)" "unprognostic (5.03e-3)" 0.3 0.2 0.3 1.9 0.4 0.5 1.8 0.4 0.3 2.8 2.9 0.1 0.0 2.2 1.1 2.6 9.2 0.4 6.8 0.5 0.3 0.4 1.9 1.9 2.4 6.6 0.3 0.0 0.3 0.5 0.0 0.2 0.2 0.3 1.6 4.5 0.1 3.2 0.1 0.3 3.5 2.5 1.3 1.2 0.5 1.8 0.6 0.2 3.2 0.3 1.7 11.3 4.6 3.5 0.0 0.0 0.0 0.0 0.0 10.2 1.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 6.6 0.0 0.5 0.0 0.0 14.2 0.0 0.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 10.2 4.8 0.0 0.0 0.0 0.0 0.0 1.2 0.3 0.4 0.4 0.3 0.3 0.4 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 EHD3 PAST3 ENSG00000013016 "EH domain containing 3" Q9NZN3 2 31234337-31269447 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.4;esophagus: 29.1" "Cell type enriched" "Detected in many" 5 "Ito cells: 172.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 17.8;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 9 "B-cells: 17.8" "Cell line enhanced" "Detected in many" "BJ: 25.6;BJ hTERT+: 63.5;HEL: 24.6;U-266/70: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751" Approved Approved "Plasma membrane" NA NA 41000000 "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713" "unprognostic (3.44e-1)" "unprognostic (8.88e-2)" "unprognostic (2.21e-1)" "unprognostic (3.79e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (5.49e-2)" "unprognostic (1.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.72e-2)" "unprognostic (9.92e-3)" "unprognostic (1.06e-1)" "prognostic unfavorable (1.02e-4)" "unprognostic (4.88e-3)" "unprognostic (9.41e-2)" "unprognostic (4.79e-3)" "unprognostic (4.92e-3)" 2.7 7.1 15.0 5.6 16.3 2.0 3.3 10.6 37.4 5.6 2.2 7.3 0.0 1.9 3.9 3.4 29.1 4.9 3.6 14.8 16.7 8.9 15.0 10.8 4.8 6.3 9.6 21.6 2.9 1.4 8.7 6.0 11.3 13.3 5.7 2.1 2.8 4.8 4.9 2.3 3.0 2.9 4.8 9.4 5.8 1.9 1.6 6.6 1.2 2.5 1.5 10.4 7.8 4.2 17.8 0.4 1.0 1.9 0.6 1.7 7.8 0.5 2.7 1.5 1.3 2.5 3.9 0.2 25.6 63.5 2.5 2.3 0.0 0.3 0.2 0.9 8.4 2.2 0.2 0.0 1.7 1.8 1.0 2.3 24.6 0.1 0.0 8.8 0.0 0.0 6.2 0.7 2.4 1.0 6.7 0.0 0.0 0.0 0.1 1.8 4.0 0.3 0.0 5.8 0.0 1.3 0.8 0.1 0.5 1.9 2.9 0.7 3.9 0.2 0.4 0.0 4.9 0.3 0.0 0.0 1.9 1.8 0.1 2.0 15.9 2.0 0.0 4.9 0.0 4.0 0.4 0.4 0.3 1.7 0.8 0.9 17.8 0.9 1.1 0.4 4.4 0.8 0.4 1.0 0.6 1.9 0.0 0.4 7.8 15.0 16.3 10.6 32.7 16.7 8.9 9.6 21.6 13.3 6.6 0.0 0.0 23.6 1.4 0.7 9.2 18.9 2.5 0.0 1.2 0.0 0.0 3.5 0.0 0.3 0.0 5.2 0.0 0.0 0.2 7.3 2.3 0.8 0.0 0.8 1.4 0.0 1.7 172.5 21.8 0.0 1.1 0.2 0.0 1.0 0.0 8.1 0.2 0.0 2.8 0.2 5.4 19.4 3.3 0.2 2.1 0.6 36.7 2.5 0.0 3.2 EPGN "ALGV3072, EPG, epigen, PRO9904" ENSG00000182585 "Epithelial mitogen" Q6UW88 4 74308473-74315307 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.3;esophagus: 39.6;tongue: 25.7" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 3.2;Basal keratinocytes: 5.4;Early spermatids: 1.7;Late spermatids: 2.2;Melanocytes: 1.7;Urothelial cells: 2.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 7.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.9" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "hTCEpi: 62.6;U-2197: 28.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA014420 Approved Nucleoplasm,Vesicles,Cytosol "Secreted in other tissues" NA NA "Nucleoplasm, Cytosol" Vesicles "HPA014420: AB_10601551" "unprognostic (7.51e-2)" "unprognostic (8.08e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-1)" "unprognostic (1.77e-1)" "unprognostic (2.38e-4)" "unprognostic (2.20e-1)" "unprognostic (2.01e-1)" "unprognostic (1.23e-2)" "unprognostic (1.27e-1)" "unprognostic (4.06e-4)" "unprognostic (3.84e-1)" "unprognostic (7.89e-2)" "prognostic unfavorable (2.40e-4)" 1.1 0.0 0.0 1.3 0.0 0.1 1.0 0.0 0.0 7.9 0.3 0.0 1.0 0.0 0.0 14.3 39.6 1.2 0.3 0.6 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.7 0.0 0.3 0.0 0.0 2.5 2.8 0.0 2.3 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.4 0.0 25.7 5.4 0.6 6.5 0.4 0.1 0.0 0.6 0.0 1.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.6 0.1 1.2 0.0 1.0 0.0 0.0 0.0 0.1 7.4 0.0 0.0 0.0 0.1 0.0 62.6 1.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.3 1.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 28.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.2 5.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.0 2.2 EPHA2 ECK ENSG00000142627 "EPH receptor A2" P29317 1 16124337-16156087 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 51.2" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 115 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 115 "dendritic cells: 11.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6" "Low region specificity" "Detected in all" CAB010464 Supported "Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "Nuclear speckles, Golgi apparatus" "CAB010464: AB_631436" "unprognostic (9.41e-2)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.67e-2)" "unprognostic (6.22e-2)" "unprognostic (9.12e-2)" "unprognostic (5.24e-2)" "unprognostic (1.29e-3)" "unprognostic (2.52e-2)" "unprognostic (7.05e-3)" "unprognostic (1.52e-3)" "unprognostic (2.77e-1)" "unprognostic (2.65e-2)" "unprognostic (2.08e-1)" "unprognostic (1.73e-1)" "unprognostic (4.77e-3)" "unprognostic (4.40e-2)" 6.7 3.4 1.3 3.1 2.6 0.0 5.2 0.5 2.1 12.1 4.9 1.6 1.9 4.3 7.8 3.8 51.2 4.6 16.7 6.4 1.1 0.8 5.7 8.2 6.6 4.7 2.7 1.3 4.5 10.2 2.2 2.8 8.9 3.4 5.8 2.6 5.4 31.0 2.8 3.4 12.7 13.1 2.7 3.0 2.8 6.8 2.4 1.2 1.2 5.7 21.8 25.5 15.2 18.5 0.0 11.4 0.0 0.0 0.0 0.0 0.0 15.6 31.7 8.8 4.2 0.6 0.7 5.2 9.5 13.4 17.2 10.9 13.2 42.4 0.0 40.9 5.4 21.3 6.4 2.1 21.9 6.0 0.0 1.4 0.0 9.2 8.4 11.3 0.0 0.0 1.0 8.2 9.3 20.7 27.0 18.3 0.0 0.0 0.0 10.9 5.0 0.0 0.0 4.2 11.8 48.6 0.0 8.0 0.0 18.2 8.1 0.0 1.3 18.4 4.5 1.2 4.8 0.6 0.1 22.6 6.1 16.5 0.4 49.8 0.0 0.1 0.1 4.7 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 1.3 2.6 0.5 2.1 1.1 0.8 2.7 1.3 3.4 1.2 50.6 28.9 0.5 100.5 179.7 0.6 5.8 40.8 37.5 33.0 8.7 3.9 8.1 0.0 31.3 5.4 17.5 57.1 0.0 12.5 0.9 7.0 56.8 5.7 19.8 1.6 0.0 2.9 32.5 2.8 0.0 3.1 4.6 25.3 1.8 19.6 5.8 62.9 20.1 0.0 1.4 2.0 32.3 17.6 0.0 0.7 217.2 6.3 0.0 17.7 155.0 EPHX3 "ABHD9, FLJ22408" ENSG00000105131 "Epoxide hydrolase 3" Q9H6B9 19 15226919-15233435 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.8;lymphoid tissue: 29.6;skin 1: 33.1;tongue: 39.6" "Group enriched" "Detected in many" 4 "Suprabasal keratinocytes: 37.9;Urothelial cells: 18.6" "Cancer enhanced" "Detected in many" "cervical cancer: 30.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 4.9" "Group enriched" "Detected in many" 18 "dendritic cells: 2.8;monocytes: 4.9" "Cell line enhanced" "Detected in some" "EFO-21: 4.0;NTERA-2: 3.7;OE19: 12.9;SuSa: 5.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA012842 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA012842: AB_10601648" "unprognostic (1.39e-1)" "unprognostic (1.16e-2)" "unprognostic (1.54e-2)" "unprognostic (1.74e-1)" "unprognostic (8.24e-2)" "prognostic favorable (2.27e-5)" "unprognostic (8.83e-3)" "unprognostic (1.50e-1)" "unprognostic (3.90e-1)" "unprognostic (4.36e-2)" "unprognostic (4.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.43e-1)" "unprognostic (3.68e-2)" "unprognostic (1.48e-1)" "unprognostic (1.30e-2)" "unprognostic (6.01e-2)" 0.2 0.1 0.1 0.2 0.3 0.1 1.0 0.1 0.3 12.5 0.2 0.2 0.4 0.1 0.9 0.3 34.8 1.1 1.7 0.1 0.5 0.1 1.6 0.2 1.6 0.0 0.2 0.0 0.6 0.0 2.2 2.4 0.2 0.4 1.5 0.1 0.6 3.4 0.6 0.2 33.1 0.2 0.2 0.2 1.2 0.5 2.7 0.2 2.4 0.2 39.6 29.6 2.8 13.6 0.0 2.8 0.2 4.9 0.0 0.0 0.5 0.1 0.3 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.5 0.3 4.0 0.1 0.2 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.6 0.0 0.5 3.7 12.9 0.5 0.0 0.0 0.0 0.1 0.8 1.6 0.2 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.0 1.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 4.9 2.8 0.0 0.5 0.1 0.3 0.1 0.3 0.5 0.1 0.2 0.0 0.4 0.2 0.0 0.6 0.0 1.5 6.3 0.2 0.3 2.5 1.4 0.0 5.2 0.0 1.5 1.7 0.5 0.3 0.1 0.0 0.0 0.0 2.5 0.7 2.0 0.0 0.0 0.6 0.0 0.0 1.3 1.3 0.0 0.0 1.4 0.0 1.0 0.0 3.1 0.3 0.0 0.0 0.0 0.0 0.0 1.2 2.1 2.1 37.9 2.2 0.0 0.0 18.6 EPS8L1 "DRC3, FLJ20258, MGC23164, MGC4642" ENSG00000131037 "EPS8 like 1" Q8TE68 19 55072020-55087923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.9;placenta: 45.0" "Group enriched" "Detected in many" 4 "Syncytiotrophoblasts: 357.9;Urothelial cells: 188.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.3;BEWO: 32.6;SK-BR-3: 10.0;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041851, HPA043545" Uncertain Supported Cytosol NA NA Cytosol "HPA041851: AB_2677706, HPA043545: AB_2678544" "unprognostic (1.91e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (7.18e-2)" "unprognostic (9.33e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.43e-2)" "unprognostic (5.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.85e-3)" "unprognostic (5.04e-3)" "unprognostic (3.02e-1)" "unprognostic (5.41e-3)" "unprognostic (2.63e-1)" 1.2 0.0 0.2 2.1 0.3 0.0 1.7 0.3 0.4 7.6 2.1 0.2 1.5 2.0 1.3 1.8 40.9 6.2 6.9 0.2 0.2 0.0 4.1 0.2 1.8 0.2 0.2 0.2 1.6 4.0 1.1 1.1 45.0 0.3 2.9 0.5 0.3 6.6 2.5 0.4 18.7 1.5 0.7 0.2 0.4 23.2 0.9 0.2 1.0 6.2 12.1 16.9 1.9 12.1 0.1 3.5 5.1 0.4 1.7 0.8 0.5 9.3 0.4 0.3 0.2 0.0 0.0 32.6 0.9 0.0 0.0 0.0 2.9 7.7 0.1 1.9 0.0 0.0 4.7 0.2 0.5 0.0 0.2 0.9 0.7 0.3 0.2 0.1 1.5 6.5 0.0 1.5 0.0 0.0 0.0 0.0 0.7 3.5 0.0 0.0 4.3 0.5 1.5 0.5 4.8 0.0 0.1 0.0 3.1 0.7 0.7 0.1 2.3 0.6 10.0 0.4 0.3 15.8 1.8 0.7 0.0 0.4 0.0 0.0 1.4 1.7 0.9 2.0 0.5 1.2 2.6 0.4 5.1 0.8 0.1 0.7 0.0 0.4 0.8 0.0 0.1 0.1 0.0 0.0 1.7 0.0 3.5 0.7 0.5 0.2 0.3 0.3 0.4 0.2 0.0 0.2 0.2 0.3 0.2 8.9 6.7 0.9 18.5 1.8 0.0 2.0 5.1 5.3 11.4 29.6 0.0 28.7 11.6 18.5 1.3 3.8 22.2 0.0 9.1 18.2 2.6 37.2 10.3 0.0 7.9 0.0 2.9 8.0 1.2 3.6 1.1 2.6 20.3 8.2 28.9 0.2 62.1 35.1 0.7 0.8 0.0 25.8 14.1 0.6 2.6 3.4 357.9 2.5 9.9 188.1 ESPL1 "ESP1, KIAA0165, SEPA" ENSG00000135476 "Extra spindle pole bodies like 1, separase" Q14674 12 53268299-53293643 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Chromosome partition" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.9;lymphoid tissue: 30.3" "Cell type enhanced" "Detected in some" 6 "Enterocytes: 4.1;Hepatocytes: 4.9;Proximal tubular cells: 5.6;Spermatocytes: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "T-reg: 1.8" "Lineage enriched" "Detected in single" 5 "T-cells: 1.8" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "CAB012185, HPA073188" Approved Supported Nucleoplasm,Vesicles NA Yes Nucleoplasm Vesicles "CAB012185: AB_304056, HPA073188: " "unprognostic (1.57e-1)" "unprognostic (3.56e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (2.91e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.01e-5)" "prognostic unfavorable (7.14e-4)" "unprognostic (1.59e-2)" "unprognostic (2.48e-1)" "unprognostic (4.17e-3)" "unprognostic (1.18e-2)" "unprognostic (7.42e-13)" "prognostic favorable (7.10e-4)" "unprognostic (2.39e-1)" "unprognostic (7.41e-2)" "unprognostic (1.42e-1)" 0.7 0.4 0.2 7.1 0.4 7.2 0.3 0.2 0.5 3.9 2.3 0.4 0.8 4.2 0.6 0.7 17.9 0.2 0.5 1.0 1.1 0.1 1.0 0.9 0.7 4.1 0.2 0.2 0.3 0.2 0.0 0.2 3.0 0.6 0.4 1.5 0.6 2.6 0.2 0.2 2.7 4.4 0.5 0.2 3.0 0.8 10.9 0.3 30.3 0.3 2.5 7.8 0.7 6.2 0.0 0.0 0.4 0.1 0.0 1.8 0.0 12.6 12.9 13.8 11.3 0.3 1.2 8.5 8.3 4.2 14.3 9.1 7.0 11.1 22.8 4.6 3.4 8.4 10.5 16.0 4.9 7.5 7.1 16.2 15.3 11.7 5.3 0.0 9.6 12.7 0.4 0.3 8.3 4.1 1.4 7.3 11.3 20.5 20.6 4.2 13.1 15.0 8.2 11.2 7.5 7.0 14.1 14.8 9.5 2.0 5.3 10.0 7.7 7.0 10.3 5.4 6.8 17.0 6.4 3.3 7.2 14.0 6.0 11.4 15.3 14.2 15.4 4.1 9.1 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 1.8 0.0 0.2 0.4 0.2 0.5 1.1 0.1 0.2 0.2 0.6 0.3 0.0 0.0 0.0 0.1 0.8 0.0 0.8 0.0 0.0 0.0 3.5 0.0 0.7 0.0 0.2 0.6 0.4 4.1 0.0 0.0 1.9 1.0 0.3 0.0 4.9 2.1 0.0 3.4 1.3 0.6 1.1 0.0 1.3 0.0 0.0 1.2 0.0 1.0 0.2 0.4 5.6 0.0 0.0 0.4 6.5 2.7 0.5 0.2 0.0 3.1 0.5 EVPL EVPK ENSG00000167880 Envoplakin Q92817 17 76004502-76027452 "Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.9;lymphoid tissue: 46.1;skin 1: 43.7;tongue: 43.1" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 21.6;Intestinal endocrine cells: 19.7;Suprabasal keratinocytes: 22.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 24.7;MCF7: 16.1;RT4: 35.7;SK-BR-3: 17.8;T-47d: 22.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002220, HPA053969" Enhanced Supported "Intermediate filaments,Cytosol" NA NA "Intermediate filaments" Cytosol "CAB002220: AB_563701, HPA053969: AB_2682326" "unprognostic (2.10e-1)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (4.21e-1)" "unprognostic (1.05e-2)" "unprognostic (1.87e-2)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.94e-1)" "unprognostic (1.44e-1)" "unprognostic (7.40e-3)" "unprognostic (2.64e-1)" "unprognostic (2.40e-2)" "unprognostic (2.31e-1)" "unprognostic (3.47e-1)" "unprognostic (7.93e-2)" "unprognostic (3.09e-2)" 0.2 0.0 0.0 2.3 0.1 1.1 1.2 0.0 0.3 11.6 5.7 0.1 2.8 4.8 1.9 1.3 69.9 0.9 4.1 0.0 0.0 0.0 4.8 0.0 5.7 0.2 0.0 0.0 0.4 2.4 1.8 1.1 2.3 0.1 3.2 0.7 0.7 10.9 4.5 0.5 43.7 7.8 2.1 0.2 0.1 1.9 0.3 0.1 0.4 6.3 43.1 46.1 5.0 21.6 0.4 1.7 1.9 0.3 1.6 1.4 0.0 11.2 9.5 0.0 0.1 0.1 0.0 4.0 0.1 0.0 0.0 0.0 1.2 6.8 0.0 0.0 0.0 0.0 24.7 0.0 3.1 0.0 0.0 0.0 0.2 7.0 7.1 0.0 0.0 1.8 0.0 5.1 0.1 0.0 0.0 0.0 1.6 0.0 0.5 0.0 16.1 0.4 1.5 0.0 5.1 4.3 4.6 0.0 0.1 7.4 35.7 0.4 0.0 4.7 17.8 0.0 0.0 22.5 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.5 0.0 1.0 0.3 0.7 0.6 0.3 0.7 0.2 0.2 0.5 0.1 0.4 1.4 0.6 1.9 1.6 0.2 1.7 0.9 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 17.9 21.6 0.0 4.0 10.4 0.0 2.2 5.1 6.7 11.4 5.2 0.0 0.1 1.7 3.7 0.0 0.0 12.7 0.0 0.5 0.1 0.7 3.8 11.6 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.9 0.6 1.7 0.0 3.7 0.0 5.7 6.8 1.8 2.9 0.0 0.0 0.5 0.1 1.1 22.6 0.0 0.0 9.3 10.3 EVPLL ENSG00000214860 "Envoplakin like" A8MZ36 17 18377662-18389647 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.2;lymphoid tissue: 10.4" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 1.9;Basal glandular cells: 1.7;Club cells: 2.3;Collecting duct cells: 1.8;Spermatogonia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.9;HaCaT: 1.9;HeLa: 3.3;hTCEpi: 11.5;RT4: 4.0;SiHa: 2.1;T-47d: 3.5" HPA045728 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Nucleoplasm, Nuclear bodies" "HPA045728: AB_10960394" "unprognostic (1.34e-1)" "unprognostic (4.88e-2)" "unprognostic (2.06e-5)" "unprognostic (1.58e-1)" "unprognostic (2.08e-2)" "unprognostic (1.64e-2)" "unprognostic (3.07e-1)" "unprognostic (3.62e-1)" "unprognostic (4.60e-4)" "unprognostic (5.28e-2)" "unprognostic (2.58e-1)" "unprognostic (1.43e-2)" "unprognostic (5.06e-2)" 0.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 3.3 0.5 0.0 0.7 0.4 0.8 0.9 22.2 0.4 0.8 0.0 0.0 0.0 0.9 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 1.7 0.2 0.0 2.1 3.1 0.1 7.8 0.4 1.4 0.0 0.1 1.7 2.5 0.0 0.1 2.2 9.5 10.4 3.5 7.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 2.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.5 0.0 0.0 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 3.4 1.1 0.0 0.0 0.0 1.0 FABP5 "E-FABP, KFABP, PA-FABP" ENSG00000164687 "Fatty acid binding protein 5" Q01469 8 81280363-81284777 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 237.0;tongue: 204.1;vagina: 141.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1256.0;Hofbauer cells: 2357.3;monocytes: 1172.2" "Cancer enhanced" "Detected in all" "cervical cancer: 268.3;head and neck cancer: 288.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 93.8;MOLT-4: 91.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017831, CAB040577, HPA051895" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Plasma membrane" "CAB017831: , CAB040577: , HPA051895: AB_2681654" "unprognostic (8.76e-2)" "unprognostic (7.28e-2)" "unprognostic (1.54e-2)" "unprognostic (9.04e-2)" "unprognostic (1.33e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-3)" "unprognostic (4.03e-3)" "unprognostic (2.71e-1)" "unprognostic (3.13e-1)" "unprognostic (6.16e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (4.69e-10)" "unprognostic (1.99e-1)" "unprognostic (3.72e-1)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" 41.4 1.5 8.5 11.8 13.2 8.5 37.3 5.5 8.9 78.7 20.6 7.9 2.2 8.0 5.7 3.1 237.0 2.1 8.5 27.1 8.5 9.8 1.6 2.7 24.8 15.1 7.6 5.0 2.0 8.7 0.7 1.9 30.0 19.1 4.4 18.2 4.2 32.9 1.6 9.4 42.9 9.7 4.5 23.0 14.9 15.6 3.8 10.6 6.6 4.4 204.1 25.7 19.5 141.9 6.8 20.3 2.5 5.9 8.2 5.2 4.3 5.8 16.7 10.2 0.0 48.8 4.6 0.0 11.9 0.6 9.3 11.8 0.2 8.0 93.8 6.8 2.9 0.1 5.4 24.8 19.1 8.0 47.6 53.9 33.8 11.9 25.2 4.3 32.3 8.8 3.5 39.3 11.5 23.7 9.4 53.4 24.9 9.7 10.2 5.6 5.6 91.6 16.5 13.5 57.9 64.9 40.9 0.0 9.9 15.0 72.5 42.4 16.1 5.8 1.9 4.4 18.5 0.1 16.6 7.6 0.0 26.5 0.1 0.1 12.6 4.9 66.8 4.3 31.0 14.9 2.5 5.0 0.3 2.3 5.9 3.7 6.8 2.7 5.2 20.3 3.3 1.3 4.5 2.0 8.2 2.0 20.1 3.5 4.3 8.5 13.2 5.5 8.9 8.5 9.8 7.6 5.0 19.1 10.6 268.0 1256.0 87.2 58.7 107.4 21.2 2.8 2.5 100.4 708.6 21.0 43.2 16.9 3.3 27.1 23.0 313.1 94.4 0.0 20.3 209.8 84.3 44.5 54.3 0.8 2357.3 20.6 189.4 31.9 161.8 37.2 5.8 624.3 195.7 1172.2 116.5 252.2 31.0 459.1 4.9 0.8 41.8 355.7 66.0 131.8 169.3 147.4 22.5 71.0 321.9 172.7 FAM3D "EF7, OIT1" ENSG00000198643 "Family with sequence similarity 3 member D" Q96BQ1 3 58633946-58666848 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6" "Group enriched" "Detected in some" 6 "Enterocytes: 558.6;Mucus-secreting cells: 1112.4;Paneth cells: 854.0;Undifferentiated cells: 821.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 151.0" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 6.7" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.7" "Cell line enriched" "Detected in single" 72 "OE19: 38.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA013844 Approved "Secreted to digestive system" NA NA 8200 "HPA013844: AB_2668897" "prognostic favorable (7.51e-4)" "unprognostic (1.07e-1)" "unprognostic (2.08e-2)" "unprognostic (9.67e-2)" "unprognostic (5.51e-2)" "prognostic favorable (1.89e-4)" "unprognostic (7.97e-2)" "unprognostic (6.54e-2)" "unprognostic (7.43e-2)" "unprognostic (5.48e-2)" "unprognostic (2.23e-2)" "unprognostic (1.42e-1)" "unprognostic (8.68e-2)" "unprognostic (1.64e-1)" "unprognostic (2.00e-1)" "unprognostic (6.97e-4)" "unprognostic (2.34e-2)" 0.3 0.2 0.3 8.5 0.3 0.0 2.2 0.2 0.2 4.4 48.2 0.3 26.1 11.2 0.5 0.3 61.2 0.3 20.0 0.2 0.2 0.2 0.5 0.2 1.5 0.2 0.3 0.2 0.2 0.8 0.0 0.3 0.5 0.3 3.3 69.2 0.3 146.0 88.6 0.4 0.8 26.1 0.8 0.2 0.3 9.5 0.3 0.2 0.3 0.6 15.2 47.1 2.2 13.1 0.0 0.7 6.7 1.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 38.6 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 6.7 0.0 0.5 0.0 0.0 0.9 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.0 0.6 0.0 7.9 0.0 0.0 0.2 56.0 28.1 9.1 14.0 0.0 0.0 0.0 0.6 0.4 0.6 558.6 0.0 0.0 0.0 0.0 70.7 9.2 0.0 0.3 0.0 146.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1112.4 0.0 1.9 854.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.1 0.3 0.0 821.7 144.0 FAM46B MGC16491 ENSG00000158246 "Family with sequence similarity 46 member B" Q96A09 1 27005020-27012836 "Predicted secreted proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 55.8;tongue: 42.0" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 59.6;Basal keratinocytes: 91.9;Suprabasal keratinocytes: 129.2" "Cancer enhanced" "Detected in many" "testis cancer: 87.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 1.3;intermediate monocyte: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 32.4;hTERT-HME1: 16.7;NTERA-2: 17.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted - unknown location" NA NA "unprognostic (1.67e-2)" "unprognostic (5.94e-3)" "unprognostic (1.61e-1)" "unprognostic (5.28e-3)" "unprognostic (3.20e-2)" "unprognostic (2.22e-2)" "unprognostic (2.44e-4)" "unprognostic (4.05e-2)" "unprognostic (1.39e-1)" "unprognostic (6.02e-3)" "unprognostic (1.34e-1)" "unprognostic (1.11e-1)" "unprognostic (1.00e-1)" "unprognostic (5.82e-2)" "unprognostic (4.85e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-2)" 3.3 0.6 0.6 3.9 0.3 0.1 10.4 0.3 0.4 20.6 13.4 0.4 3.6 0.8 8.0 2.8 55.8 5.5 4.0 9.1 0.2 0.0 3.8 0.5 11.6 0.7 0.4 0.9 3.8 1.2 1.0 0.7 7.4 0.9 6.8 1.2 1.5 23.5 11.1 0.9 36.3 3.5 21.5 0.3 0.4 6.8 4.6 0.1 0.6 3.1 42.0 18.7 23.0 13.6 0.0 0.4 1.3 2.5 0.0 0.0 0.0 1.9 0.3 4.0 1.2 0.5 0.6 1.0 2.8 0.9 11.3 4.5 7.7 2.6 0.0 4.8 1.5 2.5 6.3 0.7 10.3 3.0 0.0 0.6 0.1 1.5 1.3 5.7 0.0 0.2 2.6 32.4 3.4 16.7 0.0 0.1 0.0 0.2 0.0 1.4 1.5 0.0 0.6 17.0 1.4 0.8 0.2 0.0 0.1 11.0 0.0 0.4 0.3 5.4 12.2 7.1 8.7 9.6 0.1 0.2 2.7 9.4 0.3 0.6 0.1 0.4 0.0 0.5 0.0 1.7 0.0 0.0 1.3 0.0 2.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.4 0.2 0.0 0.4 0.9 0.9 0.1 59.6 1.9 0.0 24.5 91.9 0.1 0.0 0.0 2.7 0.0 0.0 0.0 1.7 0.0 0.0 1.4 0.5 1.1 0.0 0.0 2.6 2.4 12.8 0.0 0.0 0.5 0.0 7.0 1.8 0.0 1.4 4.6 0.8 6.8 0.0 1.2 5.0 0.0 0.0 1.8 0.0 0.6 0.0 17.8 5.8 3.9 129.2 4.5 0.0 0.9 10.6 FAM83A "BJ-TSA-9, MGC14128" ENSG00000147689 "Family with sequence similarity 83 member A" Q86UY5 8 123178960-123210079 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.8;lymphoid tissue: 28.6" "Cell type enhanced" "Detected in some" 14 "Pancreatic endocrine cells: 16.6;Suprabasal keratinocytes: 13.2;Urothelial cells: 19.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 52.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A-431: 24.3;HBEC3-KT: 37.9;hTCEpi: 20.3;K-562: 59.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA052615 Approved Nucleoplasm NA NA Nucleoplasm "HPA052615: AB_2797244" "unprognostic (4.48e-2)" "unprognostic (2.03e-3)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (8.67e-2)" "prognostic unfavorable (2.98e-9)" "unprognostic (2.62e-1)" "unprognostic (2.81e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (2.04e-1)" "unprognostic (2.22e-16)" "unprognostic (2.76e-1)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "unprognostic (6.07e-2)" 0.1 0.3 0.0 0.1 0.0 0.1 0.3 0.0 0.1 15.6 0.4 0.0 8.3 0.6 0.8 2.0 44.8 2.8 1.2 0.2 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 2.7 0.0 1.3 0.0 0.0 3.1 13.6 0.1 4.4 2.5 0.2 0.0 0.1 0.1 0.3 0.0 0.1 0.3 13.4 28.6 3.1 18.4 0.4 0.3 0.7 0.2 0.3 0.4 0.0 24.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 3.2 0.0 0.0 7.8 0.0 37.9 0.0 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 20.3 0.0 5.2 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 2.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.2 0.4 0.1 0.3 0.1 0.2 0.1 0.0 0.4 0.1 0.2 0.7 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.4 0.0 0.6 0.0 4.0 4.5 1.8 0.0 0.0 0.0 0.3 0.6 0.0 0.5 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 1.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.2 13.2 0.0 0.0 0.4 19.7 FAM83B "C6orf143, FLJ30642" ENSG00000168143 "Family with sequence similarity 83 member B" Q5T0W9 6 54846771-54942022 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 32.7;intestine: 24.6;tongue: 30.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 29.9;Basal keratinocytes: 30.0;Suprabasal keratinocytes: 35.9;Urothelial cells: 28.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 15.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 12.6;HaCaT: 14.1;HBEC3-KT: 7.7;hTCEpi: 14.2;hTERT-HME1: 18.7;RT4: 16.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA031464, HPA031465" Enhanced NA NA "HPA031464: AB_10599973, HPA031465: AB_10601566" "unprognostic (2.29e-1)" "unprognostic (3.93e-2)" "unprognostic (3.71e-2)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (7.27e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (7.60e-4)" "unprognostic (1.62e-1)" "unprognostic (3.19e-2)" "unprognostic (1.85e-1)" "unprognostic (4.35e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (1.86e-5)" 0.4 0.4 0.4 6.9 0.4 0.0 1.6 0.4 0.4 8.8 16.4 0.0 1.9 6.5 0.4 2.9 32.7 1.4 7.0 1.6 0.4 0.4 6.3 0.5 0.5 0.0 0.4 0.0 0.5 3.7 0.0 0.4 15.6 0.0 5.5 8.2 0.0 5.5 1.7 3.5 22.3 24.6 1.3 0.4 0.4 3.6 0.9 0.0 4.3 11.0 30.1 8.5 4.3 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.1 0.0 0.0 0.0 0.0 5.6 0.0 0.1 0.0 0.0 5.4 2.9 0.0 0.0 0.0 0.0 14.1 0.0 7.7 0.0 0.0 1.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 14.2 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.3 2.9 0.0 0.0 0.0 0.0 5.8 16.1 0.2 0.0 2.4 0.4 0.0 2.6 3.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 29.9 30.0 0.0 2.4 5.1 0.0 7.9 7.0 0.0 8.0 0.0 5.5 4.5 0.0 9.3 0.0 2.9 9.4 0.7 7.2 0.0 0.0 0.5 0.0 1.2 0.6 0.0 1.8 0.0 0.0 0.0 0.0 5.5 0.0 3.6 10.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 35.9 15.7 0.0 7.1 28.6 FAM83D "C20orf129, CHICA, dJ616B8.3" ENSG00000101447 "Family with sequence similarity 83 member D" Q9H4H8 20 38926312-38953106 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;smooth muscle: 69.8" "Cell type enhanced" "Detected in many" 22 "Erythroid cells: 23.3;Extravillous trophoblasts: 36.2;Syncytiotrophoblasts: 127.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "B-cells: 1.6;NK-cells: 2.4;T-cells: 4.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049333, HPA060854" Supported "Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol" Yes Yes "Mitotic spindle" "Microtubules, Cytokinetic bridge, Cytosol" "HPA049333: AB_2680717, HPA060854: " "unprognostic (7.90e-3)" "unprognostic (4.34e-2)" "unprognostic (6.41e-2)" "prognostic unfavorable (1.49e-4)" "unprognostic (1.95e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (5.44e-6)" "prognostic unfavorable (9.69e-4)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.73e-5)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.81e-14)" "unprognostic (2.57e-3)" "unprognostic (5.74e-2)" "unprognostic (2.82e-1)" "unprognostic (4.87e-2)" 0.5 0.5 0.5 4.9 0.8 7.9 0.7 0.4 1.2 1.7 29.6 0.4 0.7 3.4 0.8 1.5 39.0 0.2 5.6 1.5 0.5 0.1 2.2 1.4 2.6 1.5 0.3 0.5 0.7 0.2 0.0 0.3 2.2 0.7 7.6 3.6 1.2 3.1 1.0 0.4 4.1 16.2 69.8 0.4 1.0 22.8 3.8 0.2 9.2 0.5 8.6 17.9 24.5 6.4 1.6 0.1 0.0 0.4 2.4 4.6 1.2 31.5 19.5 15.4 12.9 1.7 2.0 27.7 14.2 8.9 28.2 17.3 29.8 14.5 8.0 14.1 9.3 21.9 27.2 21.1 24.4 26.5 2.6 8.3 9.3 15.0 21.4 1.4 4.1 4.9 1.0 1.2 16.2 9.4 3.4 15.4 3.6 8.2 11.6 16.0 17.0 6.3 6.0 12.8 18.4 24.9 6.1 28.5 4.4 8.1 8.1 7.1 11.9 41.5 34.7 6.1 15.0 21.7 4.2 7.3 18.7 23.0 21.2 31.3 3.5 5.4 8.3 8.4 6.1 13.7 0.0 0.0 0.0 0.7 0.4 2.3 1.6 2.4 2.7 0.1 1.6 2.7 3.4 0.0 2.4 0.1 0.0 4.6 1.2 0.5 0.8 0.4 1.2 0.5 0.1 0.3 0.5 0.7 0.2 0.0 2.2 0.0 5.2 2.1 0.0 0.8 0.0 1.4 1.2 0.0 0.0 2.6 0.0 0.0 0.4 0.5 2.6 23.3 0.0 36.2 0.9 0.7 0.0 5.4 4.0 0.0 1.7 1.8 2.1 0.6 0.3 0.4 0.0 0.0 2.2 0.0 0.1 3.7 0.0 4.3 0.0 19.4 2.1 11.1 14.5 1.6 127.6 2.2 2.5 4.3 FAM83G "FLJ41564, PAWS1" ENSG00000188522 "Family with sequence similarity 83 member G" A6ND36 17 18968789-19004804 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 36.0;skin 1: 33.8;tongue: 28.9" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 69.0;Suprabasal keratinocytes: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA023369, HPA023940" Enhanced Approved Cytosol NA NA Cytosol "HPA023369: AB_1848415, HPA023940: AB_1848416" "unprognostic (2.12e-2)" "unprognostic (5.90e-2)" "unprognostic (1.17e-1)" "unprognostic (9.48e-2)" "unprognostic (1.42e-3)" "unprognostic (2.04e-2)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.07e-3)" "unprognostic (1.14e-1)" "unprognostic (2.03e-2)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (5.65e-2)" "prognostic favorable (7.58e-6)" "unprognostic (9.68e-2)" "unprognostic (5.13e-2)" "unprognostic (3.74e-2)" 1.8 1.0 0.5 5.1 0.8 0.6 2.2 1.0 0.8 6.2 5.5 0.4 1.3 6.6 1.4 0.9 36.0 0.8 13.4 8.7 0.9 0.6 2.6 26.5 2.3 1.5 0.4 0.4 1.1 7.0 4.7 2.2 2.6 1.6 1.7 3.2 1.5 5.7 3.0 3.4 33.8 10.1 1.6 0.4 1.0 5.9 0.8 0.3 3.2 3.3 28.9 19.1 2.4 6.9 1.5 0.2 3.4 0.7 0.0 2.6 0.7 12.5 11.6 0.1 0.0 0.4 1.1 19.2 13.2 5.8 11.2 8.5 14.8 4.6 8.3 8.1 8.7 9.2 15.0 1.9 11.1 5.2 6.7 4.2 0.2 5.7 8.1 8.4 1.4 4.2 1.5 20.9 7.2 12.0 4.2 4.0 1.3 3.9 0.3 3.1 7.7 0.3 3.1 5.8 17.5 0.0 0.0 0.0 4.0 5.5 3.2 6.0 0.0 4.5 2.8 0.8 16.3 4.9 1.8 7.4 7.0 11.7 3.3 15.2 1.1 2.0 2.1 5.4 0.0 4.5 3.4 0.0 0.0 2.6 0.1 1.4 1.1 1.5 0.8 0.2 1.5 1.4 0.2 0.0 0.0 0.7 0.2 1.8 0.7 0.5 0.8 1.0 0.8 0.9 0.6 0.4 0.4 1.6 0.3 3.0 2.1 0.0 10.6 69.0 0.0 3.5 10.2 0.0 2.3 7.0 0.0 0.1 0.0 13.9 0.0 0.3 27.0 0.0 8.7 8.1 1.0 10.5 9.2 18.3 1.2 0.0 6.8 1.3 0.0 0.4 0.0 2.1 5.0 1.8 11.2 0.0 17.5 10.5 0.0 4.3 0.1 0.0 2.2 0.1 1.1 59.8 1.6 0.7 9.8 7.8 FAM83H FLJ46072 ENSG00000180921 "Family with sequence similarity 83 member H" Q6ZRV2 8 143723933-143733801 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.2;lymphoid tissue: 30.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 19.7;MCF7: 27.0;RT4: 16.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA024505, HPA024604" Enhanced Approved Cytosol NA NA Cytosol "HPA024505: AB_1848417, HPA024604: AB_1848418" "unprognostic (3.80e-2)" "unprognostic (3.75e-3)" "unprognostic (6.87e-2)" "unprognostic (1.63e-2)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.93e-1)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (3.95e-2)" "unprognostic (9.69e-3)" "prognostic favorable (4.42e-4)" "unprognostic (5.54e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" 0.8 1.9 1.2 4.1 1.0 0.2 2.9 0.2 1.6 8.8 12.5 0.9 6.1 6.3 1.1 3.0 42.2 3.0 17.7 0.3 1.1 0.4 5.0 10.4 3.9 0.5 0.3 0.6 1.3 6.7 5.9 2.8 8.9 0.9 5.6 2.7 2.6 8.3 2.9 0.1 17.7 17.9 1.8 0.7 0.7 9.1 1.3 0.2 1.1 6.9 27.9 30.7 5.1 9.5 0.3 0.2 0.5 0.3 0.1 0.2 0.0 13.8 6.5 0.0 0.0 0.0 0.0 12.2 0.9 0.0 0.4 0.1 5.9 12.5 0.0 10.1 0.2 0.0 19.7 0.8 12.1 0.2 1.0 2.2 0.3 13.0 4.1 1.0 0.3 0.9 0.7 14.3 0.0 3.6 0.2 0.0 0.9 7.3 0.0 0.0 27.0 0.2 0.0 2.5 14.3 6.0 0.0 0.0 1.3 3.9 16.2 3.8 0.0 10.9 12.7 2.1 1.8 13.7 1.8 0.0 0.0 3.9 0.9 0.0 1.9 2.0 0.0 0.0 0.0 0.6 0.3 0.3 0.1 0.2 0.0 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 1.2 1.0 0.2 1.6 1.1 0.4 0.3 0.6 0.9 0.2 29.8 16.8 0.0 12.2 20.3 1.2 3.6 22.9 9.4 12.5 27.9 2.0 10.1 3.3 18.5 1.1 1.2 29.9 0.0 22.0 15.5 1.8 19.5 0.0 21.2 4.0 9.5 13.8 0.6 1.9 0.0 0.0 1.1 1.7 3.6 23.7 6.0 31.6 21.5 0.4 6.5 2.1 0.0 1.2 1.2 1.0 23.5 12.2 0.8 22.5 29.2 FMO2 ENSG00000094963 "Flavin containing monooxygenase 2" Q99518 1 171185208-171211230 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 40.0;esophagus: 35.3;lung: 53.0" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 428.8;Club cells: 348.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 57 "ASC diff: 24.6;ASC TERT1: 11.2;HSkMC: 29.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA028261 Approved NA NA "HPA028261: AB_10601012" "unprognostic (1.85e-2)" "unprognostic (3.14e-2)" "unprognostic (7.44e-2)" "unprognostic (3.75e-2)" "unprognostic (2.80e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-3)" "unprognostic (3.00e-2)" "unprognostic (2.74e-1)" "unprognostic (1.58e-2)" "unprognostic (1.16e-1)" "unprognostic (4.28e-1)" "unprognostic (1.53e-1)" "unprognostic (1.26e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (3.83e-2)" 40.0 11.8 1.2 1.7 4.4 0.0 22.5 1.5 0.6 7.6 5.0 0.6 2.9 0.3 1.9 3.5 35.3 6.7 2.0 17.4 1.8 1.2 9.4 1.8 53.0 5.7 3.9 1.2 6.1 2.1 1.8 7.0 0.0 2.4 6.0 0.7 8.3 14.0 1.3 7.6 1.7 1.5 2.5 1.9 0.4 2.4 3.3 1.3 0.4 5.8 6.8 5.5 5.0 10.2 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 29.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 4.4 1.5 0.6 1.8 1.2 3.9 1.2 2.4 1.3 428.8 20.8 0.0 5.3 0.3 0.2 6.9 0.0 62.9 348.1 1.8 0.0 0.0 0.0 0.0 2.7 5.3 0.0 0.0 0.0 0.0 0.6 3.0 3.5 0.0 0.0 0.0 0.0 4.3 0.0 2.3 0.9 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 8.4 0.2 0.0 3.4 0.3 0.0 0.0 0.0 0.0 0.0 1.1 FOSL1 fra-1 ENSG00000175592 "FOS like 1, AP-1 transcription factor subunit" P15407 11 65892049-65900573 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 35.2;tongue: 46.8" "Group enriched" "Detected in many" 7 "Basal glandular cells: 279.5;Basal keratinocytes: 300.3;Glandular cells: 139.2;Suprabasal keratinocytes: 296.9;Urothelial cells: 386.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "myeloid DC: 6.9" "Lineage enriched" "Detected in many" 4 "dendritic cells: 6.9" "Cell line enhanced" "Detected in many" "PC-3: 94.2;U-2197: 63.2;WM-115: 142.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004396, HPA030728" Enhanced Supported Nucleoplasm NA Yes Nucleoplasm "CAB004396: AB_627632, HPA030728: " "unprognostic (2.88e-2)" "unprognostic (1.56e-1)" "unprognostic (9.46e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (1.80e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (9.26e-5)" "unprognostic (7.85e-2)" "prognostic unfavorable (6.40e-6)" "unprognostic (2.23e-1)" "unprognostic (1.53e-1)" "unprognostic (2.28e-1)" "unprognostic (2.82e-2)" 22.4 3.7 1.5 8.2 3.1 17.9 3.6 1.1 2.8 5.4 2.8 1.5 0.2 0.8 2.1 2.0 35.2 4.4 24.4 5.8 2.3 1.3 2.2 4.4 7.7 1.7 2.6 0.5 2.6 9.9 0.4 2.0 3.2 6.5 3.1 1.7 0.6 5.4 1.0 6.6 9.2 2.0 3.6 3.5 1.6 8.7 1.5 2.3 0.3 2.1 46.8 16.5 16.6 4.6 0.0 6.9 1.0 1.6 0.0 0.6 1.1 36.6 5.4 0.6 2.4 5.5 5.5 5.3 34.3 31.5 29.7 16.7 1.7 30.5 0.0 7.5 23.7 46.9 6.9 2.2 27.6 25.5 1.1 0.0 2.2 0.5 4.0 6.9 1.4 0.8 2.3 2.8 23.3 35.2 14.5 9.5 0.0 5.3 0.2 38.9 1.5 0.0 3.0 2.5 3.1 94.2 0.1 3.0 0.1 13.8 2.4 0.0 0.0 2.0 0.0 25.7 1.6 0.1 1.3 23.7 35.2 7.2 63.2 50.2 0.0 0.1 0.1 49.5 0.6 142.9 0.0 1.6 0.0 0.3 1.1 0.2 0.0 0.6 0.3 6.9 0.0 0.6 0.0 1.0 0.0 0.5 0.8 0.0 1.1 1.5 3.1 1.1 2.7 2.3 1.3 2.6 0.5 6.5 2.3 6.0 4.1 0.0 279.5 300.3 0.0 0.6 0.0 9.4 19.4 0.0 0.0 1.1 0.0 14.2 0.1 11.3 2.8 0.0 3.1 3.8 23.0 139.2 9.2 0.0 1.8 0.0 10.9 8.0 0.6 0.0 0.3 9.0 42.2 1.8 1.2 0.0 23.7 0.2 0.0 0.0 0.0 0.0 40.8 0.2 0.7 296.9 14.8 0.0 0.7 386.7 FOXF2 "FKHL6, FREAC2" ENSG00000137273 "Forkhead box F2" Q12947 6 1389576-1395603 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.5;intestine: 24.0;retina: 58.7" "Cell type enhanced" "Detected in some" 10 "Fibroblasts: 3.1;Leydig cells: 2.3;Melanocytes: 1.7;Peritubular cells: 2.5;Smooth muscle cells: 1.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 40.0;HEK 293: 13.3;U-2197: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "unprognostic (2.14e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "unprognostic (1.68e-1)" "unprognostic (5.39e-2)" "unprognostic (3.32e-2)" "unprognostic (8.12e-2)" "unprognostic (1.11e-1)" "unprognostic (9.89e-3)" "unprognostic (2.53e-1)" "unprognostic (4.50e-2)" "unprognostic (8.76e-2)" "unprognostic (8.75e-7)" "unprognostic (1.03e-1)" "unprognostic (4.74e-2)" "unprognostic (2.08e-2)" "unprognostic (8.29e-2)" 1.4 0.4 3.5 3.4 4.4 0.1 2.2 1.7 3.9 1.3 24.0 2.3 0.0 7.6 0.2 1.2 28.5 0.4 2.0 0.5 2.8 2.4 0.2 0.3 13.6 0.6 3.7 3.2 0.2 0.7 0.8 5.5 11.5 2.2 13.2 12.3 58.7 0.8 1.0 0.6 0.9 15.8 4.8 2.1 0.2 12.6 0.8 1.4 0.0 2.5 2.7 2.4 9.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.9 0.6 0.5 1.9 2.9 0.0 8.3 40.0 3.6 1.6 0.1 0.0 0.0 1.8 2.6 3.9 6.5 6.9 0.3 1.6 0.0 13.3 0.0 3.1 0.0 3.6 0.0 0.2 0.5 2.8 0.0 3.4 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.1 0.0 2.1 0.0 2.8 0.8 0.0 0.1 0.0 3.3 6.3 16.3 1.5 0.2 0.0 0.0 0.0 2.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.4 1.7 3.9 2.8 2.4 3.7 3.2 2.2 1.4 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.2 3.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.2 1.7 0.0 0.0 0.0 0.1 0.0 2.5 0.0 0.2 0.0 1.4 0.0 0.4 0.1 0.1 0.0 0.0 0.0 FUT3 "CD174, LE" ENSG00000171124 "Fucosyltransferase 3 (Lewis blood group)" P21217 19 5842888-5851474 "Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 106.6;Mucus-secreting cells: 61.1;Paneth cells: 66.6;Undifferentiated cells: 39.4" "Cancer enhanced" "Detected in many" "colorectal cancer: 41.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 29.9;hTCEpi: 4.7;OE19: 13.4;RH-30: 10.1;SK-BR-3: 4.8" HPA046966 Supported NA NA "HPA046966: AB_2679879" "prognostic unfavorable (6.86e-4)" "unprognostic (2.59e-1)" "unprognostic (1.06e-1)" "unprognostic (9.12e-2)" "unprognostic (8.58e-3)" "unprognostic (1.63e-3)" "unprognostic (3.88e-2)" "unprognostic (2.03e-2)" "unprognostic (4.02e-2)" "unprognostic (3.98e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "prognostic favorable (8.22e-7)" "unprognostic (5.66e-3)" "unprognostic (9.56e-2)" "unprognostic (4.30e-2)" "unprognostic (1.07e-1)" 0.2 0.1 0.2 14.5 0.2 0.0 0.4 0.2 0.2 10.9 40.4 0.2 32.5 18.8 0.4 0.5 53.6 0.7 21.5 0.1 0.2 0.2 3.8 0.9 5.1 0.1 0.2 0.1 0.5 4.7 0.0 0.3 0.6 0.1 1.0 18.1 0.2 27.5 31.6 0.1 1.0 49.3 1.0 0.2 0.1 8.1 1.3 0.1 0.3 0.1 14.9 38.4 2.9 16.1 0.2 1.6 0.8 0.6 0.0 0.5 0.0 29.9 0.0 0.1 0.1 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.4 0.0 0.0 1.3 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 13.4 0.0 0.0 10.1 1.0 0.0 0.5 0.0 0.1 0.0 4.8 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.8 0.0 0.0 1.6 0.5 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.0 4.5 0.0 1.8 0.0 1.4 0.3 12.7 2.7 2.3 0.0 0.0 0.0 0.0 33.7 4.3 0.0 106.6 0.0 12.8 0.1 0.0 0.5 9.2 0.2 0.0 0.0 13.2 0.0 0.0 5.5 0.0 0.0 0.0 0.0 61.1 1.4 29.6 66.6 0.0 12.0 32.6 0.0 0.1 0.0 0.2 0.0 0.2 0.0 39.4 16.0 FUT6 "FCT3A, FLJ40754, FT1A, FucT-VI" ENSG00000156413 "Fucosyltransferase 6" P51993 19 5830610-5839731 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0" "Cell type enhanced" "Detected in some" 13 "Enterocytes: 54.8;Mucus-secreting cells: 33.5;Proximal tubular cells: 29.8;Undifferentiated cells: 19.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1" "Group enriched" "Detected in many" 7 "granulocytes: 3.7;NK-cells: 2.1" "Group enriched" "Detected in some" 5 "Hep G2: 14.9;RPMI-8226: 5.6" "HPA043707, HPA046966" Approved Supported "Golgi apparatus" NA NA "Golgi apparatus" "HPA043707: AB_2678628, HPA046966: AB_2679879" "unprognostic (3.65e-2)" "unprognostic (3.00e-3)" "unprognostic (2.13e-3)" "unprognostic (2.78e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.12e-4)" "unprognostic (8.02e-2)" "unprognostic (6.68e-3)" "unprognostic (4.01e-2)" "unprognostic (8.53e-2)" "unprognostic (2.62e-2)" "unprognostic (4.94e-2)" "prognostic favorable (3.17e-8)" "unprognostic (1.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" 0.2 0.2 0.2 7.2 0.2 0.1 0.8 0.2 0.2 9.2 26.4 0.0 9.5 15.6 0.7 7.6 40.8 0.6 25.4 0.2 0.2 0.2 27.2 6.5 1.3 0.2 0.2 0.0 0.2 2.2 0.0 0.8 0.0 0.0 0.3 6.9 0.0 37.0 19.1 0.2 0.2 44.4 0.2 0.2 0.2 2.8 0.3 0.0 0.0 0.2 16.4 33.9 0.2 12.4 0.4 0.3 3.7 0.3 2.1 0.3 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.2 14.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 1.2 5.6 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.0 0.0 0.3 0.1 3.7 0.3 0.4 0.2 0.1 0.1 0.1 0.3 0.2 0.1 0.4 0.3 0.2 1.2 2.1 0.1 0.3 0.1 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.3 0.3 15.3 1.4 0.0 1.8 0.0 0.1 3.3 4.7 0.2 0.0 54.8 0.0 0.3 0.1 0.3 0.2 0.0 4.9 0.1 0.0 4.7 0.6 0.0 0.0 0.3 0.0 0.0 0.0 33.5 0.5 1.6 15.6 0.0 29.8 12.1 0.0 0.1 0.6 0.5 0.1 0.0 0.0 19.9 1.4 FZD10 CD350 ENSG00000111432 "Frizzled class receptor 10" Q9ULW2 12 130162459-130165740 "CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.9;lymphoid tissue: 18.6" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 3.9;Basal keratinocytes: 7.4;Smooth muscle cells: 14.4;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 8.6;BEWO: 9.9;hTCEpi: 5.7;RPTEC TERT1: 3.0;RT4: 4.8" "Region enhanced" "Detected in some" "thalamus: 7.6" "Low region specificity" "Detected in many" "HPA014484, HPA014485" Uncertain Enhanced Nucleoplasm NA NA Nucleoplasm "HPA014484: AB_1849132, HPA014485: AB_1849134" "unprognostic (2.41e-3)" "unprognostic (3.29e-1)" "unprognostic (4.74e-2)" "prognostic favorable (5.05e-7)" "unprognostic (2.81e-2)" "unprognostic (4.63e-2)" "unprognostic (8.62e-3)" "unprognostic (6.33e-2)" "unprognostic (5.41e-2)" "unprognostic (3.77e-2)" "unprognostic (2.70e-1)" "unprognostic (2.24e-3)" "unprognostic (2.66e-9)" "unprognostic (2.18e-1)" "unprognostic (3.07e-1)" "unprognostic (1.49e-2)" "unprognostic (1.07e-1)" 1.1 0.4 1.0 0.5 1.9 0.2 1.5 5.4 2.1 11.6 0.6 2.1 1.6 0.4 5.1 3.4 26.9 2.2 7.1 0.5 1.0 1.0 0.4 0.2 2.0 0.9 1.6 1.2 3.4 1.1 0.2 1.4 9.2 1.9 3.7 0.6 3.0 5.4 3.1 1.2 10.2 0.7 0.9 1.2 0.3 1.0 0.7 2.0 0.6 1.7 9.0 18.6 5.1 7.2 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.0 8.6 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 1.5 0.7 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.1 3.0 4.8 0.1 0.0 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.0 1.9 5.4 2.1 1.0 1.0 1.6 1.2 1.9 2.0 0.0 0.3 0.0 3.9 7.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 1.1 0.0 0.0 0.2 0.3 2.5 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 14.4 0.0 0.4 7.4 0.7 0.0 0.0 1.1 GABRP ENSG00000094755 "Gamma-aminobutyric acid type A receptor pi subunit" O00591 5 170763350-170814047 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.0;lymphoid tissue: 57.7" "Cell type enhanced" "Detected in some" 23 "Cholangiocytes: 48.4;Pancreatic endocrine cells: 33.1;Urothelial cells: 141.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 10.1" "Group enriched" "Detected in many" 6 "granulocytes: 10.1;monocytes: 6.1" "Cell line enhanced" "Detected in many" "A-431: 39.5;EFO-21: 46.1;HeLa: 27.7;PC-3: 63.2;SuSa: 85.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB014883 Uncertain NA NA "CAB014883: " "unprognostic (3.98e-3)" "prognostic favorable (3.37e-4)" "unprognostic (8.34e-2)" "unprognostic (1.57e-1)" "unprognostic (8.90e-2)" "unprognostic (1.27e-1)" "unprognostic (7.89e-2)" "unprognostic (4.97e-3)" "unprognostic (3.72e-1)" "unprognostic (4.93e-3)" "unprognostic (1.30e-3)" "unprognostic (2.30e-1)" "unprognostic (1.40e-2)" "unprognostic (1.60e-1)" "unprognostic (1.82e-1)" "unprognostic (5.92e-3)" "unprognostic (6.52e-3)" 1.5 0.5 0.5 1.3 0.5 1.1 31.6 0.5 1.1 18.5 1.7 0.6 2.6 2.6 30.4 9.9 37.0 2.2 8.6 1.0 0.5 0.4 6.9 3.8 2.5 0.5 0.5 0.5 1.1 4.3 0.0 2.4 5.5 0.6 6.8 0.4 0.8 25.5 3.2 2.0 10.0 3.9 0.5 0.5 0.8 5.0 1.0 0.5 2.5 0.6 3.1 57.7 1.2 20.0 0.9 1.1 10.1 6.1 0.2 1.3 3.1 39.5 1.8 1.9 1.3 0.1 0.8 4.6 0.7 0.2 0.1 0.1 7.1 4.5 0.6 46.1 0.2 0.4 14.3 1.2 0.0 0.1 0.6 1.4 2.6 27.7 1.0 0.1 0.9 2.2 0.3 0.5 0.5 0.3 1.5 0.2 2.5 10.6 5.0 0.0 1.2 1.7 0.8 16.2 0.7 63.2 2.5 1.2 1.5 2.6 2.2 1.6 0.7 14.6 0.7 0.4 85.1 0.8 0.4 1.6 3.7 13.5 3.0 2.9 1.9 1.2 1.1 0.5 2.6 0.5 10.1 2.3 6.8 0.5 1.7 1.3 0.3 0.5 0.4 0.7 0.9 0.7 0.6 5.4 0.2 6.1 1.1 0.7 3.1 0.5 0.5 0.5 0.6 0.5 0.4 0.5 0.5 0.6 0.5 3.0 1.1 0.0 14.6 0.0 0.0 0.4 48.4 12.0 15.9 1.8 0.0 3.6 0.0 0.8 0.0 0.0 0.0 0.0 12.6 0.1 0.8 15.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 33.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.4 141.9 GDPD3 MGC4171 ENSG00000102886 "Glycerophosphodiester phosphodiesterase domain containing 3" Q7L5L3 16 30104810-30113856 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 30.8;lymphoid tissue: 40.8;tongue: 36.6" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 50.9;Extravillous trophoblasts: 52.5;Late spermatids: 201.8;Proximal tubular cells: 62.4" "Cancer enhanced" "Detected in all" "urothelial cancer: 21.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "eosinophil: 1.6;neutrophil: 5.1" "Lineage enriched" "Detected in single" 19 "granulocytes: 5.1" "Group enriched" "Detected in many" 5 "MCF7: 13.7;OE19: 16.9;SK-BR-3: 48.5" "Region enhanced" "Detected in single" "cerebellum: 0.9" "Low region specificity" "Detected in many" "HPA041148, HPA041470" Uncertain Approved "Nucleoplasm,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA041148: AB_10794545, HPA041470: AB_10795121" "unprognostic (4.12e-1)" "unprognostic (2.29e-2)" "unprognostic (2.01e-1)" "unprognostic (9.99e-2)" "unprognostic (2.53e-1)" "unprognostic (4.57e-3)" "unprognostic (1.09e-1)" "unprognostic (1.36e-1)" "unprognostic (4.53e-1)" "unprognostic (8.86e-3)" "unprognostic (6.59e-3)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.89e-9)" "unprognostic (3.11e-1)" "unprognostic (3.13e-1)" "unprognostic (1.12e-1)" "unprognostic (8.79e-3)" 3.0 0.9 1.2 10.5 1.2 0.5 2.5 5.7 1.3 9.4 11.3 1.2 1.2 4.0 2.8 3.4 30.8 2.1 3.6 1.7 1.2 0.7 5.9 1.2 3.7 2.3 1.2 1.2 3.3 1.2 0.4 2.3 12.9 2.5 2.4 7.4 1.2 4.9 1.2 1.3 5.3 8.6 2.4 1.2 4.1 8.3 1.2 1.2 1.9 2.3 36.6 40.8 2.7 9.2 0.1 0.0 5.1 0.2 0.0 0.2 0.0 5.3 0.0 1.9 0.5 0.5 2.8 1.6 0.5 0.4 0.5 0.6 0.6 3.7 0.6 0.7 0.3 0.1 0.5 0.5 0.2 0.5 1.0 1.5 0.1 0.8 2.5 0.5 0.2 0.4 0.1 0.7 1.5 0.1 1.5 2.1 2.0 0.4 0.9 0.7 13.7 0.4 0.9 1.1 16.9 0.2 2.5 0.6 2.9 1.1 2.4 0.5 0.9 0.0 48.5 0.3 0.5 0.9 1.0 1.5 0.5 0.5 1.1 0.5 1.6 0.3 0.6 1.4 0.8 0.3 0.1 0.0 1.6 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 5.1 0.0 0.1 0.0 0.1 0.0 1.2 1.2 5.7 1.3 1.2 0.7 1.2 1.2 2.5 1.2 6.0 0.6 0.0 0.6 1.1 1.1 0.9 0.0 1.4 1.2 5.2 0.0 20.4 5.0 1.0 50.9 4.0 43.6 0.0 1.2 52.5 2.1 1.4 0.0 0.0 2.8 1.6 3.4 3.7 3.0 201.8 3.1 0.7 1.7 1.0 28.5 0.2 11.2 12.9 2.8 62.4 1.7 6.5 1.4 1.2 1.2 1.8 7.8 1.5 4.7 3.9 GJB3 "CX31, DFNA2, EKV" ENSG00000188910 "Gap junction protein beta 3" O75712 1 34781189-34786369 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1" "Group enriched" "Detected in many" 7 "Basal glandular cells: 49.4;Basal keratinocytes: 123.0;Pancreatic endocrine cells: 70.6;Suprabasal keratinocytes: 149.2;Urothelial cells: 169.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 26.3;CAPAN-2: 37.4;HaCaT: 30.4;HBEC3-KT: 26.0;hTCEpi: 42.7;OE19: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA074472 Supported "Vesicles,Cell Junctions" NA NA "Vesicles, Cell Junctions" "HPA074472: AB_2686694" "unprognostic (1.34e-3)" "unprognostic (2.30e-1)" "unprognostic (2.84e-2)" "unprognostic (5.22e-3)" "unprognostic (3.82e-2)" "unprognostic (2.00e-2)" "unprognostic (1.21e-4)" "prognostic unfavorable (4.56e-4)" "unprognostic (2.30e-1)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.50e-2)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (1.22e-1)" "unprognostic (1.27e-2)" "unprognostic (2.46e-2)" 0.1 0.1 1.0 2.4 0.4 0.0 3.4 1.4 1.2 6.3 2.2 0.0 0.6 0.0 0.7 3.0 40.1 0.5 4.1 0.1 0.2 0.1 0.5 0.8 0.6 0.4 0.1 0.1 0.2 0.2 0.0 0.1 11.3 0.0 3.7 2.8 0.0 3.7 0.9 0.2 49.3 0.6 0.2 0.1 0.1 3.2 0.5 0.0 0.7 0.2 32.1 25.0 4.7 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 0.0 3.6 0.0 0.0 30.4 0.0 26.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 42.7 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 16.3 6.8 0.0 0.0 0.0 12.7 10.0 0.0 0.0 4.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.4 1.2 0.2 0.1 0.1 0.1 0.0 0.0 3.0 0.0 0.0 49.4 123.0 0.0 0.3 2.5 1.4 2.3 5.2 0.0 0.0 0.0 15.7 0.0 0.1 3.1 0.0 6.3 0.1 3.1 16.8 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.9 0.0 70.6 7.0 0.0 0.0 0.0 0.0 3.1 0.0 0.2 149.2 0.1 0.0 16.1 169.4 GJB5 CX31.1 ENSG00000189280 "Gap junction protein beta 5" O95377 1 34755047-34758512 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 39.0;lymphoid tissue: 26.1;skin 1: 37.7;tongue: 28.0" "Group enriched" "Detected in some" 16 "Basal glandular cells: 21.6;Basal keratinocytes: 43.0;Suprabasal keratinocytes: 73.0;Urothelial cells: 70.5" "Group enriched" "Detected in many" 5 "cervical cancer: 36.7;head and neck cancer: 57.5;lung cancer: 13.7;urothelial cancer: 21.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 9.9;HaCaT: 31.8;HBEC3-KT: 14.2;hTCEpi: 52.7;hTERT-HME1: 8.4;RT4: 17.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA038146 Uncertain NA NA "HPA038146: AB_10697242" "unprognostic (2.62e-1)" "unprognostic (1.63e-1)" "unprognostic (3.48e-1)" "unprognostic (5.71e-2)" "unprognostic (8.26e-2)" "unprognostic (3.12e-1)" "unprognostic (7.89e-2)" "unprognostic (2.76e-2)" "unprognostic (5.35e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (4.30e-2)" "unprognostic (1.09e-3)" "unprognostic (2.36e-1)" "unprognostic (2.41e-3)" "unprognostic (5.59e-2)" "unprognostic (5.67e-3)" 0.0 0.1 0.7 0.0 0.5 0.1 2.6 0.6 2.3 7.5 0.1 0.0 0.5 0.0 0.1 2.1 39.0 0.4 3.3 0.1 0.8 0.1 0.1 0.1 0.3 0.0 0.2 0.5 0.1 0.6 0.0 0.4 7.0 0.2 3.0 0.1 0.0 5.6 2.1 0.2 37.7 0.1 0.3 0.1 0.0 0.1 0.8 0.0 0.6 0.6 28.0 26.1 3.4 11.7 0.0 0.0 0.0 0.8 0.0 0.1 0.8 9.9 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.1 31.8 0.0 14.2 0.0 0.0 0.0 2.4 0.3 0.0 0.0 0.0 0.0 0.0 52.7 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 17.7 0.0 0.0 1.2 0.5 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.8 0.7 0.5 0.6 2.3 0.8 0.1 0.2 0.5 0.2 0.0 0.0 0.6 0.0 21.6 43.0 0.0 0.4 0.0 1.4 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 73.0 0.3 0.0 0.0 70.5 GJB6 "CX30, DFNA3, ED2, EDH, HED" ENSG00000121742 "Gap junction protein beta 6" O95452 13 20221962-20232395 "Disease related genes, Predicted membrane proteins" Hearing "Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 50.5;esophagus: 97.1;tongue: 43.6" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 10.9;Early spermatids: 3.4;Late spermatids: 4.4;Suprabasal keratinocytes: 3.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 145.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Lineage enhanced" "Detected in many" "T-cells: 5.7" "Cell line enriched" "Detected in some" 9 "RT4: 64.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014846 Supported "Cell Junctions" NA NA "Cell Junctions" "HPA014846: AB_1847135" "unprognostic (5.57e-2)" "unprognostic (1.20e-1)" "unprognostic (3.90e-4)" "unprognostic (7.90e-2)" "unprognostic (2.37e-1)" "unprognostic (1.69e-1)" "unprognostic (1.83e-1)" "unprognostic (8.96e-2)" "unprognostic (9.64e-2)" "unprognostic (2.82e-2)" "unprognostic (2.82e-2)" "unprognostic (3.54e-2)" "unprognostic (1.14e-11)" "unprognostic (8.99e-2)" "unprognostic (1.16e-1)" "unprognostic (6.35e-3)" "unprognostic (5.04e-2)" 1.2 1.0 15.3 1.1 17.0 50.5 3.3 9.0 15.9 16.9 1.0 1.9 0.0 1.0 1.6 1.1 97.1 1.2 1.8 1.0 16.3 7.9 1.0 1.0 1.1 1.4 11.1 11.3 1.0 1.0 1.0 0.7 1.0 9.2 1.1 1.1 0.0 8.7 1.0 1.0 18.7 1.0 1.0 3.7 1.1 1.2 1.7 6.0 7.9 4.1 43.6 15.7 6.3 30.9 1.4 0.0 1.2 0.0 0.0 5.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 64.8 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 1.4 2.7 1.5 1.2 0.0 0.0 0.0 5.7 0.6 15.3 17.0 9.0 15.9 16.3 7.9 11.1 11.3 9.2 6.0 0.0 0.0 0.0 1.0 10.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 3.3 0.0 0.0 0.0 2.0 GNA15 GNA16 ENSG00000060558 "G protein subunit alpha 15" P30679 19 3136193-3163769 "Plasma proteins, Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 37.4;esophagus: 46.0;lymphoid tissue: 42.2" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 95.5;Suprabasal keratinocytes: 83.7;Urothelial cells: 166.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 31.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 19.9;HMC-1: 46.9;MOLT-4: 46.9;NB-4: 17.6;REH: 35.1;THP-1: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043113 Approved NA NA "HPA043113: AB_10967343" "prognostic favorable (7.57e-5)" "unprognostic (6.06e-2)" "unprognostic (3.43e-1)" "prognostic favorable (2.01e-4)" "unprognostic (4.34e-2)" "unprognostic (2.09e-1)" "unprognostic (1.14e-2)" "unprognostic (5.38e-3)" "unprognostic (1.82e-1)" "unprognostic (3.22e-2)" "unprognostic (1.42e-3)" "unprognostic (1.69e-1)" "prognostic unfavorable (4.26e-6)" "unprognostic (1.04e-1)" "unprognostic (2.16e-3)" "unprognostic (2.36e-1)" "unprognostic (2.07e-1)" 4.9 1.7 1.6 7.2 2.3 37.4 3.9 1.1 2.0 7.9 1.3 1.6 1.0 1.0 0.8 1.8 46.0 1.3 2.8 2.6 1.6 1.1 1.3 1.2 7.6 3.7 3.1 1.3 1.0 0.7 0.2 0.8 4.5 2.7 5.9 1.1 1.3 9.2 1.7 0.8 20.0 1.1 1.8 2.8 5.6 2.5 1.1 2.2 42.2 0.7 29.0 25.3 10.4 16.2 0.0 31.0 6.2 12.6 2.1 3.9 5.1 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 10.9 0.0 19.9 0.0 0.0 0.0 5.6 0.0 0.0 0.0 8.0 46.9 0.0 12.4 0.0 8.2 0.0 0.0 5.0 0.0 0.1 0.0 0.0 46.9 17.6 0.0 0.8 0.0 35.1 0.0 0.0 0.0 7.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 5.8 12.6 6.2 0.0 9.7 0.5 0.0 1.0 0.1 13.0 0.0 0.0 0.0 3.1 2.1 6.5 31.0 3.9 5.1 1.6 2.3 1.1 2.0 1.6 1.1 3.1 1.3 2.7 2.2 8.9 9.1 0.0 95.5 59.6 0.1 0.6 0.0 1.4 12.5 3.5 0.0 0.4 0.0 0.1 0.4 0.6 0.0 0.0 0.0 0.5 5.6 57.4 34.5 0.0 58.7 0.0 6.3 0.6 33.9 0.4 0.0 47.4 20.3 30.7 1.8 0.0 7.7 0.0 0.0 0.0 0.0 19.4 4.1 3.2 2.2 83.7 0.3 1.3 1.4 166.1 GPR87 GPR95 ENSG00000138271 "G protein-coupled receptor 87" Q9BY21 3 151294086-151316952 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 24.8;skin 1: 19.7;tongue: 21.9" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 127.1;Suprabasal keratinocytes: 59.6;Syncytiotrophoblasts: 171.4;Urothelial cells: 178.7" "Group enriched" "Detected in many" 6 "cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3" "Region enriched" "Detected in single" 12 "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 31.5;HaCaT: 25.2;HBEC3-KT: 33.5;hTCEpi: 44.8;hTERT-HME1: 18.8;RT4: 13.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA066313 Approved "Nucleoplasm,Lipid droplets,Mitochondria" No No "Lipid droplets, Mitochondria" Nucleoplasm "HPA066313: AB_2685656" "unprognostic (5.81e-2)" "unprognostic (2.12e-1)" "unprognostic (4.07e-3)" "unprognostic (8.60e-2)" "unprognostic (1.28e-2)" "unprognostic (4.61e-3)" "unprognostic (3.28e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (4.62e-6)" "unprognostic (8.64e-2)" "unprognostic (1.50e-3)" "unprognostic (3.66e-4)" "unprognostic (8.73e-2)" "unprognostic (3.80e-2)" "unprognostic (2.17e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.4 6.5 0.0 0.0 2.8 0.0 0.4 2.1 24.8 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.6 11.1 5.1 4.5 0.0 0.0 9.5 4.0 0.0 19.7 0.0 0.4 0.0 0.0 0.2 0.7 0.0 2.0 0.0 21.9 13.5 6.2 13.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.2 0.0 0.0 11.5 0.0 0.0 0.0 0.1 25.2 0.0 33.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 44.8 0.0 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 1.1 13.2 0.0 0.0 5.6 0.1 0.0 0.9 0.1 0.0 0.0 0.0 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.6 0.0 127.1 52.7 0.0 0.0 0.0 4.0 20.5 3.5 0.0 46.3 0.0 1.3 0.1 0.2 0.0 0.0 0.6 10.3 2.1 36.4 1.1 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 59.6 171.4 0.0 0.0 178.7 GRB7 ENSG00000141738 "Growth factor receptor bound protein 7" Q14451 17 39737927-39747291 "Cancer-related genes, Predicted intracellular proteins" "Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 79.7;Glandular cells: 69.7;Syncytiotrophoblasts: 82.5;Urothelial cells: 65.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "cerebellum: 7.4" "Cell type enriched" "Detected in single" 20 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enriched" "Detected in some" 5 "OE19: 193.7" "Region enhanced" "Detected in some" "cerebellum: 9.3" "Low region specificity" "Detected in all" "CAB005226, HPA057084, CAB073538" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330" "unprognostic (8.46e-2)" "unprognostic (2.06e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.60e-7)" "unprognostic (7.06e-3)" "unprognostic (2.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.10e-4)" "prognostic unfavorable (6.90e-4)" "unprognostic (2.59e-2)" "prognostic favorable (8.23e-5)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (5.49e-3)" "unprognostic (4.01e-2)" 2.9 0.1 0.1 2.8 0.6 0.0 16.1 7.4 1.2 6.7 12.7 0.3 25.0 6.7 2.6 8.1 53.9 14.5 16.3 0.8 0.2 0.1 23.4 5.2 12.3 0.1 0.1 0.4 3.1 20.5 5.8 3.7 42.6 1.6 10.2 6.4 0.7 14.0 25.5 0.5 19.1 12.4 2.0 0.1 0.3 7.2 2.3 0.3 0.5 8.5 6.5 17.2 7.2 11.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.6 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 4.9 2.8 0.0 0.4 0.0 0.1 2.6 0.0 1.8 0.0 0.0 0.2 0.0 0.6 4.3 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 193.7 0.4 0.0 0.0 1.9 2.2 1.6 1.1 0.0 2.1 42.8 0.0 2.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 7.4 1.2 0.2 0.1 0.1 0.4 1.6 0.3 20.8 10.0 0.0 79.7 34.0 0.0 2.0 15.3 17.4 7.9 21.0 0.0 27.0 8.3 29.6 0.0 0.5 18.0 0.0 16.9 18.8 1.9 69.7 1.1 4.0 2.5 0.0 13.8 0.0 0.0 0.0 2.6 0.9 5.0 2.8 16.8 0.3 20.5 24.6 1.1 8.6 0.0 0.0 1.0 0.4 0.2 36.6 82.5 0.9 22.1 65.1 GRHL1 "LBP-32, MGR, TFCP2L2" ENSG00000134317 "Grainyhead like transcription factor 1" Q9NZI5 2 9951693-10002277 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.3;skin 1: 34.4" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 69.0;Suprabasal keratinocytes: 115.9;Syncytiotrophoblasts: 154.4;Urothelial cells: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "eosinophil: 4.8;neutrophil: 1.7" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.8" "Group enriched" "Detected in some" 4 "BEWO: 66.4;SK-BR-3: 34.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA005798, HPA006420" Enhanced Supported Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA005798: AB_1079026, HPA006420: AB_1079025" "unprognostic (2.26e-3)" "unprognostic (5.80e-2)" "unprognostic (8.35e-2)" "unprognostic (7.33e-3)" "unprognostic (2.70e-1)" "unprognostic (2.76e-2)" "unprognostic (4.43e-3)" "unprognostic (6.73e-2)" "unprognostic (1.68e-1)" "unprognostic (1.00e-1)" "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-4)" "unprognostic (3.66e-1)" "unprognostic (3.40e-1)" "unprognostic (4.04e-2)" "unprognostic (2.14e-1)" 1.7 0.6 1.5 0.2 2.4 2.8 15.9 2.0 1.6 10.2 0.9 0.2 10.8 0.3 0.9 3.8 40.3 0.7 1.0 1.6 1.9 1.2 2.5 4.9 2.3 0.2 0.7 1.4 0.5 1.5 12.9 2.6 31.0 0.8 6.1 0.2 1.8 17.5 9.7 0.9 34.4 0.7 5.1 0.6 0.6 1.3 1.6 0.4 0.4 2.8 22.3 25.3 6.7 16.9 0.1 0.2 4.8 0.2 0.5 0.6 4.5 3.2 0.0 0.4 0.9 0.1 0.1 66.4 0.3 0.4 0.2 0.3 0.2 2.3 0.4 0.1 0.0 0.4 2.0 4.0 0.4 0.9 0.9 1.8 0.1 0.6 1.2 0.0 0.2 0.3 0.1 1.7 1.9 0.0 0.0 0.3 0.7 0.6 1.2 0.0 4.2 0.6 0.5 0.2 1.0 0.7 0.2 0.3 0.5 0.4 12.6 0.7 0.5 0.6 34.9 0.8 5.7 4.2 0.1 0.3 0.2 0.8 1.0 0.4 0.8 0.5 0.4 0.2 0.5 0.5 0.0 0.2 4.8 0.1 0.1 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.6 4.5 1.5 2.4 2.0 1.6 1.9 1.2 0.7 1.4 0.8 0.4 3.0 7.2 0.0 18.6 35.5 20.9 1.2 0.0 6.7 29.6 19.2 58.9 48.9 0.0 2.8 6.0 3.1 0.5 0.0 8.0 69.0 6.1 30.1 10.3 5.7 6.7 11.1 3.4 3.1 1.3 2.1 0.0 2.7 20.3 1.0 0.6 1.7 4.8 0.0 0.4 1.7 11.8 0.0 6.1 5.1 5.3 115.9 154.4 1.3 0.4 97.4 GRHL3 "SOM, TFCP2L4" ENSG00000158055 "Grainyhead like transcription factor 3" Q8TE85 1 24319322-24364482 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 59.0;lymphoid tissue: 60.1;tongue: 51.5" "Group enriched" "Detected in some" 5 "Suprabasal keratinocytes: 86.8;Urothelial cells: 72.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 28.9" "Region enhanced" "Detected in some" "pons and medulla: 3.6" "Group enriched" "Detected in some" 12 "eosinophil: 1.0;neutrophil: 1.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 21.4;HaCaT: 16.8;MCF7: 25.9;OE19: 9.4;RT4: 29.6;SuSa: 16.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA059960 Enhanced Approved Nucleoplasm "Intracellular and membrane" NA NA Nucleoplasm "HPA059960: AB_2684180" "unprognostic (8.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.95e-2)" "unprognostic (7.83e-3)" "unprognostic (7.58e-3)" "unprognostic (6.28e-3)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (9.01e-3)" "unprognostic (4.03e-2)" "unprognostic (1.24e-1)" "unprognostic (7.36e-2)" "unprognostic (8.59e-4)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (6.97e-3)" "unprognostic (7.42e-2)" 0.1 0.1 0.1 0.1 0.9 0.0 1.0 0.2 0.9 9.0 0.1 0.2 0.0 0.2 0.6 0.8 59.0 0.2 0.6 0.1 1.1 0.3 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.1 0.9 0.1 1.1 3.6 3.6 0.1 0.0 5.9 0.9 0.2 21.7 0.1 0.5 3.0 0.0 0.2 1.1 0.1 0.5 0.1 51.5 60.1 12.3 11.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.5 1.2 0.4 0.0 0.0 0.0 21.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 16.8 0.0 1.5 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.6 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 25.9 0.0 0.1 1.1 9.4 0.0 0.0 0.0 0.1 2.1 29.6 0.1 0.0 0.0 2.9 0.0 16.3 1.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.1 0.9 0.2 0.1 1.1 0.3 0.1 0.0 3.6 0.1 0.0 1.1 0.0 8.8 12.8 0.0 0.4 0.0 2.7 2.3 1.8 0.0 3.5 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.1 0.3 9.1 0.0 0.4 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 1.8 0.0 86.8 15.4 0.0 0.0 72.5 HAS3 ENSG00000103044 "Hyaluronan synthase 3" O00219 16 69105564-69118719 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.6;urinary bladder: 22.9" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 144.1;Suprabasal keratinocytes: 138.5;Urothelial cells: 89.2" "Group enriched" "Detected in many" 8 "cervical cancer: 17.1;head and neck cancer: 44.9;lung cancer: 23.3;urothelial cancer: 31.1" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 14.4;PC-3: 76.9;RT4: 30.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031554, CAB033850" Supported Approved Microtubules NA NA Microtubules "CAB033850: AB_2116418, HPA031554: AB_10670703" "unprognostic (3.26e-2)" "unprognostic (1.22e-1)" "unprognostic (5.12e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (7.59e-3)" "unprognostic (2.86e-3)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.36e-4)" "unprognostic (2.46e-1)" "unprognostic (3.27e-3)" "unprognostic (3.25e-2)" "unprognostic (1.32e-1)" "unprognostic (2.21e-2)" "unprognostic (3.40e-3)" 0.4 0.2 0.4 0.4 1.0 0.3 5.5 1.1 1.3 3.3 3.7 0.4 0.4 1.9 0.8 1.1 22.6 0.7 3.5 2.4 0.6 0.6 1.2 0.7 18.0 0.4 0.4 0.4 0.9 2.2 0.1 1.0 3.3 1.1 3.5 2.3 0.6 7.6 2.1 0.6 5.7 2.1 1.4 0.4 0.4 9.0 2.0 0.4 0.5 4.0 11.7 11.1 22.9 13.6 1.5 1.2 2.2 1.4 0.4 2.0 1.1 0.9 4.8 0.3 0.2 0.1 0.1 1.8 0.3 0.1 0.2 0.1 1.0 2.5 0.2 0.6 0.1 1.1 14.4 0.8 8.6 0.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.1 2.4 0.3 0.8 1.1 0.1 0.1 0.0 0.1 0.0 0.5 0.3 0.1 4.3 5.0 76.9 0.5 0.0 0.0 7.9 30.4 5.4 0.2 0.5 0.0 0.1 0.9 0.2 0.2 0.1 0.2 0.2 8.4 0.5 0.3 0.2 0.0 0.3 0.0 0.1 0.8 1.4 2.2 1.4 0.7 1.3 0.7 1.1 0.5 1.2 1.5 2.0 0.7 0.5 0.4 1.1 1.0 1.5 1.1 0.4 1.0 1.1 1.3 0.6 0.6 0.4 0.4 1.1 0.4 0.0 25.0 0.0 35.3 144.1 1.4 1.4 0.0 0.0 4.5 0.0 2.0 0.9 0.0 3.2 10.2 2.0 2.0 0.0 3.1 0.7 0.8 9.4 0.0 0.0 0.3 0.0 0.0 1.3 0.0 17.0 1.1 0.6 3.3 0.0 0.3 0.1 2.3 0.0 0.4 0.6 0.9 0.0 2.5 0.6 0.4 138.5 0.2 0.5 1.5 89.2 HES2 bHLHb40 ENSG00000069812 "Hes family bHLH transcription factor 2" Q9Y543 1 6412418-6424670 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 22.6;placenta: 60.9" "Cell type enhanced" "Detected in many" 11 "Mucus-secreting cells: 46.1;Paneth cells: 29.4;Syncytiotrophoblasts: 83.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 4.9;neutrophil: 3.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 4.9" "Cell line enhanced" "Detected in some" "BEWO: 10.9;HaCaT: 20.3;HBEC3-KT: 17.5;hTCEpi: 10.1;PC-3: 7.3;TIME: 29.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039462 Uncertain NA NA "HPA039462: AB_10673533" "unprognostic (1.96e-1)" "unprognostic (7.00e-2)" "unprognostic (1.66e-1)" "unprognostic (6.82e-3)" "unprognostic (1.13e-2)" "unprognostic (1.89e-1)" "unprognostic (2.56e-4)" "unprognostic (4.74e-2)" "unprognostic (7.41e-2)" "unprognostic (3.20e-2)" "unprognostic (5.63e-3)" "unprognostic (1.38e-1)" "unprognostic (7.67e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-2)" 0.8 0.0 0.2 0.7 0.2 0.2 0.7 0.2 0.3 6.7 6.0 0.2 0.2 0.1 0.4 0.4 22.6 2.5 0.2 0.2 0.2 0.0 1.0 0.4 3.8 0.2 0.2 0.2 0.5 0.2 0.2 0.4 60.9 0.3 1.2 4.6 0.5 2.9 0.6 0.2 14.5 0.9 0.2 0.2 0.2 0.0 1.8 0.2 0.7 0.2 8.6 6.0 0.3 11.9 0.6 0.6 4.9 0.4 0.5 0.6 0.2 0.9 0.3 0.0 0.1 0.2 0.0 10.9 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.9 0.1 0.1 20.3 0.5 17.5 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.0 10.1 0.0 0.4 0.0 5.3 0.0 0.1 0.2 0.0 1.5 0.0 0.8 0.0 1.1 7.3 0.0 0.0 0.1 0.1 0.3 0.1 0.0 1.0 5.7 0.2 1.1 0.8 0.3 29.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.4 0.6 0.5 0.3 0.3 0.4 0.5 0.4 0.1 0.6 0.4 0.6 3.9 0.5 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.3 0.2 8.9 4.6 0.8 5.2 5.8 1.5 8.1 0.0 16.0 7.9 1.8 3.9 1.5 0.0 0.3 11.3 1.8 8.9 0.0 0.0 3.6 1.9 8.3 1.1 0.0 0.9 0.0 2.9 1.8 0.3 25.8 0.3 1.3 1.7 0.0 46.1 1.2 0.3 29.4 0.7 3.3 5.4 0.0 1.0 5.6 5.7 17.1 83.1 0.0 11.0 21.1 IL12A "CLMF, IL-12A, NFSK, NKSF1, p35" ENSG00000168811 "Interleukin 12A" P29459 3 159988750-159996019 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.1" "Cell type enhanced" "Detected in some" 13 "Ciliated cells: 8.1;Sertoli cells: 6.5;Spermatogonia: 2.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 5.1" "Group enriched" "Detected in many" 7 "B-cells: 5.1;granulocytes: 1.3;T-cells: 1.6" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 7.5;HDLM-2: 11.4;SK-BR-3: 17.1" "Region enhanced" "Detected in single" "cerebral cortex: 2.7" "Low region specificity" "Detected in some" HPA001886 Uncertain "Secreted to blood" NA NA "HPA001886: AB_1079132" "unprognostic (6.23e-2)" "unprognostic (7.82e-5)" "unprognostic (1.25e-1)" "unprognostic (3.10e-2)" "unprognostic (4.22e-1)" "unprognostic (7.18e-2)" "unprognostic (4.18e-5)" "unprognostic (2.22e-1)" "unprognostic (1.91e-1)" "unprognostic (1.07e-2)" "unprognostic (1.28e-1)" "unprognostic (2.31e-2)" "unprognostic (9.57e-10)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (9.61e-2)" 0.7 1.4 3.4 1.6 6.2 3.3 2.0 2.6 5.6 0.5 1.6 1.0 0.0 1.5 1.2 0.8 10.1 5.7 0.6 1.4 3.1 2.2 1.2 0.6 5.2 2.9 3.2 1.7 1.6 1.1 0.1 1.0 0.4 5.4 0.9 1.3 0.2 2.1 1.1 0.4 0.2 1.5 0.8 2.7 2.8 1.2 0.9 4.1 0.0 0.5 0.5 2.1 0.9 1.1 5.1 0.1 1.3 0.3 0.0 1.6 0.3 2.8 0.3 0.4 2.4 0.0 0.1 0.2 3.1 1.9 3.6 7.5 1.2 0.1 0.0 0.2 0.5 4.2 0.3 0.8 0.5 3.4 11.4 3.9 0.1 0.1 0.8 2.6 0.6 5.3 0.6 0.9 6.4 2.5 2.5 1.2 0.3 0.0 2.0 2.2 0.0 0.1 0.0 0.4 0.1 1.7 2.2 0.0 0.4 0.4 0.2 0.1 1.2 0.0 17.1 0.4 0.6 0.8 1.2 0.8 0.9 0.8 2.1 5.8 1.2 0.0 0.0 1.4 5.2 0.7 0.0 0.1 1.3 0.9 0.3 1.4 1.3 0.4 1.6 0.1 5.1 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.3 3.4 6.2 2.6 5.6 3.1 2.2 3.2 1.7 5.4 4.1 0.0 1.1 1.9 1.1 0.1 0.0 0.2 0.0 8.1 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 6.5 0.0 0.0 2.5 0.1 0.0 0.0 0.5 1.6 IL18 "IGIF, IL-18, IL-1g, IL1F4" ENSG00000150782 "Interleukin 18" Q14116 11 112143251-112164117 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Inflammatory response" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9;skin 1: 57.2" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 160.8;Kupffer cells: 163.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 17.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 26.5;CAPAN-2: 42.1;HaCaT: 38.5;HBEC3-KT: 29.0;hTCEpi: 44.4;PC-3: 25.8;U-2 OS: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003980, CAB007772" Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Secreted to blood" NA Yes 196000 "Nucleoplasm, Golgi apparatus" Cytosol "CAB007772: AB_562304, HPA003980: AB_1851670" "unprognostic (2.31e-3)" "unprognostic (3.25e-1)" "prognostic favorable (2.78e-4)" "unprognostic (3.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.62e-1)" "unprognostic (1.65e-1)" "unprognostic (8.15e-2)" "unprognostic (3.23e-1)" "unprognostic (2.78e-1)" "unprognostic (1.96e-3)" "unprognostic (4.13e-1)" "unprognostic (3.58e-2)" "unprognostic (1.51e-1)" "unprognostic (3.19e-2)" "unprognostic (3.15e-2)" "unprognostic (9.01e-2)" 9.4 2.6 5.3 12.5 7.9 10.8 5.2 1.3 5.3 18.5 13.1 6.4 2.5 8.6 2.1 3.7 53.9 3.3 11.9 2.1 5.7 3.1 17.5 3.6 15.2 22.6 7.4 1.4 1.4 7.0 0.3 3.3 2.6 8.2 5.5 11.6 2.2 8.3 1.4 3.8 57.2 9.1 4.0 24.7 26.6 5.1 1.7 7.5 3.9 1.8 21.2 26.5 9.1 35.4 0.5 17.1 10.4 6.9 13.8 0.3 1.6 26.5 9.3 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 5.1 42.1 0.0 6.1 0.0 0.7 38.5 0.0 29.0 0.0 0.0 0.2 4.0 9.5 2.1 0.9 2.1 7.7 0.0 44.4 0.0 10.3 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 7.3 25.8 0.0 0.0 0.0 19.0 5.7 0.0 0.0 18.3 12.2 0.1 0.2 7.3 5.8 0.0 0.1 50.0 0.3 8.2 0.1 0.0 0.1 0.0 15.4 0.0 3.5 6.0 10.4 0.1 6.9 0.0 0.4 0.0 0.0 17.1 0.5 0.0 0.3 6.7 13.8 3.7 3.8 0.0 1.6 5.3 7.9 1.3 5.3 5.7 3.1 7.4 1.4 8.2 7.5 160.8 35.5 7.5 33.3 109.2 1.7 0.7 22.9 73.6 43.3 8.7 0.0 2.1 68.0 27.4 1.8 2.4 69.7 0.0 126.1 2.6 5.4 10.6 97.2 2.0 69.6 0.0 13.9 6.2 163.5 0.9 0.0 66.1 3.3 30.7 23.3 1.7 111.9 97.0 4.2 13.2 37.2 6.5 2.2 0.6 0.5 97.2 1.5 27.7 45.4 67.4 IL1A "IL-1A, IL1, IL1-ALPHA, IL1F1" ENSG00000115008 "Interleukin 1 alpha" P01583 2 112773915-112784590 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Inflammatory response" "Cytokine, Mitogen, Pyrogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 6.0;Early spermatids: 6.2;Late spermatids: 3.2;Macrophages: 4.8;Pancreatic endocrine cells: 2.8" "Cancer enhanced" "Detected in many" "head and neck cancer: 22.3;urothelial cancer: 17.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HBEC3-KT: 86.6;hTCEpi: 42.9;hTERT-HME1: 56.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 10800 "unprognostic (3.41e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.99e-2)" "unprognostic (4.28e-2)" "unprognostic (2.08e-1)" "unprognostic (8.03e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.62e-1)" "unprognostic (2.45e-1)" "unprognostic (4.57e-3)" "unprognostic (1.22e-1)" "unprognostic (4.30e-3)" "prognostic unfavorable (4.03e-4)" "unprognostic (1.66e-1)" "unprognostic (2.44e-1)" "unprognostic (8.62e-2)" 0.7 0.3 0.7 1.2 1.4 0.8 0.3 0.2 1.2 5.8 0.3 2.3 0.5 0.0 2.6 0.7 17.6 0.3 2.4 0.3 3.1 0.8 0.2 0.2 3.7 0.2 1.2 0.1 0.3 0.2 0.3 0.4 3.1 2.1 0.3 0.1 0.0 1.9 1.2 0.2 1.2 0.3 0.0 1.8 0.5 0.2 10.9 1.2 0.0 0.2 17.9 22.2 5.4 1.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.1 0.0 10.4 0.0 13.1 0.7 0.0 86.6 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 42.9 0.7 56.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.2 0.9 3.1 0.8 1.2 0.1 2.1 1.2 6.0 1.4 0.0 0.7 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 6.2 0.0 0.0 0.0 0.7 0.1 0.0 0.2 1.1 0.0 0.3 0.0 0.0 0.0 0.0 3.2 0.0 4.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.3 IL1RN "ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430" ENSG00000136689 "Interleukin 1 receptor antagonist" P18510 2 113107214-113134016 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 163.8;Hofbauer cells: 319.3;Suprabasal keratinocytes: 294.2;Urothelial cells: 333.6" "Cancer enhanced" "Detected in all" "head and neck cancer: 92.7" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2" "Group enriched" "Detected in many" 332 "dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1" "Cell line enhanced" "Detected in some" "A-431: 21.1;HaCaT: 41.7;RT4: 40.8;THP-1: 11.8" "Not detected" "Not detected" "HPA001482, CAB009633" Enhanced Approved Nucleoplasm,Centrosome,Cytosol "Secreted to blood" NA NA 291000 Nucleoplasm "Centrosome, Cytosol" "CAB009633: AB_2125576, HPA001482: AB_1078437" "unprognostic (3.85e-3)" "unprognostic (3.96e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.21e-1)" "unprognostic (3.63e-2)" "unprognostic (3.15e-2)" "unprognostic (2.55e-1)" "unprognostic (4.46e-2)" "unprognostic (9.54e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (5.59e-3)" "prognostic unfavorable (2.66e-6)" "unprognostic (2.05e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (4.25e-2)" "unprognostic (1.03e-1)" 17.3 0.2 0.2 7.2 0.3 32.9 1.1 0.2 0.5 27.2 3.8 0.6 1.4 1.1 1.5 0.7 217.8 0.2 4.1 0.5 0.2 0.0 0.5 23.5 2.9 1.9 0.3 0.2 0.4 0.4 0.1 0.3 3.1 0.6 1.6 0.3 0.4 30.9 1.3 0.5 14.4 3.7 0.7 0.2 3.6 5.7 1.4 0.2 1.0 0.7 123.7 194.7 3.3 42.2 0.0 17.1 65.2 17.1 0.0 0.0 4.9 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.2 0.1 0.1 0.0 0.4 41.7 0.0 1.2 0.0 0.0 0.0 0.1 0.0 7.0 0.0 0.1 7.9 0.0 5.4 0.2 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.2 0.0 5.6 0.0 4.7 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 11.8 0.1 0.5 0.0 0.3 0.0 0.3 0.0 0.1 4.0 4.7 0.1 0.0 17.1 0.3 0.0 7.6 0.0 0.0 0.0 0.0 17.1 0.0 0.0 0.0 65.2 0.0 3.4 0.1 0.0 4.9 0.2 0.3 0.2 0.5 0.2 0.0 0.3 0.2 0.6 0.2 6.0 10.6 0.5 50.9 163.8 0.0 0.3 12.7 18.7 17.0 3.5 0.0 1.3 0.0 17.2 35.3 2.2 6.5 0.0 25.2 2.5 6.6 30.8 9.3 38.4 319.3 0.0 0.0 3.1 35.8 72.7 0.6 100.5 23.6 1.0 0.6 0.0 89.0 0.0 0.4 0.0 0.0 0.0 6.6 0.7 0.1 294.2 3.8 0.9 2.2 333.6 IL20RB "DIRS1, FNDC6, IL-20R2, MGC34923" ENSG00000174564 "Interleukin 20 receptor subunit beta" Q6UXL0 3 136946230-137011085 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 64.5;skin 1: 61.2" "Group enriched" "Detected in some" 7 "Basal keratinocytes: 32.6;Early spermatids: 38.8;Late spermatids: 24.0;Suprabasal keratinocytes: 33.2" "Group enriched" "Detected in many" 5 "cervical cancer: 54.5;head and neck cancer: 50.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "hTCEpi: 106.6" "Region enriched" "Detected in single" 9 "cerebellum: 0.6" "Not detected" "Not detected" HPA063914 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA063914: AB_2732709" "unprognostic (1.35e-2)" "unprognostic (1.05e-1)" "unprognostic (7.43e-4)" "unprognostic (2.48e-4)" "unprognostic (2.74e-1)" "unprognostic (3.31e-1)" "unprognostic (7.43e-4)" "unprognostic (4.08e-3)" "unprognostic (7.64e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (3.57e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (2.55e-1)" "unprognostic (3.55e-2)" "unprognostic (1.33e-2)" "unprognostic (5.57e-2)" 1.6 0.0 0.0 0.1 0.0 0.1 4.6 0.0 0.1 13.2 0.2 0.0 0.0 0.0 1.3 0.3 64.5 0.1 0.1 0.3 0.0 0.0 0.1 2.1 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.2 2.8 0.0 1.6 0.3 0.4 4.1 0.2 0.4 61.2 0.1 0.1 0.3 0.0 0.1 0.9 0.0 0.5 0.2 22.6 17.1 0.9 19.2 0.1 0.4 0.0 0.3 0.0 0.6 0.0 4.9 0.0 0.0 0.0 3.0 12.9 0.5 0.1 0.3 0.0 0.2 0.4 0.6 0.0 2.8 1.8 0.1 16.0 0.0 26.4 0.1 0.0 0.0 0.0 3.3 0.0 17.8 0.0 0.0 2.2 106.6 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.5 0.8 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 38.8 1.0 0.6 0.0 0.2 1.1 0.8 1.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 24.0 0.3 0.8 3.3 2.8 0.7 0.0 0.8 0.0 0.7 0.1 0.0 0.0 2.3 0.6 1.5 33.2 1.4 0.0 0.5 4.8 IRX4 ENSG00000113430 "Iroquois homeobox 4" P78413 5 1877413-1887236 "Plasma proteins, Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2" "Cell type enhanced" "Detected in some" 21 "Basal keratinocytes: 43.0;Glandular cells: 12.7;Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 19 "pons and medulla: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 31.0;HaCaT: 11.5;HBEC3-KT: 6.4;MCF7: 5.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "pons and medulla: 1.9" HPA064094 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA064094: " "unprognostic (1.00e-2)" "unprognostic (1.00e-1)" "unprognostic (1.90e-1)" "unprognostic (3.01e-1)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (1.53e-1)" "unprognostic (1.35e-1)" "unprognostic (7.52e-2)" "unprognostic (7.54e-2)" "unprognostic (4.26e-1)" "unprognostic (1.70e-2)" 0.2 0.2 0.1 0.1 0.1 0.3 5.1 0.1 0.2 2.4 0.1 0.1 0.1 0.1 0.1 0.1 11.2 0.1 0.1 11.0 0.1 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 2.7 7.8 0.1 0.1 6.7 0.1 1.2 14.2 0.1 1.0 0.1 0.1 0.1 1.7 0.1 0.1 0.1 2.5 2.1 0.1 7.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.5 0.0 6.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 5.5 0.7 0.0 0.1 3.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 2.7 0.1 0.0 0.0 0.0 4.2 43.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.6 12.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 17.7 3.1 0.0 0.0 1.3 IVL ENSG00000163207 Involucrin P07476 1 152908545-152911886 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 97.1;tongue: 152.1" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 62.0" "Group enriched" "Detected in many" 5 "cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "HaCaT: 78.9;RT4: 20.7;SK-BR-3: 23.8" "CAB002243, HPA055211" Enhanced Supported "Nuclear bodies,Centrosome,Cytosol" NA NA 8000000 Cytosol "Nuclear bodies, Centrosome" "CAB002243: AB_563785, HPA055211: AB_2682739" "unprognostic (3.29e-4)" "unprognostic (1.91e-1)" "unprognostic (2.92e-2)" "unprognostic (2.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (4.82e-2)" "unprognostic (3.11e-1)" "unprognostic (3.66e-1)" "unprognostic (1.22e-2)" "unprognostic (1.32e-1)" 0.1 0.1 0.0 0.1 0.0 0.1 2.0 0.0 0.1 39.0 0.1 0.0 0.4 0.1 4.2 11.5 97.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 1.8 0.1 0.0 18.7 0.1 0.2 34.2 0.1 1.0 0.0 0.1 0.1 0.1 0.0 1.9 0.1 152.1 49.1 4.9 43.8 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 78.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.7 0.0 0.0 0.0 23.8 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.0 0.0 0.0 7.4 KLF5 "BTEB2, CKLF, IKLF" ENSG00000102554 "Kruppel like factor 5" Q13887 13 73054976-73077542 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 88.4;intestine: 88.1" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 1017.1;Suprabasal keratinocytes: 599.6;Urothelial cells: 1225.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "basal ganglia: 22.2" "Cell type enriched" "Detected in single" 18 "basophil: 16.3" "Lineage enriched" "Detected in single" 106 "granulocytes: 16.3" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.5;HaCaT: 31.5;HBEC3-KT: 27.5;hTCEpi: 39.3;OE19: 59.4;RT4: 33.2;SiHa: 28.0" "Group enriched" "Detected in many" 4 "amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3" "Low region specificity" "Detected in some" HPA040398 Approved Supported "Nucleoplasm,Golgi apparatus,Vesicles" NA NA Nucleoplasm "Golgi apparatus, Vesicles" "HPA040398: AB_10673267" "unprognostic (7.90e-3)" "unprognostic (5.11e-2)" "unprognostic (2.03e-2)" "unprognostic (1.56e-1)" "unprognostic (4.69e-2)" "unprognostic (2.75e-1)" "unprognostic (1.18e-1)" "unprognostic (3.97e-2)" "unprognostic (5.82e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (4.43e-2)" "unprognostic (1.42e-3)" "unprognostic (3.56e-3)" "unprognostic (3.98e-1)" "unprognostic (5.09e-2)" "unprognostic (1.54e-2)" 2.3 1.5 4.1 24.3 22.2 12.9 8.1 0.7 1.2 19.6 74.4 0.4 4.3 28.7 4.8 3.7 88.4 8.3 48.4 1.3 1.4 1.2 3.9 1.2 12.8 0.1 0.9 1.1 5.0 3.5 0.0 7.3 22.8 4.3 17.6 32.9 1.8 26.4 5.4 10.0 59.4 88.1 4.1 2.4 0.8 17.9 12.2 1.4 3.0 20.7 64.4 61.8 23.4 34.1 0.0 0.0 16.3 0.0 0.0 0.1 0.0 5.3 7.4 0.0 0.1 0.2 0.4 8.5 3.1 7.3 1.4 1.7 6.9 27.5 0.1 16.7 2.7 0.5 31.5 9.6 27.5 2.2 0.2 2.5 0.1 15.7 0.6 2.0 2.5 0.4 2.0 39.3 0.4 15.4 1.4 0.0 0.9 0.3 0.5 6.3 1.8 0.5 0.1 0.3 59.4 10.6 0.4 7.0 0.6 21.8 33.2 0.7 0.3 28.0 4.5 1.9 3.6 0.6 0.6 0.0 1.9 5.7 0.0 1.3 0.9 0.4 0.9 2.7 0.5 2.3 16.3 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 4.1 22.2 0.7 1.2 1.4 1.2 0.9 1.1 4.3 1.4 151.8 97.6 0.5 1017.1 460.9 0.4 5.6 79.0 128.5 151.2 34.9 2.0 57.7 18.3 30.8 305.6 1.1 308.2 0.0 40.2 87.3 46.1 522.9 3.5 2.9 5.4 9.5 195.2 0.6 0.0 162.5 6.1 6.1 55.6 5.4 327.8 0.0 63.9 284.0 1.4 2.6 0.0 0.0 28.8 7.2 25.9 599.6 48.5 0.7 397.9 1225.4 KLK10 "NES1, PRSSL1" ENSG00000129451 "Kallikrein related peptidase 10" O43240 19 51012739-51020175 "Cancer-related genes, Enzymes, Predicted secreted proteins" "Cell cycle" "Hydrolase, Protease, Serine protease" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 78.6;lymphoid tissue: 58.6;tongue: 136.3" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 29.8;Club cells: 77.3;Glandular cells: 41.6;Pancreatic endocrine cells: 43.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 50.7;HaCaT: 76.9;OE19: 49.9" "Region enriched" "Detected in single" 4 "hippocampal formation: 1.7" "Not detected" "Not detected" "Secreted in other tissues" NA NA 670000 "prognostic favorable (8.32e-4)" "unprognostic (6.06e-2)" "unprognostic (1.73e-1)" "unprognostic (4.26e-3)" "unprognostic (3.81e-2)" "unprognostic (1.80e-1)" "unprognostic (1.51e-2)" "unprognostic (2.10e-2)" "unprognostic (3.94e-1)" "unprognostic (3.38e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (2.71e-2)" "unprognostic (2.46e-6)" "unprognostic (9.34e-2)" "unprognostic (7.81e-2)" "unprognostic (2.66e-3)" "unprognostic (1.52e-2)" 1.5 0.5 0.2 1.7 0.3 0.3 2.4 0.7 0.4 20.8 0.9 0.3 0.5 0.2 2.9 0.8 78.6 7.8 36.0 0.7 0.2 0.5 0.2 0.3 4.3 0.2 0.2 0.3 7.2 0.2 0.0 0.2 0.8 0.6 1.6 0.4 0.3 11.0 0.6 0.4 17.7 0.4 0.4 0.4 0.2 0.5 1.6 0.2 1.0 0.3 136.3 58.6 0.5 33.4 0.4 0.5 2.1 0.4 0.4 0.3 0.1 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 50.7 0.0 2.8 0.0 0.0 76.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 49.9 0.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.3 0.2 0.3 0.2 0.3 0.2 0.1 0.4 0.3 0.3 2.1 0.4 0.4 0.5 0.3 0.1 0.2 0.3 0.7 0.4 0.2 0.5 0.2 0.3 0.6 0.2 29.8 1.6 0.0 13.6 6.6 0.6 0.4 7.6 10.7 77.3 0.0 0.0 0.0 0.0 3.4 0.2 0.3 0.0 0.0 14.1 0.0 0.5 41.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 10.6 1.1 0.0 1.0 0.0 0.2 43.5 0.0 5.6 0.0 0.4 0.0 0.9 0.9 1.2 3.8 0.0 0.0 0.0 18.7 KLK11 "PRSS20, TLSP" ENSG00000167757 "Kallikrein related peptidase 11" Q9UBX7 19 51022216-51028039 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 141.1;Glandular cells: 237.5;Late spermatids: 257.5;Suprabasal keratinocytes: 189.7;Urothelial cells: 143.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 11 "pons and medulla: 10.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 9.6;HaCaT: 29.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB026340 Approved "Secreted in other tissues" NA NA 320000 "CAB026340: " "unprognostic (4.23e-2)" "unprognostic (1.50e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.78e-4)" "unprognostic (2.08e-2)" "unprognostic (4.67e-1)" "unprognostic (5.32e-2)" "unprognostic (3.72e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (2.92e-2)" "unprognostic (4.16e-6)" "unprognostic (3.90e-2)" "unprognostic (2.73e-1)" "unprognostic (4.40e-2)" "unprognostic (2.53e-1)" 5.5 0.0 0.2 1.1 0.2 0.0 4.9 0.2 0.6 24.5 1.7 2.0 0.4 0.0 5.1 2.7 103.4 9.7 61.8 0.4 0.9 0.0 0.2 0.6 12.3 0.2 0.2 0.2 2.3 25.0 0.0 2.1 0.4 10.7 18.8 0.0 5.1 96.5 1.6 0.3 49.8 0.6 0.3 0.2 0.2 18.7 7.7 0.2 0.9 0.2 65.2 88.5 0.7 33.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.6 0.0 9.6 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.9 0.0 0.2 0.2 10.7 0.2 80.4 7.2 0.0 141.1 94.9 0.0 0.4 63.7 26.8 108.1 0.0 0.0 0.0 0.0 2.9 105.3 2.2 0.0 0.0 118.6 0.0 8.9 237.5 1.1 0.0 0.3 0.0 19.4 0.0 0.0 257.5 2.6 2.6 8.5 0.0 2.8 0.0 49.0 0.0 0.4 0.0 1.4 0.0 0.3 2.1 2.5 189.7 0.0 0.0 0.3 143.9 KLK6 "Bssp, Klk7, neurosin, PRSS18, PRSS9" ENSG00000167755 "Kallikrein related peptidase 6" Q92876 19 50958631-50969673 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.6;esophagus: 48.9" "Cell type enhanced" "Detected in some" 22 "Collecting duct cells: 10.4;Early spermatids: 2.0;Late spermatids: 2.1;Pancreatic endocrine cells: 4.6;Urothelial cells: 2.7" "Cancer enhanced" "Detected in many" "ovarian cancer: 131.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "A-431: 70.0;CAPAN-2: 167.5" "Region enhanced" "Detected in many" "pons and medulla: 175.6" "Group enriched" "Detected in many" 8 "midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4" HPA051837 Supported "Nucleoplasm,Nuclear membrane,Cytokinetic bridge" "Secreted in other tissues" Yes No 6800000 Nucleoplasm "Nuclear membrane, Cytokinetic bridge" "HPA051837: " "unprognostic (7.30e-2)" "unprognostic (3.32e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.38e-5)" "unprognostic (1.10e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.02e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (7.82e-4)" "unprognostic (4.45e-1)" "unprognostic (2.72e-2)" "unprognostic (1.31e-1)" "unprognostic (2.46e-1)" "unprognostic (9.07e-2)" "prognostic unfavorable (1.27e-4)" 0.9 0.9 9.7 0.9 23.5 0.9 6.5 3.3 42.2 10.0 1.0 82.0 0.0 1.1 2.0 1.2 48.9 24.6 3.8 0.9 20.1 11.8 9.0 0.9 0.9 0.9 46.1 14.9 0.9 0.9 0.9 0.2 0.9 44.3 1.0 0.9 0.0 5.9 2.8 0.9 2.9 0.9 1.0 97.6 5.1 1.0 1.5 32.6 0.0 0.9 15.7 28.1 0.9 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.3 167.5 0.0 1.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 15.4 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.1 0.2 0.0 0.1 6.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 23.5 3.3 23.1 20.1 11.8 46.1 14.9 44.3 32.6 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 2.7 KLK8 "HNP, neuropsin, ovasin, PRSS19, TADG14" ENSG00000129455 "Kallikrein related peptidase 8" O60259 19 50996007-51002711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.6;skin 1: 40.4;tongue: 46.9" "Group enriched" "Detected in some" 13 "Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 29.9;ovarian cancer: 30.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2" "Region enriched" "Detected in many" 5 "hippocampal formation: 39.6" "CAB019393, HPA035761" Enhanced Approved Vesicles "Secreted in other tissues" NA NA 950000 Vesicles "CAB019393: , HPA035761: AB_2674769" "unprognostic (4.27e-3)" "unprognostic (2.59e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (5.46e-2)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.10e-4)" "unprognostic (4.29e-2)" "unprognostic (4.66e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (6.17e-4)" 1.6 0.0 0.1 0.4 0.1 0.0 4.5 1.0 0.3 8.1 0.7 0.1 0.1 0.0 1.1 0.7 43.6 6.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.4 0.6 0.3 0.0 0.3 6.0 0.1 0.3 40.4 0.1 0.1 0.6 0.3 0.0 0.7 0.1 0.5 0.3 46.9 11.1 0.3 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.6 42.3 0.0 0.8 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 58.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 1.7 0.0 8.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.4 157.5 0.0 0.0 0.0 0.1 KRT5 "EBS2, KRT5A" ENSG00000186081 "Keratin 5" P13647 12 52514575-52520687 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 463.1;skin 1: 338.1;tongue: 522.3" "Cell type enhanced" "Detected in some" 30 "Basal glandular cells: 909.3;Basal keratinocytes: 5214.3;Suprabasal keratinocytes: 1765.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 3340.4" "Region enriched" "Detected in single" 7 "pons and medulla: 1.7" "Cell type enriched" "Detected in single" 197 "plasmacytoid DC: 19.6" "Lineage enriched" "Detected in single" 197 "dendritic cells: 19.6" "Cell line enhanced" "Detected in some" "HaCaT: 120.8;HBEC3-KT: 216.3;hTCEpi: 494.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000027, CAB000129, HPA059479" Enhanced Approved "Intermediate filaments" NA NA 6500000000 "Intermediate filaments" "CAB000027: AB_2281083, CAB000129: , HPA059479: AB_2684034" "prognostic favorable (1.27e-4)" "unprognostic (9.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.29e-2)" "unprognostic (1.84e-1)" "unprognostic (1.14e-1)" "unprognostic (1.33e-1)" "unprognostic (7.20e-2)" "unprognostic (2.82e-1)" "unprognostic (1.90e-1)" "unprognostic (1.41e-2)" "unprognostic (1.73e-1)" "unprognostic (6.01e-7)" "unprognostic (3.46e-2)" "unprognostic (5.56e-2)" "unprognostic (7.96e-2)" "unprognostic (2.81e-3)" 0.3 0.0 0.1 0.3 0.2 0.2 15.9 0.1 0.2 74.2 0.2 0.3 6.2 0.0 4.9 6.4 463.1 0.7 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 4.4 1.7 5.8 0.0 0.4 46.9 7.8 0.5 338.1 0.1 0.3 0.1 0.1 0.1 0.7 0.1 31.7 0.1 522.3 128.9 4.0 96.8 0.0 19.6 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 120.8 0.0 216.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 494.5 0.0 43.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.6 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.0 0.1 0.2 1.7 0.1 0.0 0.6 0.0 909.3 5214.3 0.0 0.6 0.0 30.8 153.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 28.8 53.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 271.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 66.8 0.0 0.0 1765.9 0.0 0.0 0.0 372.4 LAD1 ENSG00000159166 "Ladinin 1" O00515 1 201373244-201399915 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 83.9;tongue: 66.9" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 171.5;monocytes: 433.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "plasmacytoid DC: 2.8" "Lineage enriched" "Detected in single" 28 "dendritic cells: 2.8" "Cell line enhanced" "Detected in some" "A-431: 36.7;CAPAN-2: 32.6;HaCaT: 47.4;HBEC3-KT: 36.0;hTCEpi: 35.0;MCF7: 40.2;OE19: 50.5;RT4: 34.6;SK-BR-3: 56.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007256, HPA028732" Enhanced Enhanced "Actin filaments" "Secreted to extracellular matrix" NA NA "Actin filaments" "HPA007256: AB_1852681, HPA028732: AB_10602916" "unprognostic (4.95e-2)" "unprognostic (2.05e-1)" "unprognostic (3.82e-1)" "unprognostic (7.55e-3)" "unprognostic (4.66e-2)" "unprognostic (7.41e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (6.73e-4)" "unprognostic (1.06e-1)" "unprognostic (1.50e-1)" "unprognostic (1.71e-2)" "unprognostic (9.11e-2)" "unprognostic (2.31e-2)" "unprognostic (3.71e-2)" "unprognostic (1.18e-1)" "unprognostic (6.40e-2)" "unprognostic (3.28e-1)" 0.3 0.2 0.3 10.7 0.3 0.0 3.0 0.3 0.3 15.9 17.5 0.3 22.1 17.4 2.9 4.4 83.9 2.8 56.9 2.0 0.3 0.2 17.2 5.4 3.6 1.5 0.3 0.3 1.5 29.5 0.0 0.4 16.0 0.4 6.9 12.1 0.5 17.1 25.0 1.3 49.7 39.1 1.5 0.3 0.4 13.8 0.6 0.3 3.0 1.6 66.9 42.5 8.9 29.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 36.7 0.3 0.0 0.1 0.0 0.0 11.8 0.0 0.0 0.0 0.0 23.8 32.6 0.0 2.1 0.0 0.0 47.4 0.0 36.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 35.0 0.0 7.2 0.0 0.0 0.0 0.0 0.1 0.0 40.2 0.0 0.1 0.9 50.5 0.4 0.0 1.6 0.4 24.4 34.6 1.9 0.0 0.0 56.7 0.6 1.5 8.5 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.4 0.3 3.0 27.8 1.5 72.1 78.6 0.0 1.8 89.2 4.0 28.4 29.6 0.0 2.9 38.1 140.9 1.0 0.2 171.5 0.0 107.2 4.6 4.1 25.8 0.0 8.5 0.4 0.0 17.4 0.0 0.3 2.4 0.0 2.5 10.1 433.8 49.1 0.0 149.1 89.0 0.4 54.9 0.0 0.0 5.2 0.0 0.0 133.5 8.7 0.0 93.8 117.6 LPAR5 "GPR92, GPR93, KPG_010, LPA5" ENSG00000184574 "Lysophosphatidic acid receptor 5" Q9H1C0 12 6618835-6636447 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 28.4;brain: 20.3;esophagus: 21.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 17.5;Enterocytes: 15.1;granulocytes: 16.1;Hofbauer cells: 29.9;Paneth cells: 15.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 28.4;T-cells: 23.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HEL: 13.9;HMC-1: 20.2;K-562: 10.3;U-698: 10.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013170 Approved NA NA "HPA013170: AB_1849314" "unprognostic (1.94e-1)" "unprognostic (6.43e-2)" "unprognostic (1.78e-2)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.33e-1)" "unprognostic (1.37e-1)" "unprognostic (5.95e-2)" "unprognostic (3.45e-1)" "unprognostic (1.41e-2)" "unprognostic (3.62e-3)" "unprognostic (2.07e-1)" "unprognostic (6.27e-2)" "unprognostic (7.99e-3)" "unprognostic (5.43e-1)" "prognostic favorable (6.56e-5)" "unprognostic (7.43e-2)" 2.1 3.2 11.2 5.6 12.4 1.1 1.6 1.3 8.9 5.8 10.2 20.3 0.5 11.2 0.7 3.2 21.1 2.0 1.9 3.6 10.9 4.0 1.3 1.5 2.1 9.2 9.3 4.0 0.9 0.8 0.9 1.4 7.2 9.2 1.7 9.7 1.7 6.3 1.6 0.3 6.8 9.3 1.3 11.7 10.6 8.3 1.7 13.6 2.2 2.0 1.1 13.5 3.4 9.0 28.4 5.5 2.5 1.8 1.3 23.9 6.5 4.1 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 7.6 3.2 1.0 0.0 0.1 5.3 0.0 2.2 0.0 0.0 0.0 13.9 0.4 0.3 0.0 0.0 20.2 0.0 2.6 0.1 1.1 0.0 0.0 3.0 10.3 0.0 0.0 0.3 0.4 4.3 0.0 6.7 0.7 3.6 0.0 0.0 0.0 2.4 0.1 0.1 2.1 0.0 0.0 0.8 0.0 1.6 0.1 0.0 3.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 2.5 0.1 0.0 23.9 1.0 18.0 28.4 4.0 14.1 5.5 27.8 4.0 8.9 0.2 1.3 1.8 0.3 5.4 6.5 11.2 12.4 1.3 8.9 10.9 4.0 9.3 4.0 9.2 13.6 0.0 0.0 17.5 0.5 1.3 0.0 1.6 0.0 0.0 2.3 1.8 0.0 0.2 0.0 0.4 2.2 0.0 15.1 0.0 0.8 0.2 0.6 0.6 16.1 0.0 29.9 0.0 1.2 0.6 10.7 13.0 0.0 3.7 0.0 6.4 10.6 0.0 5.5 15.8 0.0 0.0 0.0 0.0 0.0 0.6 0.7 1.1 0.5 6.9 9.1 1.7 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 1.5 1.2 0.4 1.8 0.5 4.8 1.1 0.4 0.6 7.9 0.4 0.6 0.8 2.4 1.0 4.7 38.9 0.8 0.7 0.4 0.5 0.1 6.1 0.5 1.1 1.8 0.4 0.7 0.7 0.5 0.3 0.7 0.8 0.5 1.8 0.3 0.5 4.7 1.1 0.9 21.4 1.8 0.4 0.4 3.5 1.0 1.4 0.4 3.1 0.9 43.6 26.8 0.6 9.0 0.3 2.2 1.4 2.0 0.9 2.7 1.1 2.5 4.4 1.9 1.8 0.4 0.6 7.7 0.9 0.4 1.3 0.9 3.4 1.5 3.2 1.6 0.6 1.9 15.9 1.3 2.7 1.0 4.0 4.9 2.2 3.5 1.6 0.5 3.6 4.2 0.5 3.6 2.0 2.3 1.2 0.6 5.8 2.8 3.6 0.6 4.8 1.9 3.8 1.0 0.1 5.4 7.9 1.7 1.8 0.4 3.1 3.4 1.6 1.6 2.0 1.3 2.1 3.7 2.7 1.6 2.6 3.2 4.0 1.3 7.9 2.3 5.2 0.5 6.1 2.0 0.0 2.0 1.4 2.7 1.6 1.6 0.1 2.2 2.0 2.2 0.3 1.7 0.9 1.3 0.9 0.8 0.6 0.4 1.1 0.4 0.5 0.4 0.6 0.5 0.1 0.4 0.7 0.5 0.4 0.0 0.0 0.0 3.0 0.2 0.2 0.0 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.0 1.2 0.1 0.0 0.2 0.0 0.8 0.6 3.2 1.7 1.3 2.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.6 0.9 LY6D E48 ENSG00000167656 "Lymphocyte antigen 6 family member D" Q14210 8 142784880-142786592 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 236.9;skin 1: 111.6;tongue: 316.2" "Group enriched" "Detected in some" 14 "Basal keratinocytes: 1040.7;Suprabasal keratinocytes: 3379.4" "Group enriched" "Detected in many" 7 "cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "A-431: 57.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA024755, HPA064317" Enhanced NA NA 92000 "HPA024755: AB_1853410, HPA064317: AB_2685244" "unprognostic (2.13e-2)" "unprognostic (7.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.08e-2)" "unprognostic (8.97e-2)" "unprognostic (1.51e-2)" "unprognostic (3.84e-1)" "unprognostic (5.11e-2)" "prognostic unfavorable (1.94e-6)" "unprognostic (8.68e-2)" "prognostic unfavorable (1.20e-4)" "unprognostic (2.50e-1)" "unprognostic (3.97e-1)" "unprognostic (5.40e-4)" "unprognostic (1.06e-1)" 0.2 3.7 0.2 0.2 0.2 0.1 3.7 0.2 0.2 23.0 0.2 0.2 0.2 0.1 2.1 0.2 236.9 0.1 0.5 0.2 0.2 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 1.3 0.2 1.2 0.1 0.2 18.1 0.2 0.4 111.6 0.2 0.9 0.2 0.2 2.0 0.2 0.2 0.9 0.2 316.2 61.8 6.3 36.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 1.5 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 3.0 0.0 0.0 6.9 1040.7 0.0 0.0 0.0 1.4 39.8 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 4.6 0.5 2.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 155.3 0.0 0.0 0.0 4.1 0.0 0.0 0.6 0.0 0.0 2.0 0.0 0.0 3379.4 6.9 0.0 0.0 148.4 LYNX1-SLURP2 ENSG00000284505 "LYNX1-SLURP2 readthrough" 8 142764334-142778224 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.1;esophagus: 13.6" "Cell type enriched" "Detected in single" 9 "Pancreatic endocrine cells: 5.9" "Group enriched" "Detected in some" 5 "intermediate monocyte: 2.7;non-classical monocyte: 4.1" "Lineage enriched" "Detected in single" 6 "monocytes: 4.1" "Cell line enhanced" "Detected in some" "A549: 2.3;BJ: 3.6;EFO-21: 3.0;HaCaT: 2.6;SH-SY5Y: 1.7;TIME: 1.7" "Intracellular and membrane" NA NA 3.8 2.4 3.7 0.8 4.1 0.3 1.1 1.2 13.1 1.1 1.4 2.1 0.0 1.1 1.9 1.4 13.6 2.1 1.2 7.0 3.0 1.6 6.5 1.1 0.6 2.3 4.2 1.6 1.0 1.2 0.0 0.7 6.7 3.6 0.9 1.9 2.0 5.0 2.0 8.6 1.5 3.5 1.2 1.5 1.2 0.8 1.4 0.0 0.5 0.5 1.1 4.2 0.8 0.0 0.2 0.0 4.1 0.0 0.6 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.1 0.4 0.3 0.0 0.0 3.0 0.0 1.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.4 1.7 0.4 0.2 0.0 0.1 1.1 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.7 0.1 0.0 0.0 0.1 0.2 0.0 0.6 0.2 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LYPD3 C4.4A ENSG00000124466 "LY6/PLAUR domain containing 3" O95274 19 43460787-43465660 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 110.5;lymphoid tissue: 75.2;skin 1: 86.4;tongue: 70.6" "Cell type enhanced" "Detected in many" 25 "Basal keratinocytes: 448.4;Suprabasal keratinocytes: 2015.9;Syncytiotrophoblasts: 598.6;Urothelial cells: 616.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 235.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.9" "Group enriched" "Detected in many" 10 "dendritic cells: 3.5;granulocytes: 3.0;T-cells: 7.9" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.8;HaCaT: 30.1;MCF7: 33.6;RT4: 32.3;SK-BR-3: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041529, HPA041797, HPA077859" Enhanced Approved "Endoplasmic reticulum,Vesicles" NA NA 9700000 "Endoplasmic reticulum, Vesicles" "HPA041529: AB_2677534, HPA041797: AB_2677679, HPA077859: " "unprognostic (1.07e-1)" "unprognostic (1.42e-1)" "unprognostic (1.45e-1)" "unprognostic (1.13e-2)" "unprognostic (2.80e-1)" "unprognostic (2.67e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (7.86e-5)" "unprognostic (1.20e-1)" "unprognostic (6.99e-2)" "unprognostic (1.61e-1)" "unprognostic (5.09e-1)" "unprognostic (1.07e-3)" "unprognostic (5.13e-2)" "unprognostic (8.79e-2)" "unprognostic (1.11e-1)" "unprognostic (2.96e-3)" 0.3 0.4 0.3 0.4 0.3 0.8 5.8 0.3 0.3 28.0 0.3 0.3 0.3 0.0 2.1 0.7 110.5 0.5 0.3 0.3 0.3 0.0 0.4 0.3 0.3 0.3 0.3 0.3 0.8 0.3 0.0 0.3 7.4 0.3 1.4 0.0 0.5 21.7 0.3 0.6 86.4 0.4 0.8 0.3 0.3 0.1 0.3 0.3 1.9 0.3 70.6 75.2 4.1 48.3 0.2 3.5 3.0 0.4 0.1 7.9 1.9 11.2 0.1 0.0 0.2 0.1 0.0 4.7 0.4 1.2 0.4 0.5 0.1 12.8 0.0 0.5 0.3 1.7 30.1 0.0 1.3 0.2 0.0 0.1 0.2 1.5 0.2 0.1 0.0 0.2 0.5 11.4 0.0 0.1 0.5 0.0 0.9 0.0 0.0 0.0 33.6 0.2 0.0 0.0 7.2 2.5 0.1 0.0 0.0 0.3 32.3 0.0 0.1 0.1 48.4 0.5 1.5 5.3 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 0.0 1.6 0.2 4.2 1.6 3.5 0.0 7.9 6.7 3.0 0.1 0.0 0.4 1.2 1.9 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.6 0.5 55.8 448.4 0.6 0.5 5.1 0.0 1.2 14.0 0.0 74.6 1.7 1.6 0.0 2.2 0.3 0.0 0.2 59.2 26.8 34.6 5.7 0.0 12.7 3.2 0.0 0.0 0.0 0.0 0.6 2.7 140.0 1.0 1.0 3.2 2.8 0.0 0.4 0.6 0.2 0.0 18.6 0.0 0.9 2015.9 598.6 2.5 0.7 616.2 MAB21L3 "C1orf161, FLJ38716" ENSG00000173212 "Mab-21 like 3" Q8N8X9 1 116111755-116135240 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.9;skin 1: 8.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 41.7;Alveolar cells type 2: 51.9;Ciliated cells: 24.1;Club cells: 33.0;granulocytes: 16.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 15.7;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039551 Approved Nucleoplasm NA NA Nucleoplasm "HPA039551: AB_2676565" "unprognostic (9.25e-3)" "unprognostic (3.47e-3)" "unprognostic (1.44e-3)" "unprognostic (5.23e-5)" "unprognostic (2.22e-1)" "unprognostic (2.06e-2)" "unprognostic (5.36e-2)" "unprognostic (3.75e-3)" "unprognostic (1.21e-1)" "unprognostic (7.01e-2)" "unprognostic (2.49e-1)" "unprognostic (4.84e-2)" "unprognostic (1.16e-2)" "unprognostic (1.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (4.61e-2)" 0.3 0.0 0.3 2.7 0.3 0.8 0.5 0.3 0.3 2.8 2.1 0.3 0.3 0.2 0.3 0.3 9.9 0.0 0.3 0.3 0.3 0.2 2.0 3.1 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 2.2 0.3 1.1 1.8 0.3 1.3 0.7 0.6 8.7 3.4 0.3 0.3 0.3 0.4 0.7 0.3 0.3 0.3 2.5 1.7 2.1 4.2 2.6 1.3 5.5 1.2 4.4 0.7 0.0 3.4 0.1 0.8 0.6 0.1 0.0 5.3 0.6 0.2 0.0 0.0 0.3 1.3 2.1 15.7 0.1 0.3 2.9 0.1 0.1 0.1 0.7 0.1 0.9 0.4 2.8 0.0 0.9 0.5 0.0 0.4 0.1 0.3 0.1 0.0 0.5 0.9 2.4 0.0 0.3 0.5 0.5 2.2 0.7 1.0 0.8 0.8 0.4 0.6 15.1 0.5 0.8 2.4 2.0 0.6 2.5 2.5 0.4 0.5 1.0 2.5 0.7 0.6 2.3 4.0 1.0 0.5 0.3 1.0 2.6 1.2 0.3 0.6 0.6 0.5 0.8 0.4 0.5 0.3 2.6 0.7 0.7 5.5 4.4 0.7 1.3 0.2 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 41.7 51.9 0.0 2.3 0.6 0.0 0.4 0.0 24.1 33.0 3.5 0.0 3.8 1.7 0.0 0.1 0.0 0.7 0.0 0.2 0.5 0.0 0.7 16.3 0.6 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 1.5 11.4 0.0 1.0 0.6 MAL2 ENSG00000147676 "Mal, T cell differentiation protein 2 (gene/pseudogene)" Q969L2 8 119165034-119245673 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 70.4" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 369.9;Suprabasal keratinocytes: 398.5;Urothelial cells: 421.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 104.3;HaCaT: 46.6;OE19: 114.7;RPTEC TERT1: 40.4;SK-BR-3: 150.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043831 Uncertain NA NA "HPA043831: " "prognostic unfavorable (4.57e-6)" "unprognostic (3.12e-1)" "unprognostic (4.04e-1)" "prognostic unfavorable (8.44e-5)" "unprognostic (2.10e-2)" "unprognostic (1.83e-2)" "unprognostic (1.03e-2)" "unprognostic (7.20e-2)" "unprognostic (5.86e-2)" "unprognostic (2.00e-3)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.09e-1)" "prognostic favorable (2.39e-5)" "unprognostic (5.48e-2)" "unprognostic (1.34e-1)" "unprognostic (3.33e-1)" "unprognostic (9.27e-3)" 3.3 1.3 7.8 5.5 21.1 0.0 17.4 17.4 26.4 13.1 25.5 1.6 19.2 16.0 1.5 5.4 70.4 13.9 16.2 1.9 8.6 4.0 22.8 11.5 20.4 0.0 2.2 11.8 1.3 19.0 9.3 22.7 6.6 1.2 6.8 24.3 0.6 21.1 16.9 1.1 31.0 18.3 0.5 1.8 1.2 33.8 3.3 1.6 0.5 43.8 30.4 31.5 13.3 28.5 0.0 0.0 0.0 0.0 0.0 0.6 0.1 104.3 0.0 0.1 0.0 0.0 0.0 9.7 0.0 0.2 0.1 0.1 8.9 34.0 0.0 5.9 0.0 0.0 46.6 0.0 3.3 0.0 0.0 0.2 0.0 1.5 8.6 0.0 0.0 0.0 0.0 23.7 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.8 114.7 32.1 0.0 0.0 0.0 40.4 26.2 5.9 0.0 1.8 150.4 0.3 0.7 19.9 0.3 0.0 0.0 0.3 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 21.1 17.4 26.4 8.6 4.0 2.2 11.8 1.2 1.6 104.2 103.7 5.7 58.8 102.0 1.8 1.4 79.0 52.2 76.2 369.9 0.0 18.2 92.9 208.4 0.4 0.6 183.7 0.0 156.8 18.1 7.3 197.7 14.9 43.1 2.4 4.8 40.2 0.6 0.3 1.1 0.6 4.4 15.1 6.4 101.9 0.3 231.3 126.8 0.0 14.7 1.0 0.0 2.8 1.1 5.5 398.5 7.8 2.5 89.8 421.4 MALL BENE ENSG00000144063 "Mal, T cell differentiation protein like" Q13021 2 110083870-110116566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 107.7;intestine: 142.1;lung: 72.9" "Cell type enhanced" "Detected in many" 14 "Ductal cells: 224.3;Enterocytes: 724.1;Pancreatic endocrine cells: 223.5;Urothelial cells: 444.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 9.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 9.3" "Cell line enhanced" "Detected in some" "A-431: 40.7;A549: 39.9;CAPAN-2: 55.2;fHDF/TERT166: 60.6;HaCaT: 43.0;PC-3: 24.4" "Low region specificity" "Detected in single" HPA051410 Uncertain NA NA "HPA051410: AB_2681474" "unprognostic (5.17e-1)" "unprognostic (4.15e-2)" "unprognostic (2.92e-1)" "unprognostic (3.53e-1)" "unprognostic (1.92e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-1)" "unprognostic (4.46e-2)" "unprognostic (6.50e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (2.37e-1)" "unprognostic (7.27e-2)" "unprognostic (2.23e-1)" "unprognostic (2.84e-1)" "unprognostic (2.80e-1)" "unprognostic (6.50e-3)" 5.5 1.0 0.9 11.1 2.1 0.1 7.7 0.4 1.1 22.5 46.4 0.2 1.3 41.2 6.0 2.7 107.7 2.8 6.7 10.8 1.7 1.0 1.9 1.1 72.9 3.7 1.1 0.2 1.6 2.9 49.8 1.0 3.7 3.6 5.5 19.0 1.6 11.2 1.5 2.1 11.1 142.1 5.1 4.2 2.0 1.8 2.2 0.4 0.6 5.6 45.8 63.8 7.8 35.4 0.9 0.7 9.3 0.7 2.1 1.0 0.5 40.7 39.9 0.0 0.1 0.0 0.0 0.1 7.9 0.4 0.0 0.0 6.6 55.2 0.1 20.1 60.6 0.0 43.0 0.0 2.3 0.0 0.1 0.0 0.3 1.1 0.0 0.3 0.0 0.1 0.9 2.2 0.1 0.0 0.0 19.8 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.0 19.1 24.4 0.0 0.0 0.1 5.2 2.3 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.2 20.3 0.0 0.1 0.1 0.1 0.0 0.0 4.7 0.0 0.0 0.0 9.3 0.7 1.0 0.4 0.4 0.4 0.7 0.8 0.7 0.3 0.9 0.5 1.0 4.4 2.1 0.2 0.7 0.6 0.5 0.9 2.1 0.4 1.1 1.7 1.0 1.1 0.2 3.6 0.4 38.7 157.7 0.0 55.9 14.5 0.0 2.8 5.1 10.7 42.1 1.8 0.0 0.1 0.0 224.3 19.6 50.2 724.1 0.0 57.6 0.1 7.4 142.5 6.9 0.6 6.2 0.0 16.8 27.6 1.2 5.6 2.3 1.8 13.5 1.8 39.1 0.0 223.5 112.2 1.1 11.3 0.0 0.0 5.0 7.7 0.9 11.5 0.5 1.3 52.5 444.9 MPZL2 "EVA, EVA1" ENSG00000149573 "Myelin protein zero like 2" O60487 11 118253403-118264536 "Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 405.2;Basal keratinocytes: 295.4;Suprabasal keratinocytes: 408.6;Urothelial cells: 416.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9" "Group enriched" "Detected in many" 10 "dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 25.3;EFO-21: 27.9;HaCaT: 34.9;RT4: 66.3;TIME: 72.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA060740 Approved Approved "Cell Junctions" NA NA "Cell Junctions" "HPA060740: AB_2684352" "unprognostic (1.74e-1)" "unprognostic (6.02e-2)" "unprognostic (8.23e-2)" "unprognostic (3.28e-3)" "unprognostic (9.95e-3)" "unprognostic (1.56e-1)" "unprognostic (2.11e-3)" "unprognostic (3.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.45e-2)" "prognostic unfavorable (1.14e-4)" "unprognostic (1.91e-1)" "unprognostic (3.91e-2)" "unprognostic (3.07e-2)" "unprognostic (1.80e-1)" "prognostic favorable (1.62e-4)" "unprognostic (2.08e-2)" 11.7 1.7 1.5 2.8 1.5 0.0 17.1 1.5 1.6 31.0 8.5 1.0 26.3 4.4 6.8 17.8 103.8 13.4 12.3 4.7 2.4 1.5 11.7 7.9 21.7 1.8 2.4 0.6 7.4 4.6 10.2 9.2 1.5 4.0 17.8 8.7 6.2 21.6 32.8 7.8 11.4 4.4 5.6 4.3 1.3 10.0 3.7 1.3 5.7 21.7 52.3 41.1 29.4 37.4 0.0 13.4 10.9 9.3 0.3 1.0 2.8 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 25.3 0.0 27.9 0.0 0.1 34.9 0.0 8.0 0.0 0.0 2.0 0.0 0.3 7.3 0.0 0.0 0.0 0.0 19.2 0.0 0.6 0.0 18.2 0.1 0.0 0.0 0.0 10.5 0.0 0.0 0.3 7.0 0.0 0.0 0.0 1.3 3.1 66.3 0.0 0.0 1.2 12.9 0.0 0.1 5.5 0.1 72.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 9.3 2.3 0.1 7.2 1.0 0.0 0.5 0.4 13.4 0.0 0.6 0.7 10.9 0.3 1.0 0.2 0.2 2.8 1.5 1.5 1.5 1.6 2.4 1.5 2.4 0.6 4.0 1.3 77.4 91.1 0.0 405.2 295.4 0.0 3.4 28.1 46.8 146.7 122.1 0.0 1.0 0.0 32.1 0.0 28.8 29.1 0.0 45.6 0.1 7.2 133.5 6.9 13.6 0.8 0.0 5.1 23.4 4.0 0.0 0.0 11.0 20.3 0.0 3.3 0.0 45.3 14.8 0.0 5.6 0.0 0.0 7.1 0.0 0.6 408.6 14.9 2.6 32.4 416.5 MXD1 "bHLHc58, MAD, MAD1" ENSG00000059728 "MAX dimerization protein 1" Q05195 2 69897688-69942945 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 81.1;bone marrow: 72.8;esophagus: 64.8" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 212.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "neutrophil: 81.1" "Lineage enriched" "Detected in many" 49 "granulocytes: 81.1" "Cell line enhanced" "Detected in many" "hTERT-HME1: 20.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001599 Enhanced Uncertain Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria" Cytosol "HPA001599: AB_1079434" "unprognostic (1.59e-1)" "unprognostic (5.11e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (8.14e-6)" "unprognostic (1.49e-1)" "unprognostic (1.76e-1)" "unprognostic (4.36e-2)" "unprognostic (8.73e-3)" "unprognostic (3.39e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (8.50e-4)" "unprognostic (8.72e-2)" "unprognostic (3.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.61e-1)" "unprognostic (1.56e-3)" "unprognostic (1.77e-2)" 6.9 2.2 2.7 18.7 3.8 72.8 3.7 5.7 4.1 15.8 19.6 4.7 0.9 13.6 2.9 2.6 64.8 3.8 4.9 10.8 3.0 2.9 3.0 5.5 17.0 14.3 5.9 2.4 3.3 2.5 3.6 4.0 15.8 3.1 3.3 14.0 5.1 8.8 1.4 3.1 5.9 50.2 4.6 4.3 15.8 8.2 3.6 3.7 9.4 4.0 20.8 34.0 6.3 21.6 0.2 0.8 81.1 1.6 0.4 0.4 0.6 3.5 1.5 2.2 1.6 5.0 2.5 8.4 3.9 2.2 1.9 1.3 4.9 2.8 2.0 2.0 1.5 1.9 12.6 4.2 7.8 2.0 1.1 5.1 4.2 4.5 4.9 16.8 5.0 4.2 2.8 13.3 4.4 20.4 2.4 2.4 2.1 7.3 8.1 1.2 2.8 2.4 10.1 0.6 5.2 2.5 1.1 2.3 5.0 2.5 4.2 7.3 3.1 5.2 7.0 2.7 2.7 1.0 3.0 9.6 2.8 0.8 3.0 3.7 5.5 9.3 0.8 2.9 8.9 1.0 17.0 1.6 16.8 0.3 1.0 0.4 0.1 0.2 0.2 0.8 0.2 0.2 0.3 81.1 0.4 0.8 0.2 0.2 0.6 2.7 3.8 5.7 4.1 3.0 2.9 5.9 2.4 3.1 3.7 35.7 30.8 18.2 23.9 22.9 27.8 4.8 7.6 10.7 11.4 1.8 51.1 7.9 6.6 10.8 12.4 9.0 212.1 0.0 14.8 5.1 13.6 61.3 26.5 6.7 26.9 9.5 93.4 6.2 48.3 15.3 4.4 71.5 15.1 20.8 115.5 40.4 44.4 91.2 2.5 5.1 17.8 0.0 28.7 8.1 2.0 49.3 88.6 20.8 26.6 110.0 MYEOV OCIM ENSG00000172927 "Myeloma overexpressed" Q96EZ4 11 69294138-69367726 "Predicted membrane proteins" Proto-oncogene "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 29.4;breast: 16.9;esophagus: 17.3" "Cell type enriched" "Detected in some" 8 "Pancreatic endocrine cells: 116.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1" HPA012949 Uncertain Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "HPA012949: AB_1854241" "unprognostic (1.42e-2)" "unprognostic (8.56e-2)" "unprognostic (7.07e-2)" "unprognostic (3.36e-1)" "unprognostic (5.60e-2)" "unprognostic (7.28e-3)" "unprognostic (7.58e-3)" "prognostic unfavorable (2.00e-4)" "unprognostic (3.49e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (1.54e-7)" "unprognostic (2.83e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (3.35e-1)" "unprognostic (3.69e-2)" 29.4 0.2 0.0 2.4 0.0 0.2 16.9 0.1 0.0 2.6 1.1 0.0 0.4 0.4 0.5 8.1 17.3 0.0 1.3 0.1 0.0 0.2 0.2 8.6 0.1 0.2 0.0 0.1 0.1 2.1 0.0 0.1 0.0 0.0 0.1 0.6 0.9 2.0 0.0 0.6 4.9 0.8 0.1 0.0 0.3 10.7 0.4 0.0 0.1 0.1 5.3 13.6 0.2 4.7 0.5 0.0 0.0 0.1 1.0 0.3 2.1 59.2 28.4 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.2 8.7 0.2 2.6 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 1.0 2.3 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.0 0.1 0.8 0.0 13.1 0.0 0.6 0.1 0.6 0.1 0.0 0.2 1.1 0.0 0.1 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.3 0.0 0.0 0.0 3.5 0.0 0.0 0.0 15.5 10.5 0.0 0.4 0.0 8.4 0.2 0.2 1.2 0.0 0.0 2.4 0.0 0.0 0.0 0.0 4.7 0.3 0.0 0.0 0.0 1.0 0.0 116.0 12.5 0.0 0.0 0.0 0.0 1.4 0.0 0.4 1.1 0.1 0.0 0.5 6.8 MYH3 "HEMHC, MYHC-EMB, MYHSE1, SMHCE" ENSG00000109063 "Myosin heavy chain 3" P11055 17 10628526-10657309 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.1;prostate: 25.6;skeletal muscle: 18.5" "Cell type enriched" "Detected in many" 17 "Early spermatids: 325.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 28 "HSkMC: 37.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.7" "Not detected" "Not detected" HPA021808 Enhanced NA NA 17000000 "HPA021808: AB_1854242" "unprognostic (1.70e-2)" "unprognostic (1.10e-3)" "unprognostic (4.19e-4)" "unprognostic (3.35e-1)" "unprognostic (7.66e-2)" "unprognostic (1.08e-1)" "unprognostic (1.10e-2)" "unprognostic (1.28e-1)" "unprognostic (1.67e-2)" "unprognostic (3.54e-1)" "unprognostic (7.84e-4)" "unprognostic (1.29e-1)" "unprognostic (3.24e-4)" "unprognostic (1.91e-2)" "unprognostic (6.17e-3)" "unprognostic (3.40e-2)" "unprognostic (3.49e-1)" 1.0 0.5 0.7 0.8 1.0 0.6 0.8 1.9 0.8 2.2 4.1 0.6 3.5 0.9 1.9 13.2 21.1 1.0 0.6 0.6 0.9 0.6 0.8 1.8 0.6 1.0 0.9 0.6 1.4 1.3 0.5 0.7 1.1 0.6 25.6 0.9 0.6 0.7 16.2 18.5 1.5 1.4 16.5 1.2 1.6 0.8 2.8 0.6 1.8 2.3 1.7 2.0 8.5 2.6 1.0 0.1 0.0 0.1 0.9 0.7 0.0 0.1 0.6 0.4 0.7 0.6 0.2 0.6 0.4 0.2 0.3 0.3 0.6 0.1 0.4 0.2 0.2 0.1 0.6 0.3 0.1 0.6 0.4 0.6 0.6 0.1 1.0 0.2 0.3 0.9 37.9 0.2 0.4 0.5 0.1 0.0 0.8 0.2 0.0 0.1 0.4 0.5 1.3 0.6 0.1 0.4 0.5 0.5 0.1 0.2 0.2 0.0 0.2 0.2 0.0 0.2 0.4 0.2 0.1 0.2 0.0 0.6 0.1 0.0 0.8 0.6 0.1 0.1 0.2 0.3 0.0 0.1 0.0 0.7 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.9 0.0 0.1 0.6 0.0 0.7 1.0 1.9 0.8 0.9 0.6 0.9 0.6 0.6 0.6 0.0 12.7 0.0 0.8 2.6 3.8 2.6 2.5 0.0 1.2 0.0 5.9 0.4 0.0 0.4 325.0 0.5 0.9 0.0 0.5 0.6 0.4 0.7 7.0 0.6 0.1 0.0 0.0 0.6 1.2 18.6 2.6 1.2 1.7 0.0 0.5 2.9 0.5 0.0 2.5 0.0 3.9 0.0 0.1 7.7 3.6 1.4 0.5 0.9 0.8 0.1 NCCRP1 "FBXO50, LOC342897, NCCRP-1" ENSG00000188505 "Non-specific cytotoxic cell receptor protein 1 homolog (zebrafish)" Q6ZVX7 19 39196961-39201884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 101.7;lymphoid tissue: 113.1;skin 1: 49.6" "Cell type enriched" "Detected in some" 23 "monocytes: 983.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 26.8" "Region enhanced" "Detected in single" "olfactory region: 2.0" "Low region specificity" "Detected in single" HPA052812 Approved NA NA 1200000 "HPA052812: AB_2681960" "unprognostic (3.56e-3)" "unprognostic (3.69e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (4.59e-3)" "unprognostic (3.73e-3)" "unprognostic (2.78e-1)" "unprognostic (3.37e-3)" "unprognostic (1.00e-1)" "unprognostic (3.53e-3)" "unprognostic (2.04e-2)" "unprognostic (1.90e-1)" "unprognostic (6.37e-6)" "unprognostic (2.12e-1)" "unprognostic (3.00e-1)" "unprognostic (2.13e-1)" "unprognostic (1.57e-1)" 0.1 0.1 0.0 3.1 0.0 0.3 2.1 0.0 0.4 21.5 0.8 0.0 0.4 0.6 2.1 0.3 101.7 0.4 0.3 0.1 0.0 0.0 0.9 0.1 0.8 2.4 0.0 0.0 0.1 2.9 0.1 0.0 7.5 0.0 0.4 0.6 20.2 10.5 0.4 0.3 49.6 2.4 0.2 0.0 0.4 0.1 0.1 0.0 4.3 0.2 42.7 113.1 1.2 31.2 0.7 0.8 3.4 0.6 0.9 0.6 0.1 0.2 0.2 1.0 0.2 0.1 0.7 2.1 0.1 0.0 0.1 0.1 0.5 0.5 0.6 2.0 0.4 0.2 0.9 1.5 0.6 0.5 0.0 0.4 0.2 0.8 0.2 0.1 0.4 0.3 0.5 0.4 0.1 0.3 0.3 0.2 0.5 0.3 0.3 0.3 0.1 0.2 0.1 0.6 0.1 0.2 0.2 0.4 0.4 0.1 0.6 0.6 1.0 2.6 26.8 0.2 0.8 0.3 0.9 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.6 0.5 0.2 0.5 3.4 0.6 0.5 0.6 0.4 0.3 0.5 0.4 0.3 0.2 0.7 0.5 0.4 2.0 0.9 0.5 0.8 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.4 0.2 0.0 0.0 0.0 3.5 0.0 0.2 0.0 2.5 0.0 0.0 0.0 0.0 2.0 2.5 0.4 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 983.8 0.0 0.2 6.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 6.1 9.3 0.0 0.0 42.6 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070995-161089599 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;placenta: 46.6;skin 1: 39.3" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 321.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" No No 11000 "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.2 0.1 0.1 0.8 0.1 0.1 7.7 0.1 0.1 9.8 0.6 0.1 5.4 0.2 1.5 3.7 40.1 1.4 5.6 0.1 0.1 0.1 1.3 0.2 3.1 0.0 0.1 0.0 0.5 4.4 0.0 0.3 46.6 0.1 7.8 0.7 0.1 13.5 5.5 0.1 39.3 0.4 2.0 0.1 0.1 4.5 0.2 0.0 0.5 0.1 22.7 23.1 12.6 18.5 0.2 0.3 3.6 0.1 0.1 0.2 0.0 5.2 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.1 0.0 0.0 18.2 0.0 0.6 0.1 0.0 0.2 0.0 0.4 5.3 0.0 0.0 0.3 0.0 7.2 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.1 23.7 0.0 3.3 15.3 0.0 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.1 1.2 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 6.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 18.7 14.8 15.7 0.0 24.1 0.0 34.7 0.0 0.0 0.0 0.0 26.2 43.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.3 0.0 0.0 0.0 NMU ENSG00000109255 "Neuromedin U" P48645 4 55595229-55636698 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.9;skin 1: 28.3;tongue: 28.4" "Cell type enhanced" "Detected in some" 24 "Basal keratinocytes: 14.4;Erythroid cells: 23.3;Suprabasal keratinocytes: 64.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.4" "Group enriched" "Detected in some" 10 "MAIT T-cell: 7.2;memory CD4 T-cell: 2.3" "Lineage enriched" "Detected in single" 51 "T-cells: 7.2" "Cell line enhanced" "Detected in many" "HaCaT: 81.3;K-562: 63.9;Karpas-707: 29.3" "Region enhanced" "Detected in single" "pons and medulla: 4.7" "Low region specificity" "Detected in many" HPA025926 Uncertain "Secreted in other tissues" NA NA "HPA025926: AB_1854539" "unprognostic (4.42e-2)" "unprognostic (1.00e-1)" "unprognostic (5.83e-2)" "prognostic unfavorable (2.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.19e-2)" "unprognostic (7.12e-2)" "unprognostic (7.29e-3)" "unprognostic (9.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.03e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.07e-10)" "unprognostic (1.61e-1)" "unprognostic (5.66e-2)" "unprognostic (2.54e-2)" "unprognostic (5.55e-2)" 0.1 0.3 0.2 2.0 1.1 5.9 1.3 0.1 3.4 5.4 1.1 0.2 2.5 0.6 0.5 0.0 42.9 0.2 0.3 0.3 0.2 0.9 0.1 0.0 1.0 0.4 0.4 0.5 0.0 0.0 0.0 2.8 2.1 0.3 0.1 0.6 0.0 6.6 1.5 0.1 28.3 1.7 0.2 1.2 0.1 3.1 1.3 0.0 0.7 17.2 28.4 8.5 0.1 12.2 0.1 0.0 0.0 0.0 0.0 7.2 0.1 8.5 0.0 4.7 1.2 0.0 0.0 0.0 0.0 0.0 0.6 1.7 0.0 13.1 18.9 1.8 0.0 1.8 81.3 9.8 0.7 0.5 1.1 5.3 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 2.2 0.0 1.3 63.9 29.3 0.0 2.0 0.2 0.0 2.5 1.5 2.4 0.0 0.0 0.1 0.4 0.0 4.2 10.7 6.5 0.1 0.0 0.9 4.5 0.0 0.5 0.0 6.1 0.0 11.4 8.5 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 2.3 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.1 0.1 3.4 0.2 0.9 0.4 0.5 0.3 0.0 0.0 2.9 1.5 0.6 14.4 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.2 0.2 0.0 23.3 0.2 0.1 1.1 0.2 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.5 2.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 1.5 7.6 64.4 0.1 0.0 1.7 8.0 OVOL1 HOVO1 ENSG00000172818 "Ovo like transcriptional repressor 1" O14753 11 65787022-65797219 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.6;tongue: 37.4" "Cell type enhanced" "Detected in many" 16 "Syncytiotrophoblasts: 291.8;Urothelial cells: 75.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "memory CD8 T-cell: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 10.1;BEWO: 29.1;CACO-2: 7.3;HaCaT: 17.2;RT4: 16.9;SK-BR-3: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA003984 Uncertain Approved Nucleoplasm Yes NA Nucleoplasm "HPA003984: AB_1854854" "unprognostic (4.26e-3)" "unprognostic (3.39e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (3.37e-1)" "unprognostic (1.26e-2)" "unprognostic (1.95e-1)" "unprognostic (2.31e-2)" "unprognostic (2.01e-3)" "unprognostic (1.91e-1)" "prognostic favorable (1.00e-13)" "unprognostic (4.26e-2)" "unprognostic (3.51e-2)" "unprognostic (2.42e-1)" "unprognostic (9.04e-3)" 0.2 0.1 0.2 3.3 0.3 0.0 2.2 0.4 0.2 7.2 11.5 0.0 3.0 9.6 0.4 0.7 42.6 0.3 4.2 0.1 0.2 0.2 4.7 0.2 1.7 0.0 0.2 0.0 0.1 5.6 5.0 0.2 14.4 0.0 2.3 5.1 1.1 13.9 6.1 0.5 24.1 14.2 0.8 0.2 0.2 0.8 17.3 0.0 0.6 1.8 37.4 25.3 8.3 9.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 10.1 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 7.3 2.7 0.0 0.1 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.0 0.8 16.9 0.1 0.0 0.0 13.4 0.1 3.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 3.5 0.0 33.3 23.7 0.0 0.4 10.2 8.1 2.3 3.5 0.0 20.8 0.0 2.2 61.4 0.4 47.4 0.0 3.4 12.0 1.1 21.2 2.3 0.0 1.8 0.0 30.3 0.0 0.0 65.1 1.1 1.3 0.0 0.0 49.6 0.0 3.6 38.6 1.8 4.2 0.0 0.0 0.4 13.7 5.4 50.2 291.8 0.0 42.1 75.8 PERP "dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW" ENSG00000112378 "PERP, TP53 apoptosis effector" Q96FX8 6 138088505-138107511 "Predicted membrane proteins" "Apoptosis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 250.2;skin 1: 157.9;tongue: 230.6" "Cell type enhanced" "Detected in many" 14 "Basal keratinocytes: 2942.7;Suprabasal keratinocytes: 5094.7;Urothelial cells: 1450.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.3" "Group enriched" "Detected in many" 9 "granulocytes: 21.3;T-cells: 5.6" "Cell line enhanced" "Detected in many" "HaCaT: 37.9;hTCEpi: 142.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022269 Enhanced NA NA "HPA022269: AB_1855219" "prognostic unfavorable (5.46e-4)" "unprognostic (2.90e-1)" "unprognostic (1.94e-1)" "unprognostic (5.18e-2)" "unprognostic (2.82e-2)" "unprognostic (1.27e-1)" "unprognostic (6.28e-3)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.92e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (1.05e-5)" "unprognostic (4.02e-2)" "unprognostic (6.05e-2)" "unprognostic (1.13e-1)" "unprognostic (2.70e-1)" "unprognostic (1.94e-1)" "unprognostic (1.51e-2)" 4.2 1.6 1.0 2.7 1.2 0.0 25.5 1.3 0.9 51.9 12.5 0.5 7.1 6.3 6.4 11.7 250.2 7.7 15.6 14.7 1.2 1.5 4.4 28.0 8.4 1.7 1.3 0.3 3.3 11.5 5.0 3.3 31.5 1.6 17.5 5.0 2.4 46.6 7.9 1.4 157.9 23.4 7.1 1.3 0.6 8.4 1.9 0.6 6.7 8.7 230.6 113.6 14.0 57.8 1.4 0.0 21.3 0.0 0.0 5.6 0.8 10.2 11.5 0.0 1.1 8.1 8.6 24.0 16.7 18.9 2.4 1.7 9.4 21.2 0.0 6.0 4.2 19.9 37.9 2.0 30.2 0.5 16.1 9.4 0.0 11.5 8.8 5.8 0.0 0.0 6.4 142.2 0.2 15.5 13.8 9.4 0.6 0.1 4.5 0.2 7.1 0.0 0.5 4.9 24.5 6.2 0.0 3.8 0.0 16.1 12.0 4.0 0.0 17.7 9.5 8.1 11.6 5.3 2.1 11.2 4.2 1.6 4.5 0.0 1.4 1.8 0.0 3.3 0.0 8.8 21.3 0.0 0.0 3.0 0.0 5.2 1.4 3.8 2.6 0.0 0.4 0.4 1.7 0.2 0.0 0.0 0.0 5.6 0.8 1.0 1.2 1.3 0.9 1.2 1.5 1.3 0.3 1.6 0.6 196.5 66.8 11.7 1261.9 2942.7 3.4 114.6 234.4 397.5 227.5 146.5 15.7 849.6 53.0 494.4 1.4 53.7 255.2 0.0 273.4 823.5 67.6 524.2 10.4 153.4 71.8 3.2 141.3 9.8 2.2 2.0 9.8 5.1 332.3 18.0 159.9 23.8 453.2 273.5 2.5 10.1 25.6 6.5 122.7 1.8 0.9 5094.7 689.2 31.2 162.2 1450.6 PI3 "cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14" ENSG00000124102 "Peptidase inhibitor 3" P19957 20 45174876-45176544 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6" "Cell type enhanced" "Detected in many" 21 "Enterocytes: 69.5;Exocrine glandular cells: 290.8;Pancreatic endocrine cells: 135.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 2666.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1121 "neutrophil: 157.1" "Lineage enriched" "Detected in single" 1571 "granulocytes: 157.1" "Group enriched" "Detected in some" 5 "EFO-21: 26.6;HaCaT: 32.3;OE19: 29.6;PC-3: 55.0" "CAB009449, HPA017737" Enhanced Approved "Plasma membrane" "Secreted to blood" NA NA 2100000 "Plasma membrane" "CAB009449: AB_2252354, HPA017737: AB_1848107" "prognostic favorable (6.94e-4)" "unprognostic (3.61e-2)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (7.34e-2)" "unprognostic (1.85e-1)" "unprognostic (3.20e-3)" "unprognostic (5.53e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (3.84e-6)" "prognostic unfavorable (6.89e-4)" "unprognostic (8.54e-3)" "prognostic unfavorable (1.94e-8)" "unprognostic (1.23e-1)" "unprognostic (7.38e-2)" "unprognostic (1.04e-2)" "unprognostic (5.91e-3)" 0.4 0.0 0.2 8.8 0.2 0.0 0.7 0.2 0.2 85.3 9.3 0.2 0.4 0.1 7.7 0.2 200.8 0.3 4.8 0.6 0.2 0.0 0.3 0.6 3.1 0.8 0.2 0.2 0.3 0.4 0.0 0.2 0.6 0.3 1.0 3.7 0.3 35.6 0.4 0.2 6.4 3.2 0.6 0.2 1.4 0.7 5.1 0.2 23.4 0.2 468.6 173.5 1.6 118.7 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.9 0.6 0.4 26.6 0.0 0.3 32.3 0.0 6.6 0.0 0.3 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 6.3 5.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 29.6 55.0 0.0 0.2 0.0 6.3 0.1 0.0 0.0 4.5 0.6 0.0 0.0 0.0 0.0 0.2 0.3 3.2 0.0 0.2 0.1 0.4 0.1 4.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.0 11.3 0.5 5.2 0.1 0.0 0.0 7.6 0.0 13.6 17.4 0.0 0.0 0.0 14.9 0.1 0.1 69.5 0.0 290.8 0.0 0.3 25.8 4.6 0.0 0.1 0.0 16.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.4 0.0 135.9 29.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.3 0.0 0.0 33.5 18.7 PITX1 "BFT, POTX, PTX1" ENSG00000069011 "Paired like homeodomain 1" P78337 5 135027735-135034813 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8" "Cell type enhanced" "Detected in some" 27 "Basal glandular cells: 84.7;Glandular cells: 52.7;Urothelial cells: 214.7" "Cancer enhanced" "Detected in many" "cervical cancer: 73.6" "Region enriched" "Detected in single" 11 "pons and medulla: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 40.4;HeLa: 33.0;K-562: 32.2;T-47d: 48.1" "Not detected" "Not detected" HPA008743 Approved Approved Nucleoli Yes No Nucleoli "HPA008743: AB_1855413" "unprognostic (1.84e-1)" "unprognostic (1.46e-1)" "unprognostic (1.48e-1)" "unprognostic (4.62e-2)" "unprognostic (5.08e-2)" "unprognostic (5.26e-3)" "unprognostic (1.03e-2)" "unprognostic (1.66e-2)" "unprognostic (5.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.60e-2)" "unprognostic (2.27e-1)" "unprognostic (5.80e-14)" "unprognostic (6.22e-2)" "unprognostic (1.33e-1)" "unprognostic (5.98e-3)" "unprognostic (4.97e-3)" 0.3 0.3 0.0 4.7 0.0 0.3 0.2 0.0 0.2 14.8 2.8 0.0 0.0 5.6 0.5 1.2 119.4 0.3 1.9 0.2 0.0 0.0 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.2 0.2 32.9 1.3 1.0 8.8 1.1 10.8 33.0 0.2 8.6 0.5 3.2 18.6 0.0 0.2 7.4 0.4 0.0 0.0 0.4 58.8 60.8 18.2 28.9 0.3 0.3 1.4 0.4 0.4 1.1 0.2 17.2 10.6 0.0 14.2 0.6 0.2 4.4 3.4 5.0 1.7 0.6 40.4 10.2 19.4 5.5 0.2 4.2 5.9 2.3 8.3 0.1 0.2 15.0 4.8 33.0 11.1 5.2 1.7 0.0 0.4 6.0 0.0 1.9 0.1 0.0 3.0 32.2 0.0 0.5 5.3 0.1 3.8 0.0 1.5 9.5 5.7 0.3 0.3 0.2 5.4 6.6 0.0 15.1 8.2 0.0 0.1 48.1 1.1 0.6 1.9 4.8 1.0 5.3 0.0 0.0 12.7 2.5 0.1 0.0 1.4 0.3 0.1 0.9 0.3 0.5 0.3 0.6 1.1 0.2 0.3 0.3 1.0 0.7 0.4 0.4 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 84.7 1.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.4 0.0 0.3 0.0 0.4 2.0 0.9 52.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 4.4 0.3 0.0 0.0 0.0 0.3 0.0 9.9 0.3 0.0 0.0 2.0 0.0 1.4 1.4 4.1 5.9 6.4 0.0 0.6 214.7 PKP1 B6P ENSG00000081277 "Plakophilin 1" Q13835 1 201283452-201332993 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.1;skin 1: 137.6;tongue: 129.6" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 124.1;Suprabasal keratinocytes: 357.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 295.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 45.1;HBEC3-KT: 27.6;hTCEpi: 98.2;hTERT-HME1: 26.1;PC-3: 37.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027221, CAB033130" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 2700000 "Nucleoplasm, Plasma membrane" "CAB033130: AB_2164139, HPA027221: AB_10599737" "unprognostic (3.55e-3)" "unprognostic (7.63e-2)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-2)" "unprognostic (1.49e-1)" "unprognostic (5.02e-2)" "unprognostic (2.20e-3)" "unprognostic (2.67e-1)" "unprognostic (9.17e-3)" "unprognostic (2.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-1)" "unprognostic (6.59e-3)" 10.1 0.1 0.0 0.1 0.0 0.1 7.0 0.0 0.4 19.7 0.5 0.0 2.5 0.1 1.5 1.9 80.1 0.3 0.1 0.1 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.6 0.0 6.8 0.1 4.9 10.1 3.9 2.1 137.6 0.2 0.1 0.0 0.1 0.1 0.1 0.0 9.2 0.1 129.6 37.2 1.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 45.1 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.2 1.1 26.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 46.2 124.1 6.7 1.3 0.0 0.0 4.5 0.0 2.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 1.0 0.0 7.1 21.9 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 1.2 3.2 9.4 0.0 0.0 0.0 37.2 0.0 3.9 0.0 0.0 357.5 0.1 0.0 0.0 44.2 PKP3 ENSG00000184363 "Plakophilin 3" Q9Y446 11 392614-404908 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 69.0;skin 1: 48.4;tongue: 59.0" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 206.5;Extravillous trophoblasts: 144.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.6;NK-cell: 2.3" "Group enriched" "Detected in many" 5 "NK-cells: 2.3;T-cells: 1.6" "Cell line enhanced" "Detected in many" "A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5" "Region enriched" "Detected in single" 37 "cerebellum: 10.0" "Low region specificity" "Detected in many" "CAB012993, HPA062937" Enhanced Enhanced "Nucleoplasm,Cell Junctions" NA NA "Cell Junctions" Nucleoplasm "CAB012993: AB_2533221, HPA062937: AB_2684908" "unprognostic (4.74e-2)" "unprognostic (5.28e-2)" "unprognostic (4.45e-2)" "unprognostic (2.25e-2)" "unprognostic (1.58e-2)" "unprognostic (1.57e-1)" "unprognostic (8.88e-3)" "prognostic unfavorable (2.89e-5)" "unprognostic (1.25e-1)" "unprognostic (6.73e-3)" "prognostic unfavorable (3.93e-4)" "unprognostic (3.55e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.16e-2)" "unprognostic (3.41e-1)" "unprognostic (2.60e-1)" "unprognostic (3.15e-2)" 0.6 0.0 0.2 3.7 0.3 0.0 3.3 0.2 0.3 14.5 14.6 0.3 5.0 11.2 1.9 6.2 69.0 2.6 8.9 0.5 0.3 0.1 0.6 0.2 4.3 0.2 0.2 0.2 1.1 10.2 3.9 3.8 23.2 0.2 4.5 3.6 0.2 12.5 2.5 0.6 48.4 25.4 1.0 0.2 0.3 10.4 0.5 0.2 2.2 5.8 59.0 29.9 2.8 21.5 0.3 0.0 0.0 0.0 2.3 1.6 0.1 37.6 7.3 0.0 0.1 0.0 0.0 15.8 0.3 0.2 0.8 0.4 15.0 26.4 0.0 1.5 0.3 1.7 50.7 0.0 19.2 0.1 0.0 9.5 0.0 4.3 10.4 0.1 0.0 0.0 0.1 33.2 0.1 8.1 0.1 0.1 0.0 11.2 0.2 0.1 23.7 0.1 0.0 0.0 19.0 12.7 0.2 0.0 0.1 0.4 7.6 10.8 0.1 10.9 38.5 0.0 0.5 13.9 0.1 1.3 0.2 1.4 0.7 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 0.8 0.0 0.3 0.0 0.7 0.0 2.3 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.3 0.3 0.1 0.2 0.2 0.2 0.2 14.9 15.4 0.0 43.7 64.1 0.0 1.1 7.6 9.4 12.5 12.2 0.0 112.3 0.0 83.2 0.0 0.4 206.5 0.0 54.5 144.7 3.5 34.6 13.8 0.0 11.6 0.0 20.8 0.0 0.0 0.0 0.9 1.8 1.7 3.6 76.4 0.5 96.8 93.0 0.0 0.7 0.1 0.0 1.6 0.0 0.4 77.5 91.8 0.0 83.6 52.6 PLEKHN1 DKFZP434H2010 ENSG00000187583 "Pleckstrin homology domain containing N1" Q494U1 1 966497-975865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.5;lymphoid tissue: 21.2;skin 1: 31.3;tongue: 20.2" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 17.5;Glandular cells: 28.7;Pancreatic endocrine cells: 24.5;Suprabasal keratinocytes: 15.2;Urothelial cells: 37.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 2.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.3;HaCaT: 19.9;SK-BR-3: 13.6" "Not detected" "Not detected" HPA031742 Uncertain Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA031742: AB_10670704" "unprognostic (2.72e-3)" "unprognostic (8.05e-3)" "unprognostic (9.03e-2)" "unprognostic (4.47e-2)" "unprognostic (7.50e-4)" "unprognostic (2.93e-2)" "unprognostic (1.38e-2)" "unprognostic (1.78e-1)" "unprognostic (3.24e-1)" "unprognostic (1.01e-2)" "unprognostic (2.58e-3)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.97e-5)" "unprognostic (9.98e-2)" "unprognostic (1.96e-1)" "unprognostic (2.05e-2)" "unprognostic (1.44e-1)" 0.4 0.6 0.0 1.8 0.2 0.4 1.4 0.0 0.1 7.7 0.9 0.0 0.0 0.8 1.1 2.7 31.5 0.3 5.0 0.5 0.3 0.0 2.3 0.8 1.1 0.3 0.0 0.0 0.1 0.5 0.3 0.0 1.5 0.0 3.7 0.2 0.3 5.3 1.2 1.5 31.3 0.7 0.6 0.6 0.5 1.7 0.8 0.0 0.2 0.7 20.2 21.2 6.0 10.6 0.0 0.3 2.0 0.9 2.3 1.1 0.2 11.3 1.2 0.0 0.8 0.0 0.6 1.9 5.3 1.3 3.4 0.8 1.5 8.8 0.0 2.5 2.1 4.5 19.9 0.2 3.3 0.5 3.9 0.8 0.0 3.5 2.3 0.5 0.2 0.1 0.1 2.8 2.2 1.2 2.9 0.3 0.0 0.2 3.2 0.2 6.6 0.0 0.2 0.4 1.6 9.1 0.0 0.0 4.2 3.7 3.4 0.1 0.1 5.9 13.6 0.8 0.3 2.6 0.0 2.4 4.3 1.9 0.4 3.5 2.6 0.1 0.1 5.2 1.9 2.4 0.0 0.9 2.0 0.3 0.3 0.0 0.0 0.5 1.1 0.3 0.0 0.2 0.0 0.0 2.3 0.1 0.0 0.8 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.0 0.6 0.9 17.5 4.0 0.1 0.8 0.0 1.4 1.2 0.0 0.0 5.9 0.0 11.4 0.0 0.6 0.0 0.0 12.2 1.5 0.6 28.7 0.0 0.0 1.0 3.2 0.0 0.0 0.8 0.0 0.0 1.4 1.7 1.8 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.6 15.2 8.2 2.5 0.0 37.9 PPL ENSG00000118898 Periplakin O60437 16 4882507-4960741 "Plasma proteins, Predicted intracellular proteins" Keratinization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 68.5;Collecting duct cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 27.2;HaCaT: 57.0;MCF7: 20.8;SiHa: 30.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA042550, HPA059859" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 310000 "Plasma membrane" "Nucleoplasm, Cytosol" "HPA042550: AB_2678048, HPA059859: AB_2684145" "unprognostic (2.12e-2)" "unprognostic (1.78e-1)" "unprognostic (1.16e-1)" "unprognostic (3.90e-2)" "unprognostic (2.84e-2)" "unprognostic (1.40e-1)" "unprognostic (3.70e-3)" "unprognostic (5.58e-2)" "unprognostic (2.41e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.41e-2)" "unprognostic (1.31e-1)" "unprognostic (4.13e-3)" "unprognostic (2.43e-2)" "unprognostic (2.25e-1)" "unprognostic (1.19e-1)" "unprognostic (7.86e-2)" 10.8 0.7 2.2 1.4 0.7 0.2 6.8 0.6 3.0 23.5 2.9 0.2 4.1 1.7 2.6 5.1 126.9 2.9 5.8 1.8 1.8 0.2 3.0 3.3 4.7 0.2 0.0 0.9 1.7 2.8 1.6 2.8 2.9 0.5 4.6 1.0 0.7 24.3 3.3 3.2 30.7 2.0 5.0 0.0 0.2 2.1 1.5 0.0 0.5 7.2 57.8 60.9 5.0 39.9 0.1 0.0 1.6 0.0 0.0 0.0 0.0 6.9 2.5 0.0 0.0 18.7 27.2 9.0 0.0 0.4 0.0 0.1 11.6 17.8 0.1 4.1 0.3 1.0 57.0 0.3 6.8 0.0 0.0 0.4 0.0 13.8 2.0 1.2 0.0 0.0 1.3 6.3 0.0 2.2 1.4 0.0 0.0 0.0 0.0 0.0 20.8 0.0 0.0 1.8 9.2 5.4 0.0 0.0 8.7 13.6 11.1 9.4 0.1 30.5 10.2 0.1 2.8 5.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.3 0.0 3.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 2.2 0.7 0.6 3.0 1.8 0.2 0.0 0.9 0.5 0.0 68.5 23.2 0.5 33.9 31.1 7.7 3.5 30.6 12.0 30.7 54.1 5.9 1.6 1.7 15.3 0.6 6.4 4.5 0.0 4.0 1.2 11.0 30.6 0.0 10.9 0.6 1.6 37.8 4.3 0.8 0.2 51.2 1.8 16.9 1.8 3.9 5.3 16.8 5.8 3.9 0.8 11.2 0.0 5.6 3.9 2.9 44.8 1.1 0.7 5.0 47.5 PRSS22 "BSSP-4, hBSSP-4, SP001LA" ENSG00000005001 "Serine protease 22" Q9GZN4 16 2852727-2858170 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.4;lymphoid tissue: 40.1;tongue: 36.5" "Cell type enhanced" "Detected in many" 18 "Basal glandular cells: 187.4;Pancreatic endocrine cells: 242.0;Urothelial cells: 517.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 16 "cerebellum: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;MCF7: 12.7;RT4: 5.9;SK-BR-3: 13.4" "Region enhanced" "Detected in single" "cerebral cortex: 2.6" "Low region specificity" "Detected in all" HPA049161 Approved Approved Nucleoplasm "Secreted in other tissues" NA NA Nucleoplasm "HPA049161: AB_2680660" "unprognostic (1.45e-1)" "unprognostic (9.80e-2)" "unprognostic (3.50e-2)" "unprognostic (4.48e-1)" "unprognostic (2.29e-4)" "unprognostic (2.58e-1)" "unprognostic (4.42e-2)" "unprognostic (1.52e-2)" "unprognostic (5.06e-1)" "unprognostic (7.52e-2)" "unprognostic (3.74e-3)" "unprognostic (4.12e-1)" "unprognostic (2.32e-4)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" 0.4 0.7 0.0 0.4 0.0 0.6 1.3 1.5 0.4 9.9 1.0 0.0 8.6 1.5 3.0 0.6 40.4 3.0 6.8 0.4 0.0 0.0 2.4 0.7 3.0 0.4 0.0 0.0 0.4 7.5 0.4 1.1 4.3 0.0 5.1 0.6 0.0 13.4 10.6 2.3 1.3 0.4 0.7 0.0 0.4 3.5 0.4 0.0 0.0 1.5 36.5 40.1 5.2 9.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 12.7 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 13.4 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.4 0.0 187.4 20.6 0.0 0.2 33.1 8.1 23.9 15.7 0.0 30.9 1.7 101.8 0.0 0.0 4.2 0.0 86.5 19.4 0.8 63.4 0.0 0.0 2.0 0.0 3.5 0.0 0.0 0.0 0.0 0.9 6.8 1.8 5.3 0.0 242.0 10.5 0.0 0.0 0.0 0.0 1.0 0.0 0.1 24.1 8.8 0.0 5.2 517.3 PSCA ENSG00000167653 "Prostate stem cell antigen" O43653 8 142670308-142682724 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0" "Cell type enhanced" "Detected in many" 19 "Cholangiocytes: 124.9;Glandular cells: 317.3;Intestinal endocrine cells: 265.2;Urothelial cells: 540.7" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 785.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.6;HeLa: 22.6;OE19: 8.9;RT4: 32.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030783, HPA056418" Approved Supported "Plasma membrane" NA NA "Plasma membrane" "HPA030783: AB_2673611, HPA056418: AB_2683123" "unprognostic (1.21e-3)" "unprognostic (1.76e-3)" "unprognostic (3.20e-1)" "unprognostic (2.24e-1)" "unprognostic (1.77e-2)" "unprognostic (7.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.81e-3)" "unprognostic (8.25e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.60e-5)" "unprognostic (6.82e-2)" "unprognostic (2.38e-3)" "unprognostic (4.93e-2)" "unprognostic (2.68e-1)" "unprognostic (3.07e-1)" "unprognostic (1.06e-3)" 0.4 0.2 0.0 0.2 0.0 0.2 0.3 0.0 0.2 7.0 2.4 0.7 0.1 0.6 0.3 0.2 72.6 1.1 21.2 0.1 0.0 0.0 2.6 0.1 3.0 0.2 0.0 0.0 0.1 0.3 0.1 0.5 17.2 0.0 30.1 0.7 0.1 11.7 0.6 0.1 0.8 1.5 18.9 0.0 0.2 230.2 0.2 0.0 0.0 0.1 9.3 35.1 112.0 54.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 5.4 0.3 0.0 0.0 1.1 3.7 5.6 2.5 0.6 1.1 0.9 0.0 11.6 0.0 0.2 0.2 4.2 1.1 0.0 0.2 0.7 0.3 0.0 0.0 22.6 0.0 0.0 0.0 0.8 3.2 4.1 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.8 3.0 0.8 0.3 0.6 8.9 0.6 0.3 0.0 0.4 0.5 32.2 0.1 0.2 2.7 8.3 1.7 0.2 0.1 0.1 0.5 0.8 0.9 1.5 0.0 1.0 0.0 0.0 1.5 0.4 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.0 0.0 16.8 0.8 0.0 1.0 124.9 115.1 19.4 1.8 0.0 2.1 6.6 0.3 0.2 0.0 0.0 0.0 1.0 1.8 0.3 317.3 0.0 0.0 0.6 0.0 265.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.9 0.0 33.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 1.1 23.8 0.0 0.6 540.7 PTK6 BRK ENSG00000101213 "Protein tyrosine kinase 6" Q13882 20 63528001-63537370 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 44.0;intestine: 24.2;skin 1: 24.2" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 2: 34.1;Enterocytes: 90.1;Mucus-secreting cells: 39.1;Paneth cells: 65.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 10.6;CAPAN-2: 20.4;HaCaT: 16.6;hTCEpi: 22.5;OE19: 27.4;RT4: 13.0;T-47d: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB032952, HPA036070, HPA036071" Approved Supported "Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Plasma membrane, Cytosol" "CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982" "unprognostic (2.32e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "unprognostic (2.42e-2)" "unprognostic (1.41e-1)" "unprognostic (1.35e-1)" "unprognostic (1.04e-1)" "unprognostic (2.29e-1)" "unprognostic (3.03e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.26e-9)" "unprognostic (4.19e-2)" "unprognostic (1.74e-1)" "unprognostic (1.73e-1)" "unprognostic (4.24e-2)" 0.7 0.0 0.4 5.3 0.4 0.0 1.7 0.4 0.4 7.6 18.1 0.5 0.8 13.6 0.6 0.5 44.0 0.0 11.7 0.4 0.4 0.0 0.8 1.7 1.1 0.4 0.4 0.4 0.4 1.4 0.0 0.4 0.6 0.4 2.2 7.4 0.4 7.6 0.4 0.4 24.2 24.2 0.9 0.4 0.4 12.5 0.4 0.4 0.4 0.4 18.9 17.2 6.5 15.0 1.3 4.5 1.2 2.4 0.3 1.9 0.9 10.6 1.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 20.4 0.0 3.6 0.0 0.0 16.6 0.0 0.0 0.0 2.6 0.2 0.0 4.3 0.0 0.0 0.0 3.4 0.0 22.5 0.0 0.1 0.1 0.0 0.0 0.1 1.2 0.1 5.9 0.0 0.1 0.1 27.4 7.7 0.0 0.6 0.2 0.0 13.0 0.1 1.1 1.2 4.0 0.0 0.0 12.5 0.8 0.1 0.1 0.2 0.4 0.1 0.2 0.0 0.0 0.2 0.2 0.5 1.2 2.4 0.4 0.5 1.7 1.9 1.2 0.4 0.1 4.5 1.3 0.4 0.6 1.2 0.3 1.3 0.3 0.5 0.9 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 11.9 34.1 0.0 2.8 5.3 2.0 0.4 12.7 9.4 17.0 0.0 2.0 0.2 0.0 1.4 0.0 0.3 90.1 0.0 1.4 0.1 0.4 1.3 9.2 1.5 0.7 0.0 5.2 0.6 4.1 0.0 0.3 2.8 0.0 0.0 39.1 2.4 10.3 65.1 0.0 0.1 3.9 0.0 0.4 0.2 0.2 13.6 0.1 0.0 18.8 13.8 RAB25 CATX-8 ENSG00000132698 "RAB25, member RAS oncogene family" P57735 1 156061160-156070514 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 98.3" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 238.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.3;naive CD4 T-cell: 3.4" "Lineage enriched" "Detected in single" 24 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 24.3;CAPAN-2: 23.6;MCF7: 32.8;OE19: 75.9;RT4: 29.8;SK-BR-3: 48.5;T-47d: 45.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010872, CAB033645" Enhanced Uncertain "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "CAB033645: AB_1128883, HPA010872: AB_1079729" "unprognostic (2.43e-1)" "unprognostic (4.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.71e-1)" "unprognostic (2.64e-1)" "unprognostic (1.97e-1)" "unprognostic (4.27e-2)" "unprognostic (4.63e-2)" "unprognostic (2.82e-1)" "unprognostic (2.03e-2)" "unprognostic (1.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (1.38e-6)" "unprognostic (2.31e-2)" "unprognostic (3.24e-2)" "unprognostic (3.14e-2)" "unprognostic (4.94e-2)" 0.4 0.3 0.3 10.9 0.3 0.0 10.8 0.5 0.4 23.6 28.4 0.3 28.1 14.8 4.0 15.9 98.3 9.7 33.3 0.3 0.3 0.3 18.2 1.0 19.1 0.6 0.3 0.2 2.3 27.4 8.6 9.5 19.1 0.3 13.3 16.2 0.4 44.1 26.8 0.4 48.0 43.0 2.1 0.4 0.3 16.2 1.1 0.2 3.7 36.1 74.6 60.9 13.0 31.8 0.1 0.0 0.0 0.0 0.0 3.4 0.8 17.8 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 17.5 23.6 0.0 0.0 0.0 0.0 21.5 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.8 0.0 0.0 0.9 75.9 0.0 0.0 0.0 0.0 0.0 29.8 2.6 0.0 0.0 48.5 0.0 4.4 45.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 2.8 0.8 0.0 0.0 3.4 2.9 0.0 0.0 0.0 0.0 0.9 0.8 0.3 0.3 0.5 0.4 0.3 0.3 0.3 0.2 0.3 0.2 26.8 27.6 0.0 90.6 48.9 0.0 0.1 79.0 53.5 27.3 82.0 0.0 84.0 140.9 146.8 0.0 0.1 182.7 0.0 132.5 23.0 3.7 95.3 5.7 0.0 6.1 0.0 82.1 0.0 0.0 0.0 0.3 2.5 20.3 6.4 160.3 0.0 154.4 238.4 0.0 16.8 0.0 0.0 2.1 0.2 0.7 135.3 67.2 1.5 195.0 192.0 RAET1G ULBP5 ENSG00000203722 "Retinoic acid early transcript 1G" Q6H3X3 6 149916878-149923121 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.2;tongue: 18.4" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 4.2;Basal keratinocytes: 2.7;Melanocytes: 3.3;Urothelial cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 23.4;hTCEpi: 18.7;SiHa: 9.2;U-87 MG: 7.6" HPA062673 Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA062673: " "unprognostic (4.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-3)" "unprognostic (1.49e-1)" "unprognostic (4.61e-3)" "prognostic unfavorable (5.35e-4)" "unprognostic (3.05e-1)" "unprognostic (1.57e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.33e-1)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" "unprognostic (8.85e-2)" "unprognostic (9.11e-2)" 2.5 10.0 0.3 0.6 0.3 0.0 2.5 0.2 1.0 5.6 0.6 0.5 1.4 0.2 0.8 4.3 21.2 0.5 1.2 0.9 0.4 0.2 2.3 0.2 1.3 0.1 0.3 0.1 1.9 0.1 0.1 1.2 0.1 0.5 2.9 0.1 0.8 3.9 2.2 0.4 4.3 0.5 1.8 0.9 0.2 0.6 0.5 0.2 0.2 0.7 18.4 10.7 2.8 5.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 1.0 0.0 1.3 1.9 1.8 0.0 0.6 2.4 1.1 1.5 0.0 1.2 0.0 0.5 1.3 1.1 2.0 0.7 4.1 0.8 0.2 1.3 0.4 23.4 0.0 0.5 0.0 0.0 2.7 18.7 2.8 1.3 1.3 0.4 0.6 0.2 0.2 0.4 1.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.8 2.5 0.3 0.2 9.2 0.4 0.0 0.1 0.3 0.3 1.3 0.5 0.4 1.1 0.6 0.0 0.0 0.0 7.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.0 0.4 0.2 0.3 0.1 0.5 0.2 0.0 0.0 0.0 4.2 2.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.2 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.0 0.0 9.5 RAPGEFL1 Link-GEFII ENSG00000108352 "Rap guanine nucleotide exchange factor like 1" Q9UHV5 17 40177010-40195656 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 37.7;skin 1: 87.1" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 40.4;Enterocytes: 66.1;Paneth cells: 46.5;Suprabasal keratinocytes: 84.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HaCaT: 39.0;hTCEpi: 19.5;T-47d: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022895 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Nucleoplasm, Microtubules" "Cytokinetic bridge" "HPA022895: AB_1856071" "prognostic favorable (8.43e-4)" "prognostic favorable (3.28e-4)" "unprognostic (1.61e-1)" "unprognostic (1.13e-2)" "unprognostic (4.64e-3)" "unprognostic (3.48e-2)" "unprognostic (5.92e-2)" "unprognostic (1.80e-1)" "unprognostic (3.64e-2)" "unprognostic (2.67e-1)" "unprognostic (7.46e-3)" "unprognostic (8.84e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.23e-2)" "unprognostic (1.50e-1)" "unprognostic (1.15e-1)" "unprognostic (2.03e-2)" 1.5 1.3 15.9 2.7 17.2 1.8 4.1 8.2 22.7 8.9 19.5 1.8 0.9 18.8 1.6 4.3 37.7 2.9 5.9 1.1 11.2 6.2 0.6 1.7 1.6 1.1 2.8 20.2 0.8 1.6 0.8 2.7 1.2 5.5 3.4 17.7 1.3 5.7 3.2 4.6 87.1 15.5 2.0 1.9 1.4 12.6 2.4 2.9 0.2 0.9 13.3 10.7 6.5 19.4 0.1 0.9 2.9 0.4 0.0 0.6 0.0 2.1 1.1 5.8 4.3 0.6 1.4 2.8 0.8 0.6 1.1 1.3 2.4 3.1 1.7 0.8 1.1 1.0 39.0 1.1 1.3 1.6 3.1 2.9 1.0 1.3 2.4 0.7 2.1 3.6 1.6 19.5 1.2 0.5 1.7 1.7 5.8 0.7 1.2 0.8 6.0 1.9 2.5 1.8 10.7 1.1 3.6 0.7 1.0 0.7 11.4 11.2 2.3 1.3 13.2 0.5 5.1 34.1 1.6 3.3 1.4 2.9 1.5 1.3 1.9 1.8 1.4 3.3 1.3 1.7 0.0 0.1 0.0 0.6 0.0 0.0 0.1 0.4 0.4 0.9 0.0 0.1 0.2 2.9 0.0 0.4 0.2 0.0 0.0 15.9 17.2 8.2 22.7 11.2 6.2 2.8 20.2 5.5 2.9 0.0 0.6 0.8 9.6 40.4 2.1 1.6 20.4 0.0 1.2 1.8 5.9 0.1 0.0 0.5 2.4 1.6 66.1 0.0 0.7 0.2 1.0 5.0 5.7 3.8 0.5 1.6 4.7 4.9 0.8 1.4 3.1 1.6 5.0 1.8 32.6 2.8 1.2 46.5 3.5 0.0 4.6 0.0 1.4 11.5 10.4 84.8 0.6 0.0 32.3 31.9 RASSF10 ENSG00000189431 "Ras association domain family member 10" A6NK89 11 13009577-13012106 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 9.3" "Cell type enhanced" "Detected in some" 14 "Ciliated cells: 13.4;Distal tubular cells: 21.6;Pancreatic endocrine cells: 6.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A549: 9.5;CAPAN-2: 8.5;HaCaT: 13.1;HMC-1: 6.5;RPTEC TERT1: 13.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA040406 Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040406: AB_2732485" "unprognostic (6.71e-2)" "unprognostic (5.12e-2)" "unprognostic (5.06e-2)" "unprognostic (2.41e-3)" "unprognostic (6.25e-3)" "prognostic favorable (2.76e-4)" "unprognostic (3.43e-3)" "unprognostic (8.04e-2)" "unprognostic (5.89e-2)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (4.12e-5)" "unprognostic (4.45e-2)" "unprognostic (1.73e-1)" "unprognostic (2.88e-1)" "unprognostic (1.65e-2)" 0.2 0.0 0.4 0.2 1.0 0.0 3.9 0.0 1.7 1.1 1.4 1.0 0.0 1.8 0.0 1.3 9.3 5.2 2.5 0.2 1.0 4.7 0.0 1.8 0.0 0.0 0.6 1.2 0.0 3.8 0.1 0.0 0.6 1.6 0.5 0.4 8.0 0.1 0.8 4.1 0.6 0.0 0.1 0.0 5.6 2.4 1.0 1.1 0.1 8.1 7.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 9.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.5 0.0 0.6 0.0 0.3 13.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 2.4 0.0 1.3 0.0 0.0 13.3 1.4 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 3.8 0.0 0.0 0.8 0.0 13.4 4.5 1.8 0.0 0.1 21.6 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 1.1 0.0 0.1 0.0 2.4 0.6 0.0 0.0 0.3 0.0 0.0 0.0 1.1 0.5 6.7 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 5.3 3.5 RHBDL2 FLJ20435 ENSG00000158315 "Rhomboid like 2" Q9NX52 1 38885807-38941799 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.9" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 26.3;Pancreatic endocrine cells: 31.9;Suprabasal keratinocytes: 24.8;Undifferentiated cells: 31.4;Urothelial cells: 36.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.2;CAPAN-2: 26.6;HaCaT: 13.8;RT4: 26.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043807 Approved NA NA "HPA043807: AB_10961118" "unprognostic (3.34e-2)" "unprognostic (2.96e-1)" "unprognostic (4.57e-2)" "unprognostic (2.56e-1)" "unprognostic (7.26e-3)" "unprognostic (2.19e-2)" "unprognostic (1.04e-3)" "unprognostic (5.81e-2)" "unprognostic (2.36e-1)" "unprognostic (2.87e-1)" "unprognostic (4.07e-3)" "unprognostic (1.23e-1)" "unprognostic (7.47e-9)" "unprognostic (1.11e-2)" "unprognostic (2.46e-1)" "unprognostic (4.12e-2)" "unprognostic (4.20e-2)" 1.4 0.0 2.9 6.7 2.7 0.0 1.5 0.4 4.0 5.5 14.9 1.7 0.4 0.7 1.9 0.7 18.9 0.7 6.9 4.9 4.2 2.1 0.5 0.4 2.1 1.5 4.9 0.7 1.2 2.4 0.0 0.4 1.0 1.6 3.1 14.7 0.8 8.2 0.4 0.4 13.4 0.9 0.9 7.9 0.6 12.3 8.4 0.4 1.3 0.4 12.2 16.4 6.9 8.2 1.7 2.1 5.3 1.7 0.9 0.9 0.7 8.2 3.3 0.2 0.1 0.1 1.0 0.9 0.4 0.1 0.6 0.1 0.5 26.6 0.2 1.9 3.8 2.4 13.8 0.0 4.9 0.3 0.1 0.1 0.1 2.0 1.8 0.5 0.0 0.3 0.6 0.6 4.0 0.0 2.5 0.8 0.2 0.0 0.2 0.5 0.0 0.0 0.1 0.2 0.9 0.7 0.1 0.1 0.0 0.0 26.8 0.2 0.1 2.8 6.8 0.2 0.3 3.5 0.2 0.5 3.0 0.3 0.2 0.2 0.2 0.3 0.3 2.6 0.4 0.1 3.6 1.7 1.1 0.8 1.1 0.4 1.7 0.6 0.5 1.9 1.1 0.7 0.7 5.3 0.9 0.7 2.1 0.9 0.7 2.9 2.7 0.4 1.5 4.2 2.1 4.9 0.7 1.6 0.4 0.0 0.3 0.0 6.7 15.8 2.4 0.4 2.5 9.4 6.8 3.5 0.0 0.4 0.0 11.2 2.8 1.1 26.3 0.0 14.2 0.2 2.3 11.4 4.6 0.0 0.2 1.6 2.4 1.3 0.0 0.4 0.6 0.0 1.7 1.0 21.0 1.5 31.9 23.0 0.0 0.0 1.6 6.5 2.0 0.0 0.0 24.8 0.6 0.0 31.4 36.7 RHOV "ARHV, Chp, WRCH2" ENSG00000104140 "Ras homolog family member V" Q96L33 15 40872214-40874289 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 74.8;skin 1: 31.5;tongue: 29.2" "Cell type enhanced" "Detected in many" 10 "Paneth cells: 151.1;Suprabasal keratinocytes: 247.3;Urothelial cells: 237.2" "Cancer enhanced" "Detected in many" "cervical cancer: 91.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SK-BR-3: 84.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA053343 Enhanced NA NA "HPA053343: AB_2682122" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (8.29e-3)" "unprognostic (4.34e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (3.29e-3)" "unprognostic (1.05e-1)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (8.43e-3)" "unprognostic (5.63e-3)" 0.2 0.0 0.4 0.4 0.4 0.0 7.8 0.8 0.9 8.8 0.9 0.2 0.5 0.1 0.6 4.8 74.8 1.2 0.6 0.2 0.4 0.3 1.9 0.2 1.9 0.2 0.2 0.5 0.2 7.4 0.4 0.7 7.3 1.2 4.2 1.1 0.2 12.6 1.1 0.2 31.5 0.5 0.7 0.3 0.3 0.3 0.8 0.3 2.0 0.2 29.2 27.9 5.2 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.4 0.0 0.7 0.0 0.0 1.3 0.0 0.2 0.1 0.0 1.0 1.1 0.0 0.6 0.0 0.0 19.7 1.1 0.1 0.0 2.6 3.2 0.1 2.8 0.1 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.5 0.5 0.1 0.0 6.7 0.1 0.5 0.4 4.8 0.9 0.9 0.1 0.4 1.3 8.6 1.0 0.2 2.0 84.5 0.0 0.1 10.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.8 0.9 0.4 0.3 0.2 0.5 1.2 0.3 0.0 2.7 0.0 28.5 74.8 0.0 0.8 5.1 2.7 13.6 27.9 0.0 47.9 11.6 77.6 0.0 0.1 5.4 0.0 50.4 4.7 2.4 75.1 1.1 0.0 4.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 30.4 6.4 9.1 0.0 17.2 151.1 0.7 0.8 0.0 0.0 3.1 0.0 0.9 247.3 35.5 0.0 15.6 237.2 RIPK4 "ANKK2, ANKRD3, DIK, PKK, RIP4" ENSG00000183421 "Receptor interacting serine/threonine kinase 4" P57078 21 41739369-41767106 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 9 "naive CD4 T-cell: 1.5;neutrophil: 2.2" "Group enriched" "Detected in many" 17 "granulocytes: 2.2;T-cells: 1.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 15.9;GAMG: 20.8;HaCaT: 23.5;hTCEpi: 15.8;RPTEC TERT1: 14.2;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030942 Enhanced NA NA "HPA030942: AB_2732462" "unprognostic (8.93e-2)" "unprognostic (2.67e-1)" "unprognostic (6.32e-3)" "unprognostic (7.87e-2)" "unprognostic (1.24e-1)" "unprognostic (5.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.88e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (6.22e-5)" "prognostic unfavorable (3.48e-4)" "unprognostic (9.98e-2)" "prognostic favorable (6.52e-4)" "unprognostic (2.69e-1)" "unprognostic (2.95e-3)" "unprognostic (2.28e-1)" "unprognostic (2.78e-2)" 1.0 0.2 0.2 0.8 0.2 0.1 3.3 0.2 0.2 6.7 9.4 0.3 12.0 6.8 1.7 6.5 42.1 4.2 17.1 1.1 0.4 0.2 10.8 17.3 5.4 0.4 0.2 0.1 1.8 14.4 4.7 6.8 2.8 1.1 10.6 1.3 4.8 10.2 14.8 0.2 11.7 11.6 2.0 0.3 0.2 11.2 2.7 0.0 8.1 13.6 12.3 26.6 5.2 11.0 0.0 0.0 2.2 0.1 0.0 1.5 0.2 6.8 4.4 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.1 0.1 11.4 15.9 0.0 6.7 1.4 20.8 23.5 0.3 9.5 0.0 0.0 4.7 0.0 3.3 4.2 0.0 0.0 0.0 0.0 15.8 0.1 2.1 0.0 0.0 7.1 0.0 0.0 0.0 5.0 0.9 0.0 0.4 4.5 13.1 0.0 0.0 1.1 14.2 15.1 2.3 0.1 7.7 7.8 7.1 0.7 4.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 5.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.1 2.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.1 1.1 0.0 26.8 10.8 0.0 26.1 14.1 0.0 1.0 12.7 17.4 14.8 3.5 0.0 7.0 8.3 10.8 0.4 0.0 17.3 0.0 9.0 4.7 0.7 20.1 2.3 16.1 0.9 0.0 21.8 0.0 1.6 1.1 0.0 0.6 6.8 0.0 13.4 0.0 14.2 8.7 0.0 10.0 0.9 0.0 0.3 1.1 0.6 13.2 2.1 0.0 9.8 19.5 RNF223 ENSG00000237330 "Ring finger protein 223" E7ERA6 1 1070966-1074307 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.8;lymphoid tissue: 17.1;tongue: 14.8" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 16.4;Urothelial cells: 31.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 11.9;CAPAN-2: 8.9;HaCaT: 5.6;MCF7: 19.0;OE19: 5.5;SK-BR-3: 13.0;T-47d: 8.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (4.71e-1)" "unprognostic (2.79e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.08e-5)" "unprognostic (3.50e-1)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (3.91e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-3)" "unprognostic (1.50e-1)" "unprognostic (1.16e-1)" "unprognostic (4.58e-1)" "unprognostic (9.52e-3)" 0.0 0.0 0.0 1.4 0.0 0.4 0.8 0.0 0.5 8.3 1.4 0.0 0.0 0.4 1.0 0.3 28.8 0.2 1.9 0.0 0.0 0.0 0.6 0.3 0.9 0.1 0.0 0.0 0.0 1.0 0.1 0.0 6.5 0.0 4.2 0.8 0.0 3.3 0.4 0.7 3.5 0.2 2.6 0.0 0.2 7.8 0.1 0.0 0.0 0.2 14.8 17.1 4.9 9.3 0.6 0.6 1.9 0.4 0.3 0.4 0.0 11.9 0.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.4 8.9 0.0 0.1 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.0 0.0 0.1 0.0 5.5 0.2 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.1 13.0 0.2 0.1 8.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 1.9 0.4 0.2 0.3 0.1 0.1 0.3 0.2 0.4 0.0 0.6 0.2 0.4 0.9 0.3 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 6.4 0.5 0.0 0.4 0.0 2.7 0.0 1.8 0.0 0.2 0.0 6.7 0.0 0.0 5.1 0.0 2.8 16.4 0.0 4.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 9.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.2 0.0 2.8 31.4 RNF224 ENSG00000233198 "Ring finger protein 224" P0DH78 9 137227271-137229638 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "esophagus: 4.8;pituitary gland: 7.7" "Cell type enhanced" "Detected in single" 20 "Proximal tubular cells: 1.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.4;HeLa: 5.3;MCF7: 12.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.45e-1)" "unprognostic (2.34e-3)" "unprognostic (7.01e-4)" "unprognostic (6.04e-2)" "unprognostic (5.26e-2)" "unprognostic (1.70e-3)" "unprognostic (3.87e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-3)" "unprognostic (4.57e-2)" "unprognostic (5.24e-2)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "unprognostic (4.95e-2)" "unprognostic (1.27e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 0.0 0.6 0.5 0.1 0.7 0.3 0.0 0.2 0.9 0.3 0.0 1.0 0.4 0.1 4.8 2.0 1.0 0.3 0.5 0.5 2.8 0.0 1.1 0.4 0.1 0.0 1.5 0.2 7.7 0.0 0.9 0.0 4.6 0.0 0.1 1.5 1.6 0.0 0.1 0.4 1.2 1.2 1.0 0.1 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.5 0.7 1.9 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.6 7.4 0.2 0.3 0.0 0.4 3.5 0.0 0.1 0.0 2.5 0.6 0.0 5.3 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.3 0.6 0.0 12.9 0.1 0.2 0.6 0.9 1.7 0.8 0.3 0.3 0.1 0.8 0.0 1.7 0.7 2.8 0.1 1.0 2.8 0.3 0.2 0.3 0.2 1.6 0.0 0.9 0.2 0.2 0.3 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RNF39 "HZFw1, LIRF" ENSG00000204618 "Ring finger protein 39" Q9H2S5 6 30070266-30075887 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 28.3;skin 1: 26.4" "Group enriched" "Detected in many" 4 "Basal glandular cells: 43.3;Glandular cells: 56.0;Urothelial cells: 159.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "OE19: 8.8;U-266/84: 6.7" "Group enriched" "Detected in some" 4 "cerebral cortex: 8.0;hippocampal formation: 4.2" "Group enriched" "Detected in some" 5 "cerebellum: 17.9;cerebral cortex: 9.3;hippocampal formation: 5.7" "CAB019278, HPA047115" Uncertain Approved "Vesicles,Plasma membrane,Centrosome" NA NA "Vesicles, Plasma membrane, Centrosome" "CAB019278: , HPA047115: AB_2679938" "unprognostic (1.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.53e-2)" "unprognostic (5.72e-3)" "unprognostic (3.08e-2)" "unprognostic (4.05e-2)" "unprognostic (1.38e-1)" "unprognostic (2.22e-2)" "unprognostic (1.59e-2)" "unprognostic (4.45e-3)" "unprognostic (3.61e-2)" "unprognostic (2.06e-4)" "unprognostic (5.61e-2)" "unprognostic (1.31e-1)" "unprognostic (2.04e-1)" "unprognostic (2.57e-2)" 0.3 0.2 0.1 0.3 0.3 0.4 5.1 0.3 0.9 7.3 0.7 0.0 1.1 0.9 0.8 0.3 28.3 0.8 1.1 0.2 0.2 0.1 0.3 0.3 3.6 0.3 0.2 0.0 0.6 2.3 0.4 0.4 9.7 0.3 8.1 0.4 0.6 10.2 0.6 0.4 26.4 0.4 1.0 0.2 0.2 4.3 0.8 0.0 0.3 0.4 10.1 11.7 7.8 12.4 0.0 0.0 1.3 0.0 0.2 0.0 0.0 2.4 0.0 0.6 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.1 1.4 0.0 1.2 0.0 0.4 2.2 1.0 0.2 0.0 0.0 0.1 0.3 0.0 1.6 0.0 0.1 1.4 0.0 1.8 0.6 0.5 0.0 0.8 0.0 1.1 0.0 8.8 0.0 0.3 0.3 0.0 1.6 0.3 0.2 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.4 0.5 0.0 0.2 1.6 6.7 0.6 0.5 0.1 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.4 0.2 0.1 0.2 0.0 0.3 0.0 3.0 2.4 0.0 43.3 15.9 0.5 0.3 5.1 1.4 3.4 0.0 0.0 0.0 0.0 5.5 0.4 0.0 0.4 0.0 2.9 0.0 0.4 56.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 1.0 1.7 0.0 14.8 0.0 1.1 0.0 0.5 0.0 0.9 0.0 0.2 20.8 0.6 0.0 0.5 159.5 S100A14 "BCMP84, S100A15" ENSG00000189334 "S100 calcium binding protein A14" Q9HCY8 1 153614255-153616986 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.0;tongue: 189.3" "Cell type enhanced" "Detected in many" 15 "Basal keratinocytes: 2079.3;Enterocytes: 1153.1;Suprabasal keratinocytes: 3157.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 11 "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "A-431: 61.0;HaCaT: 84.7;HBEC3-KT: 120.1;hTCEpi: 179.0;OE19: 129.5;SK-BR-3: 126.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA027613 Enhanced Approved "Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol" NA NA 110000 "Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol" "HPA027613: AB_10602298" "unprognostic (1.73e-1)" "unprognostic (1.85e-1)" "unprognostic (1.48e-1)" "unprognostic (3.94e-2)" "unprognostic (1.75e-2)" "unprognostic (6.27e-2)" "unprognostic (2.30e-2)" "unprognostic (9.48e-2)" "unprognostic (2.50e-1)" "unprognostic (2.16e-1)" "unprognostic (2.75e-3)" "unprognostic (2.89e-1)" "unprognostic (3.16e-3)" "unprognostic (8.41e-2)" "unprognostic (1.80e-1)" "unprognostic (4.81e-2)" "unprognostic (9.53e-2)" 0.6 0.0 0.6 4.3 0.6 0.0 6.4 0.6 0.6 38.0 19.2 0.6 3.9 21.4 5.7 2.6 256.0 1.2 7.9 0.6 0.6 0.0 2.4 1.2 7.5 0.6 0.6 0.6 0.7 4.6 6.6 0.8 1.4 0.7 1.9 19.6 0.7 41.8 3.1 0.6 41.4 23.8 1.0 0.6 0.6 9.4 0.9 0.6 8.9 9.6 189.3 71.0 2.2 79.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 61.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.6 11.1 0.0 0.1 0.0 0.0 84.7 0.0 120.1 0.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 179.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 129.5 0.1 0.0 0.0 0.2 0.6 4.0 0.0 0.0 0.1 126.4 0.1 3.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.7 0.6 56.6 133.0 0.5 298.4 2079.3 0.0 4.4 214.0 18.7 91.0 33.2 0.0 0.6 41.4 164.9 0.0 0.2 1153.1 0.0 59.6 1.7 22.4 341.3 28.7 5.8 0.3 0.0 147.3 1.3 0.0 0.0 0.0 5.3 229.5 3.6 470.4 0.0 202.6 775.0 0.0 3.1 0.0 0.0 33.3 0.0 0.0 3157.3 0.2 0.7 410.3 819.7 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 223.9;tongue: 102.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 2.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 117.9;SK-BR-3: 142.9" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" NA NA 92000 Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (3.18e-4)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 20.1 5.5 9.3 8.0 7.2 0.0 11.9 3.4 8.3 37.2 21.1 8.3 3.2 16.2 8.7 7.2 223.9 7.6 18.2 9.5 6.7 5.4 14.3 27.0 18.3 7.5 7.1 5.7 15.3 4.1 6.5 3.3 14.9 7.2 9.3 14.5 5.1 35.5 5.4 9.8 43.1 31.2 10.6 5.9 13.4 10.6 12.3 4.6 3.2 11.3 102.1 87.5 11.3 51.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 56.4 27.2 1.4 3.2 9.4 35.7 3.7 32.3 29.7 26.6 23.6 25.5 31.6 0.0 51.9 48.3 6.0 41.5 0.0 72.5 15.6 0.1 0.0 0.0 23.7 7.5 10.8 0.0 0.0 16.9 69.7 64.4 50.7 34.8 117.9 0.0 0.6 0.0 58.5 75.0 0.0 0.1 6.0 100.1 73.6 0.0 16.4 0.1 100.2 20.3 0.0 0.1 23.8 142.9 4.7 12.9 44.4 0.3 63.2 16.0 25.6 15.4 73.0 0.0 0.2 0.1 47.6 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 7.2 3.4 8.3 6.7 5.4 7.1 5.7 7.2 4.6 35.7 18.0 15.1 744.7 563.0 0.4 29.7 119.8 26.8 103.5 102.9 2.0 12.3 61.3 584.7 3.2 283.5 336.2 0.0 172.2 7.2 105.8 697.0 19.5 109.5 4.7 0.0 133.3 333.3 22.5 10.0 62.2 11.1 106.3 12.6 178.6 38.3 790.1 294.7 57.7 126.7 1.8 6.5 41.5 1.7 1.2 794.3 6.9 12.8 201.3 1359.9 S100A8 "60B8AG, CAGA, CFAG, CGLA, MRP8, P8" ENSG00000143546 "S100 calcium binding protein A8" P05109 1 153390032-153391188 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" Antimicrobial "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1" "Cell type enriched" "Detected in many" 13 "Kupffer cells: 10543.8" "Cancer enhanced" "Detected in all" "cervical cancer: 2290.9;head and neck cancer: 2382.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "classical monocyte: 320.7;neutrophil: 720.9" "Group enriched" "Detected in many" 8 "granulocytes: 720.9;monocytes: 320.7" "Group enriched" "Detected in some" 28 "hTCEpi: 28.2;SK-BR-3: 103.3;THP-1: 54.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB002791, HPA024372" Enhanced Supported "Intermediate filaments,Cytosol" "Secreted to blood" NA NA 10900000 530000000 "Intermediate filaments" Cytosol "CAB002791: , HPA024372: AB_1856536" "unprognostic (1.98e-1)" "unprognostic (1.13e-1)" "unprognostic (3.79e-2)" "unprognostic (1.58e-2)" "unprognostic (8.60e-3)" "unprognostic (9.26e-3)" "unprognostic (4.92e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (6.13e-2)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" "prognostic unfavorable (8.94e-7)" "unprognostic (1.17e-1)" "unprognostic (8.90e-2)" "unprognostic (8.27e-2)" "unprognostic (8.94e-3)" 14.0 0.8 0.8 30.5 2.6 718.8 1.1 0.5 1.6 123.0 2.8 0.7 0.4 0.4 12.0 1.2 532.3 5.5 2.1 36.7 1.5 0.5 1.4 4.3 26.2 37.3 3.3 0.4 2.1 2.7 0.1 0.9 4.7 3.3 1.4 0.4 1.3 92.4 0.3 2.5 6.2 1.0 9.0 1.8 72.4 2.0 1.9 0.9 2.6 4.6 597.1 257.6 5.0 224.1 0.6 63.7 720.9 320.7 0.3 0.6 244.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.7 0.0 2.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 28.2 0.0 0.9 0.0 0.0 0.0 1.2 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.4 103.3 0.0 0.0 0.7 54.9 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 1.6 0.0 8.2 320.7 38.9 0.4 26.5 0.6 0.6 0.3 0.2 63.7 0.3 0.3 0.3 720.9 0.3 6.4 2.5 0.4 244.7 0.8 2.6 0.5 1.6 1.5 0.5 3.3 0.4 3.3 0.9 208.4 808.2 43.2 0.7 17.4 0.0 2.9 56.0 117.8 215.0 14.0 0.0 4.1 0.0 0.1 217.1 1.6 0.0 23.3 0.8 8.6 1.6 0.4 209.3 16.4 431.8 0.0 0.0 84.7 10543.8 69.5 3.7 783.2 0.0 0.0 0.0 0.0 0.9 0.0 1.4 14.7 0.0 0.0 1.0 2.2 0.5 99.0 5.6 20.3 0.0 19.6 S100A9 "60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14" ENSG00000163220 "S100 calcium binding protein A9" P06702 1 153357854-153361027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity" "Antimicrobial, Antioxidant" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6" "Cell type enriched" "Detected in many" 7 "Kupffer cells: 11072.0" "Cancer enhanced" "Detected in all" "cervical cancer: 5468.0;head and neck cancer: 6692.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 381.5;neutrophil: 638.3" "Group enriched" "Detected in many" 6 "granulocytes: 638.3;monocytes: 381.5" "Cell line enriched" "Detected in some" 6 "SK-BR-3: 233.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA004193, CAB009441" Enhanced Supported "Nucleoplasm,Cell Junctions,Cytosol" "Secreted to blood" NA NA 10600000 1400000000 "Nucleoplasm, Cell Junctions, Cytosol" "CAB009441: AB_2184420, HPA004193: AB_1856537" "unprognostic (1.72e-1)" "unprognostic (3.33e-2)" "unprognostic (2.40e-1)" "unprognostic (3.94e-3)" "unprognostic (1.36e-2)" "unprognostic (5.45e-3)" "prognostic unfavorable (1.13e-6)" "unprognostic (1.10e-2)" "unprognostic (4.31e-1)" "unprognostic (3.06e-1)" "unprognostic (1.35e-2)" "unprognostic (5.59e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.48e-1)" "unprognostic (7.52e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-2)" 19.5 2.1 1.3 41.9 4.2 820.1 4.1 0.9 2.1 143.6 4.4 0.7 0.4 0.7 4.9 4.0 642.6 9.9 4.4 51.2 2.5 0.4 2.8 4.8 29.2 169.0 5.3 0.6 3.4 4.4 0.1 0.9 10.4 5.2 2.2 0.7 2.0 109.6 0.5 3.4 7.5 1.4 13.1 2.1 103.2 3.5 2.9 1.4 3.8 6.7 477.6 228.0 24.3 237.0 0.5 87.5 638.3 381.5 0.3 1.0 323.2 2.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.8 36.6 0.0 0.0 2.2 0.0 15.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.8 0.0 0.0 0.0 0.7 0.3 0.0 2.9 0.0 0.3 0.0 0.2 0.0 0.0 0.5 7.7 0.0 9.5 0.1 0.0 0.3 233.1 0.1 0.1 3.6 29.6 0.6 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 6.7 0.0 5.3 381.5 46.4 0.5 31.6 1.0 0.4 0.4 0.3 87.5 0.5 0.3 0.3 638.3 0.3 15.0 2.9 0.5 323.2 1.3 4.2 0.9 2.1 2.5 0.4 5.3 0.6 5.2 1.4 214.4 574.2 57.1 52.5 17.7 0.0 2.5 66.2 112.4 185.4 34.9 0.0 111.0 5.0 49.4 1.3 7.0 0.5 23.3 32.9 44.2 7.1 19.6 151.1 16.4 1627.6 0.0 0.0 71.2 11072.0 2.2 5.5 1162.8 0.0 4.6 2.1 0.0 10.3 0.8 0.0 16.3 0.2 0.0 2.5 0.3 1.3 29.1 1033.7 24.9 1.9 291.7 SAMD9 "C7orf5, FLJ20073, KIAA2004" ENSG00000205413 "Sterile alpha motif domain containing 9" Q5K651 7 93099513-93118023 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 34.6;lymphoid tissue: 35.4" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 59.6;T-cells: 50.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 29.4;GAMG: 28.8" "Low region specificity" "Detected in all" "HPA021318, HPA021319" Approved Supported Vesicles,Cytosol NA NA Cytosol Vesicles "HPA021318: AB_2183383, HPA021319: AB_1856554" "unprognostic (3.66e-2)" "unprognostic (5.35e-1)" "unprognostic (8.60e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (8.96e-2)" "unprognostic (1.38e-1)" "unprognostic (7.48e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (4.76e-2)" "unprognostic (3.37e-2)" "prognostic unfavorable (8.31e-5)" "unprognostic (6.00e-2)" "prognostic unfavorable (8.40e-7)" "unprognostic (5.91e-2)" "unprognostic (1.37e-2)" "unprognostic (2.18e-2)" "unprognostic (3.64e-1)" 9.6 4.0 2.3 9.2 2.4 5.2 2.6 1.0 1.6 9.3 6.8 0.6 0.9 4.3 2.8 3.0 34.6 2.7 4.3 2.5 1.3 1.5 6.3 3.5 7.8 10.8 2.5 1.1 6.3 2.3 0.1 6.4 11.3 3.1 5.3 7.0 0.7 5.7 1.6 2.4 1.5 12.7 2.2 2.5 21.7 6.3 2.5 1.7 35.4 3.3 9.9 9.5 4.8 9.7 5.5 3.0 15.6 9.8 7.4 7.6 2.6 11.7 1.5 0.4 0.1 5.3 6.8 0.1 4.6 19.3 22.2 29.4 0.0 13.1 4.9 7.3 11.4 28.8 13.9 0.0 4.2 7.5 16.8 0.5 7.2 7.9 0.0 2.4 8.0 10.0 3.0 6.1 7.3 2.0 1.2 3.3 5.5 0.5 12.3 4.6 0.0 11.9 6.6 0.0 0.0 3.3 3.9 3.9 5.6 0.1 1.5 1.9 0.2 3.6 1.4 3.8 0.0 0.4 3.9 14.2 5.2 1.9 15.5 2.5 7.4 1.4 4.6 5.4 4.7 5.1 15.6 3.6 12.7 7.6 7.0 7.3 5.0 5.9 6.5 3.0 5.5 6.3 5.7 15.5 7.4 9.8 2.1 7.2 2.6 2.3 2.4 1.0 1.6 1.3 1.5 2.5 1.1 3.1 1.7 8.9 3.0 23.2 7.5 2.1 1.6 0.9 2.5 20.1 9.1 14.0 0.0 1.5 0.0 20.9 0.0 24.8 12.1 0.0 10.8 4.6 8.3 6.6 41.7 1.0 10.7 6.4 2.9 8.0 24.0 0.2 14.1 26.3 3.3 13.6 20.9 2.0 32.1 59.6 11.7 2.1 0.0 12.9 9.2 0.2 0.0 1.6 0.3 50.7 3.3 25.5 SCNN1B ENaCbeta ENSG00000168447 "Sodium channel epithelial 1 beta subunit" P51168 16 23278231-23381299 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.4" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 92.3;Club cells: 66.0;Collecting duct cells: 54.1;Enterocytes: 54.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 26.4" "Region enhanced" "Detected in single" "cerebellum: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 19.4;RT4: 10.4;U-266/70: 32.0;U-266/84: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA015612 Uncertain NA NA "HPA015612: AB_1856629" "unprognostic (7.45e-2)" "unprognostic (1.76e-3)" "unprognostic (1.39e-1)" "unprognostic (6.74e-3)" "unprognostic (1.74e-2)" "unprognostic (5.11e-3)" "unprognostic (7.74e-2)" "unprognostic (5.49e-3)" "unprognostic (2.60e-1)" "unprognostic (2.40e-1)" "unprognostic (3.68e-1)" "unprognostic (2.84e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.32e-1)" "unprognostic (4.66e-2)" "unprognostic (3.93e-3)" "unprognostic (1.25e-2)" 35.1 0.2 0.1 4.0 0.2 0.0 21.2 1.1 0.1 28.3 27.2 0.0 1.3 1.3 2.9 2.5 42.4 1.3 3.3 0.6 0.0 0.0 13.0 0.0 31.1 1.3 0.0 0.0 2.0 0.8 0.3 1.6 25.2 0.3 5.7 19.7 0.5 29.7 2.4 3.9 13.2 1.7 4.2 0.1 1.9 8.9 1.6 0.0 0.6 16.2 17.8 15.5 5.6 19.6 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.9 0.0 10.4 0.1 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 32.0 11.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.2 1.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 92.3 27.0 2.2 14.0 2.7 0.0 0.8 0.0 10.7 66.0 54.1 0.0 0.7 0.0 0.0 0.0 0.7 54.8 0.0 0.4 0.2 0.2 4.3 8.1 0.0 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 10.1 0.0 7.9 0.0 0.2 9.3 0.0 0.0 0.0 0.0 0.3 0.0 0.2 4.6 1.8 0.0 7.6 17.0 SDR16C5 "EPHD-2, RDH-E2, RDHE2" ENSG00000170786 "Short chain dehydrogenase/reductase family 16C member 5" Q8N3Y7 8 56300010-56320776 "Enzymes, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 27.5;lung: 34.0;skin 1: 35.9;tongue: 25.8" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 44.7;Alveolar cells type 2: 125.1;Basal keratinocytes: 45.3;Ciliated cells: 48.2;Pancreatic endocrine cells: 58.7;Suprabasal keratinocytes: 63.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 36 "memory B-cell: 9.1;naive B-cell: 2.5" "Lineage enriched" "Detected in single" 56 "B-cells: 9.1" "Group enriched" "Detected in some" 4 "CAPAN-2: 18.0;HaCaT: 9.0;hTCEpi: 14.9;OE19: 21.3;T-47d: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025224 Enhanced NA NA "HPA025224: AB_1856163" "unprognostic (1.66e-1)" "unprognostic (8.88e-2)" "unprognostic (9.46e-2)" "unprognostic (4.18e-4)" "unprognostic (8.83e-3)" "prognostic favorable (7.88e-4)" "unprognostic (1.66e-1)" "unprognostic (2.51e-1)" "unprognostic (2.42e-1)" "unprognostic (1.78e-3)" "unprognostic (2.39e-1)" "unprognostic (2.48e-5)" "unprognostic (2.55e-1)" "unprognostic (8.17e-2)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" 0.3 0.2 2.0 2.0 1.9 0.0 7.4 0.9 6.2 8.1 5.9 0.2 0.0 1.7 0.2 0.0 27.5 0.2 1.5 0.2 0.6 1.2 0.2 0.2 34.0 0.3 1.4 2.9 0.2 0.3 0.0 0.5 0.0 10.6 0.3 3.0 0.2 9.2 0.0 0.3 35.9 16.9 0.2 0.4 0.2 12.9 0.5 0.2 0.0 0.2 25.8 21.1 1.0 11.5 9.1 0.0 0.0 0.0 0.0 0.1 0.1 3.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 9.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 21.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.0 1.9 0.9 6.2 0.6 1.2 1.4 2.9 10.6 0.2 44.7 125.1 0.0 5.5 45.3 0.2 0.1 10.2 48.2 36.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.1 0.0 1.2 0.0 1.5 5.5 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 3.3 1.0 7.1 9.9 58.7 3.2 0.0 0.0 1.4 0.0 0.3 0.2 4.1 63.1 0.0 0.0 4.5 19.5 SERPINB2 "HsT1201, PAI2, PLANH2" ENSG00000197632 "Serpin family B member 2" P05120 18 63871692-63903890 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Plasminogen activation" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 70.6;placenta: 222.1" "Cell type enhanced" "Detected in many" 27 "Basal keratinocytes: 1993.2;Suprabasal keratinocytes: 920.9;Syncytiotrophoblasts: 367.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 26.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 16.3;eosinophil: 7.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 16.3" "Cell line enhanced" "Detected in some" "GAMG: 33.9;HaCaT: 81.3;U-138 MG: 97.3;U-2197: 147.8" "Region enriched" "Detected in single" 14 "cerebellum: 2.9" "Low region specificity" "Detected in all" "HPA015480, HPA076608" Enhanced "Intracellular and membrane" NA NA 110000 "HPA015480: AB_1855456, HPA076608: " "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.46e-2)" "unprognostic (1.36e-4)" "unprognostic (1.17e-1)" "unprognostic (1.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (9.69e-2)" "unprognostic (3.76e-3)" "unprognostic (1.90e-1)" "unprognostic (4.33e-6)" "unprognostic (3.89e-2)" "unprognostic (3.94e-1)" "unprognostic (3.29e-1)" "prognostic unfavorable (1.55e-5)" 6.0 0.0 0.1 2.9 0.2 8.7 2.6 0.2 0.1 6.4 0.8 0.1 0.1 0.0 0.7 0.4 70.6 3.1 0.1 0.4 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.1 0.6 0.3 0.0 0.1 222.1 0.2 0.3 0.0 0.1 11.3 0.2 0.3 25.7 0.2 0.3 0.1 0.3 0.1 0.2 0.1 0.9 0.2 49.0 37.7 1.1 13.8 0.0 0.2 16.3 3.9 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 19.7 21.0 0.7 1.5 0.1 0.0 0.0 0.0 0.7 33.9 81.3 0.0 16.7 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 9.7 4.4 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 1.6 97.3 0.0 147.8 0.0 0.0 0.0 0.0 2.6 0.2 11.3 16.3 3.9 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.3 0.0 2.4 1993.2 0.0 0.4 0.0 21.4 34.2 0.0 0.0 3.1 0.0 76.7 0.0 0.5 0.0 0.0 6.1 1.5 3.5 3.8 0.0 0.0 2.8 0.0 0.0 0.0 5.6 0.0 0.0 59.8 89.4 2.8 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 920.9 367.4 0.0 0.0 42.5 SERPINB5 "maspin, PI5" ENSG00000206075 "Serpin family B member 5" P36952 18 63476761-63505085 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 99.3;skin 1: 60.7;tongue: 118.8" "Cell type enhanced" "Detected in many" 18 "Basal keratinocytes: 856.4;Suprabasal keratinocytes: 1062.2;Urothelial cells: 663.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 124.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 147.0;HBEC3-KT: 48.5;hTCEpi: 102.0;hTERT-HME1: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009570, HPA019025, HPA019132, HPA020136" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 660000 Vesicles "CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (9.24e-2)" "unprognostic (1.04e-3)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.36e-1)" "unprognostic (3.47e-3)" "prognostic unfavorable (5.71e-6)" "unprognostic (1.28e-1)" "unprognostic (1.84e-6)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (3.14e-1)" "unprognostic (8.38e-2)" 0.2 0.1 0.1 0.9 0.1 0.0 9.7 0.1 0.1 23.6 2.7 0.1 0.7 3.9 2.1 0.5 99.3 0.1 4.3 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 4.1 1.0 0.1 11.1 0.3 0.1 60.7 6.8 0.9 0.1 0.1 2.2 0.4 0.1 5.1 0.1 118.8 41.2 7.1 19.7 0.6 0.5 1.2 0.4 1.0 0.5 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.4 0.0 0.0 147.0 0.0 48.5 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 102.0 0.0 25.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.2 10.7 0.0 0.0 0.0 0.0 10.7 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.3 0.4 0.2 0.1 0.2 0.2 0.4 0.2 0.6 0.5 0.3 1.2 1.0 0.2 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 229.2 856.4 0.0 0.2 0.0 16.0 20.5 3.5 0.0 0.2 0.0 0.1 7.6 0.0 5.4 0.0 0.0 0.2 8.7 51.7 0.0 0.0 0.0 0.0 3.4 0.0 0.0 15.2 0.6 0.2 59.1 0.0 3.2 0.0 9.5 46.0 0.0 0.0 0.0 0.0 14.4 2.6 0.6 1062.2 0.1 0.0 7.0 663.3 SFN YWHAS ENSG00000175793 Stratifin P31947 1 26863138-26864457 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 6884.3;Suprabasal keratinocytes: 9365.4;Urothelial cells: 2426.4" "Cancer enhanced" "Detected in all" "head and neck cancer: 2526.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 12 "basophil: 7.1" "Lineage enriched" "Detected in single" 12 "granulocytes: 7.1" "Cell line enhanced" "Detected in many" "A-431: 70.1;HaCaT: 110.7;HBEC3-KT: 170.4;hTCEpi: 114.4" "Low region specificity" "Detected in some" "CAB006268, HPA011105, CAB040552, HPA061603" Enhanced Supported "Nucleoli rim,Cytosol" "Secreted in other tissues" NA NA 54000000 Cytosol "Nucleoli rim" "CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: " "unprognostic (5.70e-2)" "unprognostic (1.26e-1)" "unprognostic (8.37e-2)" "prognostic favorable (1.92e-4)" "unprognostic (1.26e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (5.68e-5)" "unprognostic (1.71e-2)" "unprognostic (2.99e-1)" "unprognostic (3.96e-1)" "prognostic unfavorable (6.01e-4)" "unprognostic (3.83e-1)" "prognostic unfavorable (7.45e-6)" "unprognostic (7.90e-3)" "unprognostic (3.25e-1)" "unprognostic (8.12e-2)" "unprognostic (2.06e-2)" 0.4 0.0 0.5 3.1 0.5 0.0 3.8 0.4 0.7 37.5 10.7 0.5 0.5 5.9 3.3 0.7 256.2 0.0 6.0 0.3 0.6 0.1 1.2 0.5 8.2 0.3 0.4 0.3 0.3 0.3 0.0 0.3 3.4 0.8 5.9 4.0 0.3 25.5 0.4 0.4 123.8 13.2 0.5 0.7 0.3 6.6 0.4 0.4 3.1 0.4 256.0 107.4 9.1 47.7 0.0 0.0 7.1 0.0 0.0 0.6 0.0 70.1 11.8 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.0 4.3 37.1 0.6 3.1 0.0 0.0 110.7 0.0 170.4 0.0 16.7 0.5 0.0 11.8 12.5 0.0 0.0 0.1 0.0 114.4 0.0 29.9 0.0 0.0 0.0 0.1 0.4 0.0 15.0 0.0 0.0 0.2 12.2 19.7 0.0 0.0 3.9 26.5 16.2 0.0 0.0 16.9 3.0 0.1 0.2 7.9 0.1 0.0 0.0 32.4 0.0 0.4 0.1 0.5 0.3 0.1 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.5 0.5 0.4 0.7 0.6 0.1 0.4 0.3 0.8 0.4 166.7 216.2 0.5 1339.8 6884.3 0.0 0.3 33.1 30.8 122.8 15.7 0.0 6.7 3.3 52.1 0.0 0.6 409.5 0.0 68.0 45.3 37.0 487.4 31.2 0.0 1.6 0.0 64.7 0.6 0.3 0.0 0.0 15.6 506.2 1.8 78.2 0.0 315.2 136.8 0.0 0.0 0.0 0.0 110.7 0.0 0.2 9365.4 5.0 0.0 146.1 2426.4 SIM2 "bHLHe15, MGC119447, SIM" ENSG00000159263 "Single-minded family bHLH transcription factor 2" Q14190 21 36699133-36749917 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 8.9;Collecting duct cells: 8.7;Distal tubular cells: 8.3;Glandular cells: 6.5" "Cancer enhanced" "Detected in many" "prostate cancer: 11.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 13.3;PC-3: 23.0;RPTEC TERT1: 28.9;RT4: 17.4" "Region enhanced" "Detected in single" "hypothalamus: 0.5" "Not detected" "Not detected" HPA029295 Approved Supported "Nucleoplasm,Nuclear bodies" No No "Nucleoplasm, Nuclear bodies" "HPA029295: AB_10610425" "unprognostic (1.17e-3)" "unprognostic (6.46e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (8.62e-2)" "unprognostic (1.43e-2)" "unprognostic (8.30e-2)" "unprognostic (5.46e-3)" "unprognostic (1.65e-2)" "unprognostic (1.09e-1)" "unprognostic (5.16e-3)" "unprognostic (9.18e-2)" "unprognostic (9.18e-7)" "unprognostic (2.98e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "prognostic favorable (2.88e-4)" 0.5 0.3 0.8 0.1 2.3 0.0 0.1 2.4 2.3 2.8 0.2 0.2 0.0 0.1 0.3 1.5 31.3 0.3 0.2 0.1 2.5 1.1 16.1 0.1 0.1 0.1 1.4 0.7 0.1 0.1 1.2 1.7 0.1 0.3 6.8 0.0 0.2 0.4 0.0 15.7 0.3 0.1 0.0 0.4 0.1 5.5 0.2 1.3 0.0 0.2 11.0 28.7 1.5 0.4 0.3 0.7 0.0 0.0 0.0 0.8 0.0 3.2 5.0 0.2 0.2 0.0 0.0 5.0 0.1 0.0 0.4 0.0 2.6 7.6 0.1 4.6 0.1 9.0 1.7 2.5 0.0 0.2 3.9 7.9 0.1 7.2 0.2 0.0 0.0 0.0 0.8 0.7 0.0 1.4 13.3 0.0 0.1 0.1 0.0 8.4 1.9 0.0 0.0 0.2 3.2 23.0 0.0 0.1 0.1 28.9 17.4 0.2 0.3 8.2 0.0 0.7 0.8 2.1 0.2 0.3 0.0 1.4 0.5 0.2 0.1 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.8 2.3 2.4 2.3 2.5 1.1 1.4 0.7 0.3 1.3 0.0 0.0 0.0 8.9 0.2 0.2 2.0 0.0 0.0 0.0 8.7 0.0 0.0 8.3 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.5 0.2 0.2 0.4 0.0 0.0 0.0 1.8 SMAGP "hSMAGP, MGC149453, MGC149454" ENSG00000170545 "Small cell adhesion glycoprotein" Q0VAQ4 12 51244558-51270890 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.4" "Group enriched" "Detected in many" 9 "Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 39.4;OE19: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039711 Enhanced Supported "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Nucleoplasm, Cell Junctions" "HPA039711: AB_10674985" "unprognostic (2.55e-3)" "unprognostic (2.63e-1)" "unprognostic (3.96e-2)" "unprognostic (3.63e-3)" "prognostic unfavorable (5.36e-4)" "unprognostic (3.01e-1)" "unprognostic (1.63e-3)" "unprognostic (6.26e-2)" "unprognostic (7.48e-2)" "unprognostic (9.11e-2)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.46e-1)" "prognostic favorable (2.24e-4)" "unprognostic (4.32e-3)" "unprognostic (1.60e-1)" "unprognostic (1.99e-2)" "unprognostic (1.52e-1)" 7.5 6.9 0.9 11.3 1.7 0.9 26.3 1.1 1.3 13.1 22.6 0.9 5.3 6.9 8.0 13.6 53.4 3.2 21.8 6.0 1.0 1.0 10.9 4.3 17.6 14.2 1.5 0.4 5.2 14.9 4.6 1.9 50.0 3.0 4.8 24.3 2.6 10.2 6.9 3.6 12.6 8.5 3.4 4.3 11.5 14.1 4.8 0.7 1.2 4.2 28.7 33.1 7.9 24.6 22.5 2.6 8.6 3.7 12.3 9.5 3.5 23.3 7.2 0.8 0.8 3.2 12.7 39.4 18.0 18.1 9.2 5.7 14.2 24.6 0.2 3.2 11.1 3.4 8.3 5.1 6.9 12.9 1.1 4.1 3.1 0.9 4.7 8.9 0.7 3.0 8.2 5.3 19.9 18.0 21.1 22.1 6.0 2.4 1.3 14.8 20.6 3.8 2.8 3.6 47.5 27.9 0.2 0.3 0.8 13.3 5.4 0.9 1.1 3.9 15.8 2.8 9.9 13.6 1.2 7.7 10.3 9.8 0.5 10.9 0.4 0.6 0.4 15.1 7.7 5.5 1.9 3.7 6.4 9.5 2.4 6.1 22.5 4.2 6.9 2.6 17.6 3.9 7.0 8.6 12.3 2.6 1.5 2.7 3.5 0.9 1.7 1.1 1.3 1.0 1.0 1.5 0.4 3.0 0.7 0.0 18.8 28.2 46.4 19.3 1.2 1.1 53.5 8.1 12.5 15.7 0.0 1087.3 41.4 27.1 6.5 53.4 61.6 0.0 95.9 65.5 13.8 46.6 12.7 5.8 83.3 1.6 19.7 38.1 5.4 2.1 12.0 6.7 13.5 5.4 100.2 2.5 97.3 73.7 9.2 15.3 1.2 25.8 8.1 5.2 28.8 26.0 704.6 15.2 97.4 72.3 SPNS2 ENSG00000183018 "Sphingolipid transporter 2" Q8IVW8 17 4498838-4539035 "Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.9" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 25.5;Collecting duct cells: 21.0;Endothelial cells: 25.3;Proximal tubular cells: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.2;NK-cell: 1.2" "Group enriched" "Detected in many" 4 "granulocytes: 1.2;NK-cells: 1.2" "Cell line enhanced" "Detected in some" "BEWO: 11.0;RPTEC TERT1: 57.9;SK-BR-3: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068717 Uncertain NA NA "HPA068717: AB_2686021" "unprognostic (3.03e-2)" "unprognostic (4.76e-2)" "unprognostic (8.08e-2)" "unprognostic (3.53e-2)" "unprognostic (2.78e-1)" "unprognostic (6.30e-3)" "unprognostic (1.10e-3)" "unprognostic (2.33e-1)" "unprognostic (1.70e-1)" "unprognostic (1.63e-3)" "unprognostic (2.99e-2)" "unprognostic (2.98e-2)" "unprognostic (4.48e-2)" "unprognostic (2.20e-2)" "unprognostic (1.68e-1)" "unprognostic (2.19e-2)" "unprognostic (6.89e-2)" 9.8 2.1 10.3 5.8 13.6 7.9 8.6 5.3 19.5 8.2 4.9 22.6 0.0 13.1 5.4 2.1 45.9 4.6 13.8 7.2 11.0 7.8 31.2 3.3 16.1 5.4 21.3 10.9 1.8 7.3 2.3 1.3 9.0 25.0 3.2 3.2 11.6 11.2 3.2 5.0 13.8 8.5 5.8 12.3 9.1 21.7 2.0 15.7 0.0 5.2 10.9 15.7 8.4 13.1 0.0 0.2 1.2 0.0 1.2 0.2 0.0 3.2 0.4 0.0 0.1 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 4.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.6 0.0 0.0 0.0 1.3 0.0 5.7 0.0 6.0 0.1 0.2 0.0 0.1 57.9 0.2 1.9 0.0 0.0 26.9 0.0 1.9 0.9 2.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.3 1.2 0.0 0.0 0.0 0.0 10.3 13.6 5.3 19.5 11.0 7.8 21.3 10.9 25.0 15.7 6.0 8.8 0.0 0.2 1.5 0.6 0.8 25.5 1.4 12.5 21.0 0.0 0.1 1.7 14.3 0.2 25.3 1.3 0.0 2.7 14.8 1.7 4.6 0.0 5.6 0.9 6.4 0.0 14.7 0.8 0.0 0.6 0.7 1.7 0.0 10.8 0.3 11.9 0.0 0.4 23.7 0.7 0.0 2.3 0.5 0.4 2.0 1.6 0.0 0.4 1.4 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552075-48599425 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6" "Cell type enhanced" "Detected in many" 13 "Glandular cells: 53.7;Suprabasal keratinocytes: 120.1;Urothelial cells: 113.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 27.6;MCF7: 16.9;OE19: 44.8;T-47d: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA041724, HPA043539, HPA076510" Enhanced Supported Vesicles NA NA Vesicles "HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: " "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 4.0 0.1 0.2 28.7 0.8 0.0 9.2 2.9 2.2 5.2 91.8 0.3 2.3 0.0 0.1 0.1 2.5 0.1 6.5 0.0 0.2 0.0 0.1 0.2 0.8 0.1 11.4 0.0 6.9 0.0 0.0 12.4 6.9 0.2 45.7 13.4 0.0 0.1 0.0 0.7 0.2 0.0 0.5 1.1 79.6 78.6 0.6 32.0 0.7 1.5 2.5 1.0 1.1 3.1 0.9 4.5 5.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 27.6 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 2.5 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.9 0.0 0.2 0.0 44.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.3 0.1 0.0 13.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.8 0.4 2.1 0.9 3.1 0.4 1.8 1.4 0.7 0.7 0.6 1.2 1.4 1.1 1.0 1.5 1.1 0.9 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 17.9 0.3 0.0 28.4 21.4 0.0 0.6 2.5 4.0 13.6 8.7 0.0 2.8 0.0 11.1 0.0 0.3 8.6 0.0 1.0 2.7 2.0 53.7 0.0 0.0 0.6 0.0 4.6 0.0 0.0 0.2 0.3 0.2 11.8 0.0 7.1 1.2 10.8 7.0 0.0 0.8 0.6 0.0 2.8 0.2 7.5 120.1 1.6 0.0 2.6 113.8 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364202 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.0;esophagus: 33.8" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 26.6;Horizontal cells: 20.6;Leydig cells: 19.0;Urothelial cells: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7" "Lineage enriched" "Detected in single" 66 "T-cells: 11.7" "Cell line enhanced" "Detected in some" "HaCaT: 7.1;RPTEC TERT1: 8.4;SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA058296: AB_2683672" "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.8 5.2 15.9 1.5 33.0 0.9 8.1 9.9 21.3 3.4 0.9 4.0 4.7 1.5 0.9 24.3 33.8 3.6 1.3 9.6 30.6 14.6 13.7 4.0 3.2 1.9 6.8 12.8 27.8 7.6 8.3 16.5 1.0 6.6 4.4 0.8 1.2 13.2 5.7 1.2 3.5 0.9 0.9 2.4 0.8 7.6 5.1 3.8 0.3 1.5 8.1 13.8 2.7 9.1 0.0 0.0 0.0 0.1 0.1 11.7 1.8 4.3 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.7 0.5 4.5 1.3 0.0 1.4 0.1 0.0 7.1 0.2 1.1 0.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 5.0 0.4 0.0 0.3 3.2 3.1 0.0 0.1 2.1 0.9 0.0 0.1 0.0 8.4 2.0 29.0 0.3 0.0 2.4 0.0 0.6 1.8 0.2 0.0 1.3 5.2 0.0 2.6 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.1 6.0 0.0 7.4 1.9 0.0 0.0 11.7 2.1 0.0 0.1 0.0 0.0 1.0 1.8 15.9 33.0 9.9 17.9 30.6 14.6 6.8 12.8 6.6 3.8 0.0 4.5 0.0 5.3 0.6 15.9 9.1 0.0 8.1 12.5 15.7 9.8 0.0 26.6 0.6 2.5 0.4 0.0 0.0 6.3 0.0 0.7 6.8 0.0 1.5 2.1 20.6 1.2 0.0 0.0 2.8 19.0 0.1 5.0 0.0 0.0 1.1 2.7 0.0 11.7 0.2 6.1 0.0 1.0 0.5 5.9 1.5 0.0 1.3 0.0 26.8 TACSTD2 "EGP-1, GA733-1, M1S1, TROP2" ENSG00000184292 "Tumor associated calcium signal transducer 2" P09758 1 58575423-58577773 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Tumor antigen" "Amyloidosis, Corneal dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.9;salivary gland: 56.4" "Cell type enhanced" "Detected in many" 15 "Basal glandular cells: 5162.0;Glandular cells: 2977.4;Urothelial cells: 7434.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 12.4" "Group enriched" "Detected in many" 65 "dendritic cells: 3.7;granulocytes: 12.4;monocytes: 3.2" "Cell line enhanced" "Detected in some" "A-431: 75.7;CAPAN-2: 102.7;HaCaT: 102.9;RT4: 35.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA043104, HPA055067, CAB072852" Enhanced Supported "Nucleoli,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoli, Vesicles" "CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687" "unprognostic (1.80e-2)" "unprognostic (3.08e-1)" "unprognostic (3.67e-3)" "unprognostic (1.22e-1)" "unprognostic (5.70e-2)" "unprognostic (2.15e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (1.99e-1)" "unprognostic (1.03e-2)" "unprognostic (1.71e-2)" "unprognostic (7.91e-2)" "prognostic favorable (3.99e-4)" "unprognostic (7.10e-2)" "unprognostic (2.55e-1)" "unprognostic (6.91e-3)" "unprognostic (2.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 17.1 0.0 0.0 23.1 0.0 0.0 1.7 2.6 103.9 2.7 0.9 0.0 0.0 0.0 10.4 0.0 8.0 0.0 0.0 0.0 9.0 0.0 0.0 1.5 15.7 0.0 56.4 12.6 0.0 42.1 0.0 0.0 0.0 0.0 7.3 0.0 0.1 20.6 17.7 36.1 0.0 3.7 12.4 3.2 0.0 0.0 1.8 75.7 0.0 0.0 0.1 0.0 0.0 29.0 0.0 0.0 0.0 0.0 0.0 102.7 0.0 9.9 6.4 0.0 102.9 0.0 18.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 1.1 0.0 4.3 0.0 0.0 0.1 0.0 16.3 0.0 0.1 0.0 16.7 0.1 0.0 0.0 0.0 13.8 35.5 0.0 0.0 3.3 27.4 0.1 0.3 17.9 0.1 4.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.2 12.4 0.0 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.8 321.6 110.2 1.3 5162.0 1324.0 0.0 0.3 287.9 277.1 312.8 1212.6 0.0 74.9 36.5 1546.3 0.0 14.3 0.4 0.0 1122.5 4.7 23.0 2977.4 8.1 0.6 7.6 0.0 0.0 0.6 0.3 0.0 0.0 32.3 108.0 54.1 2.9 0.0 1294.2 4.0 0.0 3.3 0.0 0.0 47.2 0.5 0.9 1339.0 65.6 0.0 0.9 7434.9 TBX6 ENSG00000149922 "T-box 6" O95947 16 30085793-30091887 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 7.9;Sertoli cells: 6.5;Urothelial cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 9.9;U-266/70: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA062498 Approved Nucleoplasm NA NA Nucleoplasm "HPA062498: AB_2732686" "unprognostic (2.47e-1)" "unprognostic (1.32e-3)" "unprognostic (5.62e-5)" "unprognostic (1.49e-1)" "unprognostic (4.76e-2)" "unprognostic (2.35e-2)" "unprognostic (3.35e-1)" "unprognostic (5.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.29e-1)" "unprognostic (1.77e-2)" "unprognostic (3.87e-1)" "unprognostic (2.76e-2)" "unprognostic (2.95e-1)" "unprognostic (4.21e-2)" "unprognostic (5.05e-3)" "unprognostic (4.26e-2)" 1.2 1.4 1.4 1.0 1.5 0.6 0.9 0.9 1.5 2.7 1.2 0.9 0.9 1.8 0.9 1.0 22.8 1.6 1.3 0.9 1.5 1.0 1.8 1.2 1.2 1.2 1.7 0.9 1.9 19.8 3.2 2.3 0.9 2.1 3.2 0.3 2.3 3.9 2.2 2.8 5.0 1.7 0.9 1.5 1.8 7.8 2.4 1.2 1.6 2.3 5.1 16.3 5.5 8.6 4.4 1.3 3.3 2.6 1.3 1.9 1.1 0.9 1.1 0.6 1.1 1.5 0.8 0.8 0.3 0.2 0.0 0.2 1.3 4.3 1.9 2.3 0.2 0.2 1.3 0.5 0.9 0.0 1.4 0.8 1.2 1.7 0.9 1.1 0.2 2.6 0.3 1.2 0.3 0.5 0.9 0.6 4.2 0.1 4.3 0.1 3.6 0.7 0.5 0.9 5.9 0.9 2.8 0.1 3.1 0.0 9.9 1.4 2.0 0.2 0.9 1.2 0.5 1.8 1.7 0.5 1.2 0.7 0.6 0.0 10.4 2.4 0.3 1.2 1.8 0.4 3.1 2.6 0.8 1.8 2.3 1.2 1.3 0.9 1.3 1.3 4.4 1.9 1.7 3.3 1.3 0.8 1.1 1.8 1.1 1.4 1.5 0.9 1.4 1.5 1.0 1.7 0.9 2.1 1.2 0.0 1.1 0.8 2.9 1.0 1.4 0.4 0.0 1.4 0.0 1.8 7.9 1.4 0.0 0.7 0.0 1.4 0.7 0.0 1.0 0.6 0.6 2.9 0.0 0.2 0.5 0.0 0.0 0.6 1.0 0.0 0.9 1.0 0.0 0.0 0.9 1.9 2.1 1.4 1.1 0.4 3.1 6.5 0.1 1.7 2.3 0.9 1.9 0.0 0.7 6.4 TMEM154 FLJ32028 ENSG00000170006 "Transmembrane protein 154" Q6P9G4 4 152618632-152680165 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 75.4;esophagus: 36.1;lymphoid tissue: 38.0" "Cell type enhanced" "Detected in many" 12 "Basal keratinocytes: 65.9;Ciliated cells: 60.2;granulocytes: 97.2;Suprabasal keratinocytes: 169.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 7 "basophil: 49.8;eosinophil: 44.8;neutrophil: 75.4" "Lineage enriched" "Detected in many" 9 "granulocytes: 75.4" "Cell line enhanced" "Detected in many" "HBEC3-KT: 24.7;HMC-1: 28.5;Karpas-707: 22.2;U-266/70: 27.8;U-937: 22.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA019184, HPA055411" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA "Nuclear membrane" Nucleoplasm "HPA019184: AB_2670088, HPA055411: " "unprognostic (1.09e-1)" "unprognostic (3.56e-1)" "unprognostic (5.17e-2)" "unprognostic (3.09e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-1)" "unprognostic (2.24e-1)" "unprognostic (2.96e-1)" "unprognostic (2.64e-1)" "unprognostic (1.65e-1)" "unprognostic (5.00e-3)" "unprognostic (7.67e-2)" "unprognostic (2.23e-3)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "unprognostic (1.13e-1)" "unprognostic (3.53e-1)" 1.4 0.7 0.8 12.5 0.8 8.3 2.0 0.7 0.7 5.0 1.4 1.3 0.9 1.0 1.1 1.2 36.1 1.1 2.4 1.7 0.8 0.8 1.0 4.8 7.9 20.4 1.3 0.1 0.7 0.8 0.1 3.5 3.5 0.8 3.9 1.1 0.5 16.1 2.5 1.3 28.7 3.0 2.2 1.2 16.2 2.7 0.6 0.1 8.2 1.5 26.0 38.0 7.1 6.3 8.3 2.9 75.4 6.0 0.1 3.4 2.2 12.2 0.0 0.1 0.0 0.2 3.5 5.6 3.1 11.5 3.4 6.5 0.1 1.6 12.6 1.3 2.8 3.7 9.0 0.0 24.7 6.3 0.0 0.0 0.7 0.1 0.0 3.7 9.7 28.5 3.4 11.9 10.9 9.5 0.0 8.4 7.8 0.0 22.2 0.2 0.8 3.8 3.0 0.6 0.0 2.9 0.4 0.0 0.0 19.5 7.5 0.0 0.5 0.7 2.4 0.4 3.5 0.3 6.9 3.4 0.5 2.0 0.3 4.3 27.8 9.4 6.9 4.7 22.1 2.6 49.8 5.8 44.8 0.8 5.9 1.5 8.3 1.8 1.3 2.9 7.2 1.8 1.2 75.4 0.1 6.0 0.3 3.4 2.2 0.8 0.8 0.7 0.7 0.8 0.8 1.3 0.1 0.8 0.1 11.9 22.9 42.2 7.7 65.9 0.0 1.4 0.0 60.2 19.4 21.0 2.0 21.8 0.0 6.1 0.0 5.7 0.0 0.0 3.3 12.7 5.5 5.3 97.2 3.9 4.2 3.2 1.2 0.6 8.7 0.0 0.6 15.0 5.0 0.0 0.6 0.0 12.8 9.1 0.0 0.3 0.4 0.0 1.9 0.0 0.2 169.9 21.6 15.8 3.1 23.5 TMEM184A "MGC9712, SDMG1" ENSG00000164855 "Transmembrane protein 184A" Q6ZMB5 7 1542235-1560821 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.2;intestine: 39.3" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 57.2;Mucus-secreting cells: 31.0;Paneth cells: 31.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "MCF7: 15.2;RT4: 17.3;SCLC-21H: 17.8;SK-BR-3: 27.6;T-47d: 24.4" "Low region specificity" "Detected in many" "HPA053790, HPA071312" Uncertain Uncertain Nucleoplasm NA NA Nucleoplasm "HPA053790: AB_2682263, HPA071312: AB_2686387" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (2.38e-1)" "unprognostic (4.41e-3)" "unprognostic (1.07e-1)" "unprognostic (2.36e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-1)" "unprognostic (1.69e-1)" "unprognostic (1.53e-1)" "unprognostic (1.31e-1)" "unprognostic (6.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (5.47e-2)" 0.4 0.1 0.2 3.5 0.2 0.1 1.6 0.2 0.3 8.6 15.6 0.2 8.0 15.1 1.7 2.9 40.2 4.4 9.6 0.2 0.2 0.1 5.3 18.0 1.5 0.2 0.2 0.3 0.9 24.7 3.1 5.4 14.3 0.4 5.1 4.0 0.3 10.3 12.0 2.3 17.9 39.3 1.2 0.2 0.2 7.5 3.8 0.2 0.5 0.3 22.9 31.9 10.0 15.8 0.8 0.8 2.0 0.5 0.4 0.5 0.0 9.7 6.6 0.0 0.0 0.0 0.0 2.2 0.3 0.1 0.4 0.0 8.9 11.7 0.2 3.4 0.1 3.6 7.5 0.0 4.4 0.1 0.1 0.2 0.0 6.0 4.0 0.1 0.0 0.0 0.0 4.3 0.1 3.9 0.2 0.0 2.9 0.1 0.0 0.0 15.2 0.0 0.0 0.3 6.0 8.6 0.2 0.0 4.7 3.3 17.3 17.8 0.0 2.9 27.6 0.0 0.2 24.4 0.0 0.0 0.0 3.7 4.6 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.2 0.5 0.1 0.3 0.2 0.3 0.2 0.1 0.8 0.4 0.3 2.0 0.4 0.2 0.8 0.3 0.0 0.2 0.2 0.2 0.3 0.2 0.1 0.2 0.3 0.4 0.2 3.0 4.1 0.8 5.3 3.5 0.9 2.5 17.8 13.4 10.3 8.7 0.0 6.6 1.7 11.9 0.0 0.7 57.2 0.0 9.6 7.7 1.3 11.9 1.1 12.4 0.7 0.0 6.9 0.0 1.2 0.0 0.0 1.7 0.0 1.0 31.0 0.0 12.3 31.6 0.0 3.8 0.4 0.0 1.0 0.0 0.0 8.2 14.1 0.0 13.3 11.3 TMEM40 FLJ11036 ENSG00000088726 "Transmembrane protein 40" Q8WWA1 3 12733525-12769457 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5" "Cell type enhanced" "Detected in many" 24 "Cytotrophoblasts: 120.6;Suprabasal keratinocytes: 176.4;Syncytiotrophoblasts: 549.0;Urothelial cells: 120.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 73.7;hTCEpi: 16.6;hTERT-HME1: 21.0;RT4: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044165, HPA073122" Enhanced Approved Cytosol NA NA 7000000 Cytosol "HPA044165: AB_10961279, HPA073122: " "unprognostic (2.51e-3)" "unprognostic (1.96e-2)" "unprognostic (2.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.27e-1)" "unprognostic (1.92e-1)" "unprognostic (5.15e-4)" "unprognostic (5.96e-2)" "unprognostic (3.15e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-3)" "unprognostic (2.47e-1)" "unprognostic (1.20e-3)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 0.0 0.2 1.4 1.8 0.0 0.0 11.7 0.0 0.0 0.4 0.0 0.9 0.6 62.9 1.6 0.1 1.6 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 53.6 0.1 2.3 0.0 0.0 6.6 1.4 0.4 24.0 0.0 0.7 0.0 1.1 0.0 0.4 0.0 0.4 0.0 40.5 41.8 10.6 18.6 0.0 0.5 4.5 0.6 0.0 0.3 21.1 7.4 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.3 0.4 0.2 1.1 0.0 0.0 0.0 0.2 2.1 0.0 73.7 1.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 16.6 0.0 21.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.4 10.3 0.0 0.0 0.0 9.2 0.0 1.4 0.8 0.2 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.6 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.5 0.0 0.0 0.5 0.0 21.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 71.9 57.1 0.0 3.3 0.0 22.7 6.8 1.8 0.0 120.6 0.0 0.5 0.6 0.4 0.0 0.0 0.0 12.6 4.3 9.6 0.0 0.6 9.6 0.0 0.0 0.0 0.3 1.6 0.3 0.2 10.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.3 0.2 1.9 176.4 549.0 0.0 0.0 120.1 TMEM79 "FLJ16057, FLJ32254, MATT, MGC13102" ENSG00000163472 "Transmembrane protein 79" Q9BSE2 1 156282935-156293185 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 47.5;skin 1: 35.7;tongue: 37.2" "Cell type enhanced" "Detected in many" 9 "Suprabasal keratinocytes: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 22.0;SK-BR-3: 18.1;T-47d: 19.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA055214 Enhanced Approved "Nucleoli fibrillar center" NA NA "Nucleoli fibrillar center" "HPA055214: AB_2682741" "unprognostic (3.12e-1)" "unprognostic (2.96e-1)" "unprognostic (1.26e-1)" "unprognostic (8.17e-2)" "unprognostic (5.51e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (2.61e-5)" "unprognostic (6.37e-2)" "unprognostic (2.44e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.12e-3)" "prognostic unfavorable (4.31e-7)" "unprognostic (1.72e-1)" "unprognostic (1.96e-1)" "unprognostic (3.98e-2)" "unprognostic (2.37e-1)" 1.2 1.3 2.4 1.2 5.1 2.0 3.4 3.4 3.7 12.5 1.2 3.6 1.9 1.8 1.3 1.9 47.5 1.5 1.9 1.0 2.0 1.1 1.1 1.4 1.0 1.8 5.6 1.4 1.5 1.0 3.8 2.5 4.5 3.1 19.0 1.1 1.2 9.4 2.1 1.9 35.7 1.3 1.1 3.2 1.6 1.6 0.9 5.2 3.7 1.5 37.2 24.2 3.3 20.5 5.2 4.1 7.8 4.1 3.0 5.2 3.1 8.2 4.9 1.7 3.2 1.2 1.3 4.1 2.4 1.0 4.4 1.7 5.7 2.3 1.6 5.3 0.6 1.6 7.4 1.9 3.7 1.9 5.5 2.8 1.5 2.0 1.6 2.3 1.7 2.3 1.3 22.0 3.3 3.3 3.2 0.9 5.6 6.9 10.3 2.0 9.8 4.8 2.7 2.5 6.2 3.9 5.7 1.6 3.3 0.9 2.6 3.0 3.3 2.9 18.1 4.7 2.1 19.4 5.0 2.3 8.1 2.7 2.9 6.4 8.0 8.3 3.5 5.6 4.1 6.1 0.0 4.1 5.6 3.9 1.4 3.9 3.7 3.4 4.0 3.2 5.2 4.4 5.2 7.8 3.0 2.6 4.1 4.0 3.1 2.4 5.1 3.4 3.7 2.0 1.1 5.6 1.4 3.1 5.2 3.0 1.0 2.0 1.1 11.7 3.2 0.8 5.1 2.7 2.3 1.8 2.0 5.9 1.7 1.9 0.1 1.5 2.6 0.0 2.9 1.6 1.9 11.3 0.0 2.0 3.0 7.9 2.9 1.3 2.4 0.0 1.4 1.4 5.0 6.4 2.1 1.5 3.0 2.5 0.7 1.1 2.2 0.0 0.8 1.2 1.9 29.0 6.2 3.5 2.6 4.9 TMPRSS11E "DESC1, TMPRSS11E2" ENSG00000087128 "Transmembrane serine protease 11E" Q9UL52 4 68447449-68497604 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.8;lymphoid tissue: 39.1;tongue: 40.5;vagina: 36.6" "Group enriched" "Detected in some" 6 "Basal glandular cells: 12.6;Urothelial cells: 38.8" "Group enriched" "Detected in many" 6 "cervical cancer: 22.0;head and neck cancer: 25.3;lung cancer: 11.5;urothelial cancer: 7.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory B-cell: 1.8" "Lineage enhanced" "Detected in single" "B-cells: 1.8" "Group enriched" "Detected in some" 6 "HaCaT: 5.0;HBEC3-KT: 1.9;OE19: 5.2;SuSa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA051062 Enhanced "Intracellular and membrane" NA NA "HPA051062: AB_2681329" "unprognostic (2.53e-1)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" "unprognostic (9.14e-2)" "unprognostic (5.03e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (2.22e-1)" "unprognostic (9.70e-3)" "unprognostic (2.16e-1)" "unprognostic (3.74e-2)" "unprognostic (4.03e-2)" "unprognostic (8.39e-2)" "unprognostic (1.27e-1)" "unprognostic (3.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 28.9 0.0 0.0 1.2 0.0 1.1 10.5 103.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.4 0.0 0.0 13.6 0.5 0.0 1.6 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.1 0.0 40.5 39.1 2.6 36.6 1.8 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 5.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.9 0.0 0.0 38.8 TMPRSS4 "MT-SP2, TMPRSS3" ENSG00000137648 "Transmembrane serine protease 4" Q9NRS4 11 118077012-118121890 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9" "Cell type enhanced" "Detected in many" 18 "Enterocytes: 108.9;Paneth cells: 61.7;Undifferentiated cells: 54.6;Urothelial cells: 226.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "basophil: 4.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 4.5" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.9;HaCaT: 16.2;OE19: 64.5;RPTEC TERT1: 26.6;RT4: 33.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA006238 Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA006238: AB_1080316" "unprognostic (1.48e-1)" "unprognostic (3.27e-2)" "unprognostic (1.19e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-2)" "unprognostic (5.50e-2)" "unprognostic (8.17e-3)" "unprognostic (1.95e-2)" "unprognostic (2.41e-1)" "unprognostic (9.62e-2)" "prognostic unfavorable (3.14e-4)" "unprognostic (2.87e-3)" "unprognostic (2.80e-1)" "unprognostic (4.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.10e-2)" "unprognostic (9.96e-3)" 0.3 0.3 0.2 14.2 0.3 0.0 0.3 0.3 0.2 11.4 23.5 0.1 0.0 16.1 3.1 2.8 60.9 0.6 45.4 0.3 0.3 0.3 17.7 0.3 3.2 0.0 0.2 0.0 0.3 0.4 0.0 0.3 0.8 0.1 9.9 26.2 0.2 4.0 0.0 0.3 2.4 27.4 4.2 0.2 0.3 13.7 0.7 0.0 0.6 0.3 13.7 41.0 43.9 22.3 0.5 0.1 4.5 0.7 0.2 0.1 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 37.9 0.0 1.4 0.0 0.0 16.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 1.1 0.0 64.5 0.0 0.0 0.0 0.0 26.6 33.2 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.1 0.9 0.2 0.7 0.1 0.1 0.0 0.2 0.3 0.3 0.2 0.3 0.3 0.2 0.0 0.1 0.0 0.0 1.7 0.0 21.5 1.0 0.0 0.6 0.0 17.4 36.4 10.4 0.0 0.1 0.0 0.1 2.6 0.0 108.9 0.0 6.6 1.6 0.2 6.8 5.7 0.0 0.2 0.0 4.1 0.0 0.0 1.3 0.0 1.0 0.0 0.0 49.1 0.0 30.7 61.7 0.0 1.4 0.0 0.0 0.7 0.0 0.1 5.5 0.2 0.0 54.6 226.3 TP53AIP1 p53AIP1 ENSG00000120471 "Tumor protein p53 regulated apoptosis inducing protein 1" Q9HCN2 11 128934731-128943399 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 19.6;lymphoid tissue: 15.2;skin 1: 22.5;tongue: 31.5" "Cell type enhanced" "Detected in some" 18 "Basal glandular cells: 9.5;Basal keratinocytes: 40.4;Ciliated cells: 14.7;Suprabasal keratinocytes: 28.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 1.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "Karpas-707: 1.6;RT4: 3.4;SK-BR-3: 2.3" "HPA044300, HPA048797" Uncertain NA NA "HPA044300: AB_2678888, HPA048797: AB_2680524" "unprognostic (4.12e-7)" "unprognostic (3.00e-2)" "unprognostic (1.48e-1)" "unprognostic (1.64e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-2)" "unprognostic (1.18e-1)" "unprognostic (4.66e-2)" "unprognostic (1.22e-1)" "unprognostic (6.62e-2)" "unprognostic (1.03e-1)" "unprognostic (2.94e-1)" "unprognostic (6.57e-6)" "unprognostic (1.10e-2)" "unprognostic (3.71e-1)" "unprognostic (7.75e-2)" "unprognostic (1.78e-2)" 0.1 0.3 0.3 0.1 0.3 0.2 1.6 0.3 0.3 4.6 0.1 0.2 4.2 0.0 0.4 8.9 19.6 3.2 0.1 0.1 0.3 0.6 0.5 0.1 0.5 0.1 0.1 0.1 0.1 0.1 0.0 0.9 0.1 0.1 1.2 0.1 0.1 3.0 1.2 0.9 22.5 0.2 0.1 0.1 0.1 0.2 0.6 0.1 15.2 0.1 31.5 6.7 0.2 11.0 0.4 0.1 1.9 0.2 0.2 0.3 0.1 0.4 0.0 0.2 0.5 0.7 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 0.6 1.5 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.5 0.0 0.3 0.2 0.0 0.4 0.4 0.5 0.2 0.0 0.1 0.1 1.6 0.0 0.2 1.0 0.0 0.8 0.4 0.6 0.0 0.4 0.0 0.0 3.4 1.2 0.1 0.0 2.3 0.0 0.1 0.7 0.0 0.0 0.8 0.7 0.5 0.4 0.0 0.0 0.4 0.0 0.3 0.1 1.3 0.1 0.1 0.2 0.2 0.1 0.2 0.3 0.0 0.0 0.4 0.2 0.1 1.9 0.2 0.1 0.1 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.6 0.1 0.1 0.1 0.1 0.0 0.3 0.0 9.5 40.4 0.2 0.2 0.0 14.7 3.4 0.0 0.0 0.0 6.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.4 1.2 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 28.5 0.2 0.0 0.2 2.5 TPRG1 "FAM79B, FLJ41238, FLJ43694" ENSG00000188001 "Tumor protein p63 regulated 1" Q6ZUI0 3 188947214-189325304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.3;lymphoid tissue: 32.9" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 35.7;Early spermatids: 102.2" "Cancer enhanced" "Detected in many" "breast cancer: 7.0" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 8.8;Karpas-707: 4.5;OE19: 21.7;U-266/70: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA044751, HPA060187" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA044751: AB_2679073, HPA060187: AB_2684217" "prognostic favorable (5.43e-4)" "unprognostic (8.71e-3)" "unprognostic (2.10e-3)" "unprognostic (2.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.33e-3)" "unprognostic (1.55e-2)" "unprognostic (9.88e-2)" "unprognostic (2.66e-1)" "unprognostic (2.71e-1)" "unprognostic (1.40e-2)" "unprognostic (3.79e-1)" "unprognostic (3.52e-8)" "unprognostic (8.50e-2)" "unprognostic (9.53e-2)" "unprognostic (1.38e-1)" "unprognostic (3.73e-2)" 16.1 1.0 0.3 0.9 0.8 0.0 14.4 1.7 0.8 19.7 1.2 0.1 1.0 0.0 5.0 1.6 43.3 5.2 1.6 2.4 0.2 0.2 0.6 5.1 2.7 0.3 0.3 0.5 1.9 0.3 0.0 0.8 1.0 0.5 2.5 0.0 0.8 3.7 0.7 5.0 14.5 0.5 1.9 0.3 0.7 0.4 2.6 0.3 7.9 0.8 25.5 32.9 2.3 17.8 0.2 0.7 1.3 2.3 0.0 6.3 1.3 0.8 0.2 0.3 0.0 2.0 1.7 0.0 0.0 0.0 0.0 0.1 1.0 2.1 1.2 3.3 0.1 0.5 0.2 0.0 0.0 0.0 8.8 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.5 0.4 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.2 0.3 0.0 0.0 0.6 21.7 0.3 0.0 0.0 1.5 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.7 3.9 0.6 0.0 0.1 0.3 0.0 0.3 4.2 3.3 0.3 0.1 0.0 0.1 0.0 2.3 0.0 6.0 1.8 0.9 0.2 4.9 6.3 0.7 0.0 1.0 2.5 1.3 0.0 1.6 0.1 5.4 1.3 0.3 0.8 1.7 0.8 0.2 0.2 0.3 0.5 0.5 0.3 35.7 1.7 5.7 16.1 4.9 0.2 0.7 0.0 1.4 10.3 0.0 0.0 0.3 0.0 0.3 102.2 0.7 0.0 0.0 0.5 0.2 1.4 1.5 1.1 6.6 5.0 0.0 0.0 0.0 1.9 7.8 6.6 2.2 0.0 0.0 0.0 0.0 4.6 0.0 2.8 0.0 0.0 0.0 0.7 1.2 1.1 5.1 0.2 13.4 0.2 5.1 TRIM29 "ATDC, FLJ36085" ENSG00000137699 "Tripartite motif containing 29" Q14134 11 120111275-120185529 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 176.3;lymphoid tissue: 93.6;skin 1: 90.1;tongue: 113.6" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 97.6;Basal keratinocytes: 241.7;Suprabasal keratinocytes: 402.6;Urothelial cells: 144.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 93.4" "Region enriched" "Detected in single" 8 "pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 54.2;hTCEpi: 72.1;RT4: 28.5;SiHa: 40.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA020053, HPA074841" Enhanced Approved "Nucleoplasm,Intermediate filaments,Cytosol" NA NA "Intermediate filaments" "Nucleoplasm, Cytosol" "HPA020053: AB_1858280, HPA074841: " "unprognostic (1.10e-1)" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (2.88e-4)" "unprognostic (9.79e-3)" "unprognostic (3.08e-2)" "unprognostic (3.30e-1)" "unprognostic (5.24e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.37e-2)" "unprognostic (4.29e-3)" "prognostic favorable (4.93e-4)" "unprognostic (2.59e-1)" "unprognostic (2.91e-2)" "unprognostic (4.15e-2)" 0.3 0.2 0.1 0.0 0.1 0.1 7.3 0.0 0.1 30.4 0.6 0.2 1.6 0.3 3.1 2.9 176.3 3.7 0.8 0.1 0.1 0.1 0.5 0.4 1.4 0.0 0.0 0.0 0.4 0.2 0.0 2.2 24.4 1.1 11.1 0.5 0.0 25.5 4.8 0.9 90.1 0.2 1.6 0.3 0.0 0.2 0.7 0.0 7.5 0.1 113.6 93.6 9.6 42.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 3.4 0.0 0.8 0.0 0.1 54.2 0.0 12.4 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.1 0.0 72.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 28.5 0.2 0.9 40.5 5.7 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 1.0 0.0 97.6 241.7 0.0 1.1 2.5 33.5 13.6 0.0 0.0 37.9 0.0 1.3 21.4 0.4 2.1 0.0 3.9 5.0 5.4 34.5 1.1 0.0 4.4 0.0 2.4 0.0 0.0 78.0 0.6 1.7 21.9 0.0 2.3 0.0 33.2 0.8 0.0 0.2 0.0 0.0 7.2 0.6 1.4 402.6 20.7 0.0 1.4 144.0 TTC22 FLJ20619 ENSG00000006555 "Tetratricopeptide repeat domain 22" Q5TAA0 1 54779712-54801267 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 46.8" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 45.7;Mucus-secreting cells: 19.6;Paneth cells: 38.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 8.4;CAPAN-2: 10.4;HaCaT: 11.9;hTCEpi: 6.8;OE19: 14.0;RPMI-8226: 7.6" "Low region specificity" "Detected in single" HPA035072 Uncertain NA NA "HPA035072: AB_10602252" "prognostic favorable (2.06e-4)" "unprognostic (8.52e-2)" "unprognostic (4.84e-2)" "unprognostic (4.98e-2)" "unprognostic (1.01e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (7.73e-4)" "unprognostic (2.02e-1)" "unprognostic (2.60e-1)" "unprognostic (3.07e-2)" "unprognostic (4.57e-2)" "unprognostic (7.27e-2)" "unprognostic (1.51e-3)" "unprognostic (5.08e-3)" "unprognostic (1.00e-1)" "unprognostic (3.16e-2)" "unprognostic (2.21e-1)" 0.3 0.4 1.0 4.2 3.5 0.6 1.5 0.2 0.4 12.1 11.8 0.2 5.1 10.1 1.6 2.4 46.8 2.1 7.7 0.2 1.1 0.6 6.6 6.4 5.0 1.5 0.3 0.5 0.6 5.7 8.2 5.7 0.5 0.6 3.6 7.3 1.0 9.5 3.9 0.1 12.2 27.7 0.3 0.3 1.1 8.7 0.5 0.7 3.0 5.3 18.4 21.0 1.8 18.8 1.2 0.1 4.0 0.1 2.9 6.5 0.7 8.4 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.8 10.4 0.1 0.4 0.0 0.0 11.9 0.0 3.5 0.0 3.7 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.1 0.1 14.0 1.1 0.1 0.0 7.6 0.4 2.1 0.3 0.2 0.7 0.1 0.0 0.2 0.3 0.2 0.1 0.2 0.0 0.2 0.1 0.8 2.0 0.1 0.1 0.1 0.0 1.4 0.1 4.0 6.0 0.0 3.6 1.2 2.9 6.5 0.1 0.9 2.5 3.1 2.3 2.9 0.1 0.1 3.9 0.7 1.0 3.5 0.2 0.4 1.1 0.6 0.3 0.5 0.6 0.7 0.0 1.9 0.0 5.9 1.1 0.0 1.8 12.7 2.7 2.3 3.5 0.0 0.2 6.6 4.5 3.0 0.0 45.7 0.0 7.9 0.4 0.2 5.1 0.0 1.8 0.0 0.0 2.4 0.0 0.0 0.4 0.3 0.0 1.7 0.0 19.6 0.0 7.9 38.5 0.0 7.4 0.0 0.0 0.0 0.2 0.6 4.0 0.0 3.5 11.9 11.7 TTC9 "KIAA0227, TTC9A" ENSG00000133985 "Tetratricopeptide repeat domain 9" Q92623 14 70641787-70675360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 42.0" "Cell type enhanced" "Detected in many" 10 "Pancreatic endocrine cells: 24.0;Urothelial cells: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.7;Daudi: 10.3;RH-30: 14.4;SK-BR-3: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "unprognostic (2.37e-2)" "unprognostic (6.01e-2)" "unprognostic (9.29e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.81e-2)" "unprognostic (2.38e-2)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.18e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.10e-8)" "unprognostic (1.22e-2)" "unprognostic (1.01e-1)" "unprognostic (3.16e-2)" "unprognostic (9.38e-2)" 1.3 1.7 7.6 4.2 11.0 1.3 4.3 6.3 9.7 4.0 1.3 1.5 2.2 1.3 1.8 2.0 42.0 10.8 3.9 2.4 7.5 6.5 2.3 1.5 4.8 8.9 4.6 10.3 0.6 1.4 2.1 3.2 5.8 9.8 3.1 1.4 1.5 9.8 2.2 6.5 5.4 2.0 1.4 2.9 5.8 4.4 1.0 1.5 1.2 4.6 7.2 18.6 3.2 9.0 3.4 0.2 2.3 3.5 0.0 3.4 0.7 11.7 1.4 4.5 0.2 0.0 0.0 4.8 0.2 0.1 0.3 1.5 0.2 5.9 10.3 1.6 0.1 1.0 4.3 3.3 0.4 0.2 0.3 1.2 1.4 0.4 3.3 0.0 0.0 3.0 0.4 0.8 0.0 0.1 0.2 0.0 2.3 0.0 0.9 4.8 5.8 0.2 0.1 2.5 8.5 1.5 2.4 14.4 0.1 7.4 2.7 2.8 1.3 1.3 24.4 0.0 2.8 8.5 0.4 0.0 0.0 2.2 0.0 0.2 0.0 0.1 3.2 0.0 0.2 0.1 0.0 0.0 1.5 1.1 0.7 2.5 1.8 2.0 1.5 0.2 3.4 3.4 1.9 2.3 0.0 3.5 0.0 1.0 0.7 7.6 11.0 6.3 9.7 7.5 6.5 4.6 10.3 9.8 1.5 3.0 7.4 5.2 3.4 0.9 2.8 1.6 15.3 10.7 3.4 8.7 5.9 18.7 1.7 18.9 0.2 3.3 0.0 0.0 4.9 1.2 1.0 10.4 1.1 1.6 2.2 0.0 1.2 0.0 6.4 0.6 0.0 0.0 6.8 0.0 0.3 16.0 24.0 0.0 0.0 0.0 5.1 0.0 0.5 0.0 1.3 1.5 6.2 2.5 0.6 48.2 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942000-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.8" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 7 "T-cells: 5.5" "Cell line enhanced" "Detected in many" "SiHa: 32.0;U-2197: 23.1" CAB018974 Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB018974: " "unprognostic (2.09e-5)" "prognostic unfavorable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 3.3 1.7 4.5 1.9 2.3 4.3 5.9 5.3 6.5 1.6 0.6 0.0 0.0 0.9 0.6 0.5 10.8 0.5 1.6 4.1 4.4 1.0 1.9 1.7 6.2 1.1 1.0 2.1 0.2 1.6 0.3 1.1 4.4 3.9 0.6 0.7 0.3 1.5 0.4 0.6 1.0 0.4 2.0 0.6 0.5 0.7 3.6 0.1 0.5 3.5 4.6 2.4 4.1 5.2 0.0 0.0 0.0 0.0 0.8 5.5 0.9 9.2 0.8 0.2 2.9 0.5 2.8 1.6 9.6 5.6 10.1 8.3 3.5 5.3 0.0 14.7 10.9 14.5 6.6 3.6 8.8 5.8 4.2 1.9 0.5 1.4 0.0 3.6 0.0 0.7 1.3 6.8 8.9 3.9 8.2 5.7 8.0 1.1 0.0 7.4 6.4 0.8 0.0 0.0 1.7 4.9 1.4 2.2 0.0 14.3 2.7 0.3 0.0 32.0 0.7 0.9 1.6 0.9 4.0 8.9 6.6 8.3 23.1 11.0 0.0 0.0 0.4 9.5 5.1 4.7 0.0 0.0 0.0 5.5 0.0 0.6 0.0 1.8 3.2 0.0 0.0 0.6 3.9 0.0 0.8 0.0 0.0 3.0 0.9 4.5 2.3 5.3 6.5 4.4 1.0 1.0 2.1 3.9 0.1 0.0 2.2 0.0 5.4 3.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.9 6.3 3.8 0.0 0.0 7.4 0.2 0.9 0.9 0.0 0.0 1.8 0.0 0.0 9.2 1.2 6.4 0.0 1.7 1.7 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 1.0 2.3 3.2 2.5 0.0 2.9 0.0 3.2 UPK3B "FLJ32198, MGC10902, p35, UPIIIb" ENSG00000243566 "Uroplakin 3B" Q9BT76 7 76510428-76516521 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0" "Cell type enriched" "Detected in some" 10 "Alveolar cells type 1: 113.2" "Group enriched" "Detected in many" 12 "ovarian cancer: 64.6;urothelial cancer: 78.4" "Region enriched" "Detected in single" 58 "pons and medulla: 5.8" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2" HPA010506 Approved NA NA "HPA010506: AB_1080479" "unprognostic (8.33e-2)" "unprognostic (1.30e-1)" "unprognostic (3.62e-3)" "unprognostic (2.26e-3)" "unprognostic (7.87e-2)" "unprognostic (8.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.63e-1)" "unprognostic (4.03e-1)" "unprognostic (5.92e-2)" "unprognostic (1.37e-2)" "unprognostic (4.06e-2)" "unprognostic (8.37e-9)" "unprognostic (3.56e-2)" "unprognostic (2.01e-1)" "unprognostic (1.66e-1)" "unprognostic (6.34e-2)" 28.5 0.3 0.0 7.1 0.0 0.4 0.3 0.0 0.3 1.5 6.9 0.1 0.0 0.3 0.8 7.9 40.2 2.8 3.0 9.4 0.0 0.0 0.3 0.4 34.1 0.4 0.0 0.0 13.2 0.3 0.3 0.1 0.3 5.8 1.4 0.3 0.8 1.4 0.3 0.4 1.1 0.5 1.5 0.2 0.4 0.6 6.1 0.0 0.2 0.3 6.1 25.0 20.5 2.1 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.6 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 28.5 0.0 0.2 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.2 2.3 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 113.2 3.5 0.0 0.2 1.4 0.0 0.3 2.5 4.0 9.1 3.5 3.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 1.1 0.0 0.1 1.6 0.0 0.6 0.0 0.0 11.2 0.9 3.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 2.5 0.1 0.0 0.1 2.5 UPK3BL1 "UPK3BL, UPLP" ENSG00000267368 "Uroplakin 3B like 1" "B0FP48, E5RIL1" 7 102637025-102642791 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 45.1;lymphoid tissue: 34.6" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9;Alveolar cells type 2: 10.7;Ciliated cells: 9.4;Club cells: 5.7;granulocytes: 7.0;monocytes: 3.6;Pancreatic endocrine cells: 2.9" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 48.8" HPA011403 Supported NA NA "HPA011403: AB_2668503" "unprognostic (4.63e-1)" "unprognostic (1.39e-1)" "unprognostic (1.53e-2)" "unprognostic (2.45e-1)" "unprognostic (3.28e-1)" "unprognostic (6.19e-3)" "unprognostic (3.35e-1)" "unprognostic (2.88e-1)" "unprognostic (9.39e-3)" "unprognostic (4.00e-1)" "unprognostic (8.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-1)" "unprognostic (1.79e-1)" "unprognostic (3.93e-2)" 3.0 2.2 2.1 3.3 2.7 7.9 3.0 4.5 2.1 6.5 2.9 3.6 3.4 1.7 45.1 3.7 1.0 2.2 3.0 1.9 4.6 4.0 3.4 7.1 2.1 3.7 3.8 3.4 4.3 1.7 5.9 1.5 7.7 23.7 6.5 5.1 4.6 0.9 2.0 8.8 3.0 1.3 13.1 34.6 11.8 15.1 5.3 6.8 13.6 5.9 7.1 9.6 4.7 7.4 5.9 3.8 1.6 1.6 0.2 5.2 0.0 0.8 0.9 2.2 0.9 4.0 1.1 1.4 0.9 1.2 48.8 1.1 5.4 0.6 6.6 8.6 1.1 2.4 1.7 0.5 1.9 2.0 3.2 7.1 0.0 1.3 6.7 6.9 0.2 2.8 4.1 2.5 16.9 3.0 16.2 1.7 6.4 1.8 3.0 2.1 6.1 7.0 5.9 2.6 6.0 10.1 2.6 2.4 3.2 0.8 3.0 2.3 14.5 6.2 5.1 2.8 4.3 2.0 0.7 3.1 4.5 2.4 13.6 5.9 8.5 9.6 5.2 4.4 5.3 5.0 4.7 6.8 4.9 6.3 4.8 7.1 7.1 1.7 6.8 7.9 4.7 8.9 10.7 0.0 0.0 0.0 0.0 0.0 0.0 9.4 5.7 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 7.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.6 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 UPK3BL2 ENSG00000284981 "Uroplakin 3B like 2" E5RIL1 7 102538417-102543849 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 12.2;lymphoid tissue: 12.8" "Cell type enriched" "Detected in single" 14 "Ciliated cells: 1.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA011403 Approved NA NA "HPA011403: AB_2668503" 0.8 0.0 1.5 6.5 1.0 0.3 0.0 0.6 1.0 0.7 0.4 12.2 0.9 0.6 0.0 0.0 0.1 0.8 3.4 0.4 0.7 0.2 0.3 1.2 0.8 1.5 3.6 2.7 2.8 0.9 0.1 3.2 0.4 0.0 4.5 12.8 2.5 5.0 8.4 6.1 3.7 1.0 7.9 1.3 5.8 9.0 3.9 6.8 1.9 0.6 13.4 10.7 13.4 13.5 16.7 3.1 9.8 6.6 5.3 4.0 1.4 18.9 0.4 5.0 3.7 7.3 11.0 2.3 14.8 5.3 7.8 5.7 7.3 6.5 7.4 3.9 3.6 3.1 6.1 8.6 6.1 15.3 4.9 23.9 6.4 9.6 1.5 2.8 1.8 5.0 2.1 9.6 7.6 22.9 5.0 5.5 6.0 2.9 5.4 7.0 3.1 5.4 2.7 7.2 3.2 4.6 4.3 15.3 4.8 4.1 2.0 10.3 5.2 0.2 3.7 2.6 7.9 1.9 2.9 4.7 3.1 2.5 1.5 5.0 5.6 2.8 6.1 1.0 2.0 8.4 3.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USH1G "ANKS4A, FLJ33924, Sans" ENSG00000182040 "USH1 protein network component sans" Q495M9 17 74916084-74923256 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.9;epididymis: 11.4;esophagus: 11.8" "Cell type enhanced" "Detected in some" 17 "Early spermatids: 7.8;Late spermatids: 12.2;Muller glia cells: 11.4" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.6" "Region enriched" "Detected in single" 20 "cerebellum: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 4.5;hTCEpi: 4.2;K-562: 3.1;MCF7: 4.8;OE19: 4.6;U-2 OS: 2.6" "Region enriched" "Detected in single" 12 "olfactory region: 12.1" "Low region specificity" "Detected in some" HPA024360 Uncertain NA NA "HPA024360: AB_1858660" "unprognostic (2.95e-1)" "unprognostic (6.17e-2)" "unprognostic (6.34e-4)" "unprognostic (2.92e-2)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (5.59e-4)" "unprognostic (1.60e-1)" "unprognostic (1.39e-1)" "unprognostic (8.64e-2)" "unprognostic (1.69e-1)" "unprognostic (2.11e-1)" "unprognostic (3.10e-4)" "unprognostic (1.57e-1)" "unprognostic (8.48e-2)" "unprognostic (2.25e-1)" "unprognostic (3.35e-2)" 0.0 1.4 0.0 0.0 0.4 0.3 0.0 13.9 0.2 1.4 0.0 0.0 1.1 0.3 1.9 11.4 11.8 0.2 0.0 0.1 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 3.6 0.4 0.0 0.0 0.0 0.5 0.1 0.0 1.3 0.9 0.1 0.0 4.2 0.7 1.5 0.0 0.0 0.0 2.6 0.0 0.5 0.0 1.2 0.8 0.5 1.7 0.0 0.0 0.3 0.1 0.0 0.3 0.1 0.1 0.1 0.2 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.4 0.1 0.0 0.0 0.0 4.5 0.9 0.2 0.0 0.7 0.2 0.0 0.0 0.1 0.0 0.0 0.5 0.1 4.2 0.0 0.0 0.0 0.1 0.0 3.1 0.3 0.0 4.8 0.0 0.1 0.1 4.6 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.5 0.0 0.2 0.7 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 13.9 0.2 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.3 0.0 0.0 0.0 0.0 11.4 0.0 2.9 0.4 0.1 0.2 0.0 0.0 0.2 0.4 0.3 0.2 0.0 0.0 0.0 ZBTB7C "ZBTB36, ZNF857C" ENSG00000184828 "Zinc finger and BTB domain containing 7C" A1YPR0 18 48026673-48410752 "Predicted intracellular proteins, Transcription factors" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.6" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 19.7;Mucus-secreting cells: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "RT4: 30.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (1.32e-1)" "unprognostic (1.11e-2)" "prognostic favorable (1.59e-4)" "unprognostic (2.83e-3)" "unprognostic (6.60e-2)" "unprognostic (2.91e-3)" "unprognostic (8.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.58e-2)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "unprognostic (1.54e-1)" "unprognostic (1.05e-2)" "unprognostic (2.71e-1)" "unprognostic (5.52e-3)" "unprognostic (3.85e-3)" "unprognostic (2.89e-2)" 3.3 6.8 1.7 4.9 1.8 0.1 4.5 0.8 4.9 10.4 10.2 1.9 7.3 1.2 3.0 13.5 38.6 10.3 18.2 3.0 1.8 2.7 1.6 1.3 5.8 0.2 2.9 2.1 10.8 1.1 6.1 2.8 3.5 3.8 3.6 9.6 5.9 12.8 5.7 1.6 19.2 2.7 3.0 4.9 8.7 9.9 6.5 1.5 0.0 15.7 22.9 20.8 6.7 14.9 1.5 1.1 3.2 2.2 0.7 1.3 0.2 0.0 0.0 1.0 0.8 0.1 0.3 0.6 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.0 1.2 2.0 0.1 0.3 0.1 0.2 0.9 0.1 2.4 0.0 0.0 0.1 0.4 0.1 0.5 0.1 0.3 0.0 0.0 0.9 0.1 0.0 0.4 0.5 1.3 0.3 0.4 6.1 0.1 0.1 0.0 6.8 1.0 30.5 4.1 5.0 0.4 0.2 0.0 1.2 0.7 0.0 0.0 0.1 0.5 0.4 0.0 0.0 0.3 0.1 2.0 0.1 0.2 3.2 0.8 0.7 1.3 0.9 0.6 0.3 0.6 1.1 0.0 1.5 0.5 0.9 1.1 0.7 2.2 1.1 0.3 0.2 1.7 1.8 0.8 4.9 1.8 2.7 2.9 2.1 3.8 1.5 6.0 1.0 0.0 4.9 5.5 0.6 2.4 15.3 8.1 5.7 1.8 0.0 10.8 0.0 0.7 8.7 2.7 19.7 0.0 3.6 0.4 1.9 5.0 0.0 0.6 1.3 1.6 4.6 0.0 1.3 2.6 3.4 0.0 3.3 0.0 27.8 0.3 0.9 7.0 11.3 0.0 2.3 12.9 11.4 0.7 0.4 7.8 10.5 0.0 17.2 9.7 ZNF185 SCELL ENSG00000147394 "Zinc finger protein 185 with LIM domain" O15231 X 152914442-152973480 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 93.5;esophagus: 67.6" "Cell type enhanced" "Detected in many" 10 "Pancreatic endocrine cells: 42.4;Suprabasal keratinocytes: 18.4;Urothelial cells: 17.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 21.6" "Group enriched" "Detected in many" 5 "granulocytes: 21.6;monocytes: 13.9" "Cell line enhanced" "Detected in many" "A-431: 31.7;EFO-21: 37.7;HBEC3-KT: 26.2;PC-3: 23.2;TIME: 61.8" "Low region specificity" "Detected in all" "HPA000400, HPA016438" Enhanced Supported "Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol" NA NA 5400 "Plasma membrane, Cytosol" "Actin filaments, Focal adhesion sites" "HPA000400: AB_1080685, HPA016438: AB_1859109" "unprognostic (1.34e-1)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (2.43e-2)" "unprognostic (9.75e-3)" "unprognostic (2.69e-1)" "unprognostic (2.49e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (7.94e-2)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.30e-5)" "unprognostic (5.18e-2)" "unprognostic (8.12e-2)" "unprognostic (1.99e-1)" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.60e-1)" 3.9 1.7 1.8 2.0 3.2 0.8 1.8 2.7 2.0 14.3 1.8 1.4 10.7 0.0 3.8 93.5 67.6 3.1 2.0 1.9 1.7 0.8 2.0 1.1 3.3 3.1 2.1 1.1 1.2 0.9 0.1 2.3 4.0 1.7 4.2 0.3 1.3 10.1 28.1 1.5 9.9 1.2 1.4 1.2 3.7 0.8 1.9 2.0 1.2 3.9 1.4 6.6 2.1 22.8 0.4 3.8 21.6 13.9 0.2 0.6 10.2 31.7 6.7 0.6 0.4 0.8 1.1 1.5 1.5 0.1 3.9 0.5 0.2 9.6 0.4 37.7 2.3 0.4 4.5 0.9 26.2 16.3 0.3 0.6 2.0 2.7 1.0 1.9 0.1 0.1 0.8 18.8 0.4 15.4 3.9 20.2 0.4 0.1 0.3 0.1 7.5 0.1 0.1 0.5 8.1 23.2 0.1 0.1 0.2 2.0 3.0 0.2 2.2 0.0 6.0 0.9 6.5 6.2 0.7 61.8 0.2 13.7 0.8 1.1 0.3 0.2 0.2 0.4 2.3 0.4 21.6 13.9 5.7 0.5 12.9 0.3 0.4 0.4 0.6 3.8 0.3 0.6 0.3 9.5 0.2 10.2 2.5 0.5 10.2 1.8 3.2 2.7 2.0 1.7 0.8 2.1 1.1 1.7 2.0 11.9 1.6 0.5 4.9 8.1 0.5 1.0 2.5 2.7 4.5 8.7 2.0 3.2 0.0 8.6 0.2 0.5 0.0 0.0 2.6 4.3 2.8 5.1 1.1 0.0 8.6 0.0 0.0 0.6 8.8 0.0 1.1 4.6 3.3 4.6 2.1 3.0 42.4 0.0 1.1 0.9 0.0 0.0 0.5 2.3 5.3 18.4 0.6 0.0 3.3 17.6 ZNF750 "FLJ13841, Zfp750" ENSG00000141579 "Zinc finger protein 750" Q32MQ0 17 82829435-82840578 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Differentiation, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 59.3;lymphoid tissue: 54.2;skeletal muscle: 84.2" "Cell type enhanced" "Detected in some" 14 "Cytotrophoblasts: 18.3;Suprabasal keratinocytes: 35.9;Syncytiotrophoblasts: 57.0;Urothelial cells: 46.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 5 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 17.4;hTCEpi: 6.4;MCF7: 4.6;SK-BR-3: 13.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021573, HPA023012" Enhanced NA NA "HPA021573: AB_1859438, HPA023012: AB_1859439" "unprognostic (3.46e-3)" "unprognostic (1.94e-2)" "unprognostic (7.51e-2)" "unprognostic (2.63e-1)" "unprognostic (1.45e-1)" "unprognostic (9.73e-2)" "unprognostic (4.48e-2)" "unprognostic (6.55e-3)" "unprognostic (1.34e-1)" "unprognostic (4.33e-2)" "unprognostic (6.30e-3)" "unprognostic (1.23e-2)" "unprognostic (5.30e-3)" "unprognostic (3.04e-2)" "unprognostic (5.94e-2)" "unprognostic (2.04e-1)" "unprognostic (4.25e-2)" 0.4 0.1 0.1 0.1 0.1 0.1 3.0 0.1 0.1 14.0 0.1 0.0 9.0 0.2 0.9 3.8 59.3 0.4 0.2 0.2 0.1 0.1 0.2 0.1 2.3 0.1 0.1 0.0 0.1 0.1 0.6 2.2 19.5 0.0 3.2 0.1 0.0 38.3 13.2 84.2 46.2 0.1 0.4 0.1 0.1 0.1 0.2 0.0 3.4 6.7 44.1 54.2 3.2 16.8 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.0 1.1 1.0 0.0 13.0 0.0 1.5 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 5.1 0.0 13.2 4.6 0.0 0.4 0.0 6.7 10.3 0.0 0.0 18.3 0.0 0.0 1.4 0.6 0.0 0.0 0.0 1.0 0.3 6.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 57.0 0.0 0.0 46.4